Document:

EX-4.2

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 EXHIBIT 4.2 

URBAN COMPASS, INC. 

SEVENTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

July 26, 2019 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 TABLE OF CONTENTS 

 

									
	 	 	 	 	 	  	Page	 
	 1.
	 	 Definitions
	  	 	2	 
			
	 2.
	 	 Registration Rights
	  	 	4	 
		 	 2.1
	 	Request for Registration	  	 	4	 
		 	 2.2
	 	Company Registration	  	 	6	 
		 	 2.3
	 	Form S-3 Registration	  	 	7	 
		 	 2.4
	 	Obligations of the Company	  	 	9	 
		 	 2.5
	 	Information from Holder	  	 	10	 
		 	 2.6
	 	Expenses of Registration	  	 	10	 
		 	 2.7
	 	Delay of Registration	  	 	11	 
		 	 2.8
	 	Indemnification	  	 	11	 
		 	 2.9
	 	Reports Under the 1934 Act	  	 	13	 
		 	 2.10
	 	Assignment of Registration Rights	  	 	14	 
		 	 2.11
	 	Limitations on Priority Registration Rights	  	 	14	 
		 	 2.12
	 	“Market Stand-Off” Agreement	  	 	15	 
		 	 2.13
	 	Termination of Registration Rights	  	 	16	 
			
	 3.
	 	 Covenants of the Company
	  	 	16	 
		 	 3.1
	 	Delivery of Financial Statements	  	 	16	 
		 	 3.2
	 	Inspection	  	 	18	 
		 	 3.3
	 	Termination of Information and Inspection Covenants	  	 	18	 
		 	 3.4
	 	Right of First Offer	  	 	18	 
		 	 3.5
	 	Directors’ and Officers’ Insurance	  	 	20	 
		 	 3.6
	 	Observer Rights	  	 	20	 
		 	 3.7
	 	Committee Representation	  	 	21	 
		 	 3.8
	 	Proprietary Information and Inventions Agreements	  	 	21	 
		 	 3.9
	 	Employee Agreements	  	 	21	 
		 	 3.10
	 	Indemnification Matters	  	 	21	 
		 	 3.11
	 	Confidentiality	  	 	22	 
		 	 3.12
	 	Applicable ABAC/Sanctions/Money Laundering Laws	  	 	23	 
		 	 3.13
	 	Successor Indemnification	  	 	27	 
		 	 3.14
	 	Tax Covenants	  	 	27	 
		 	 3.15
	 	Termination of Certain Covenants	  	 	28	 
			
	 4.
	 	 Miscellaneous
	  	 	29	 
		 	 4.1
	 	Successors and Assigns	  	 	29	 
		 	 4.2
	 	Governing Law	  	 	29	 
		 	 4.3
	 	Counterparts; Facsimile	  	 	29	 
		 	 4.4
	 	Titles and Subtitles	  	 	29	 
		 	 4.5
	 	Notices	  	 	29	 
		 	 4.6
	 	Expenses	  	 	30	 
		 	 4.7
	 	Entire Agreement; Amendments and Waivers	  	 	30	 
		 	 4.8
	 	Severability	  	 	32	 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

									
		 	4.9	 	Aggregation of Stock	  	 	32	 
		 	4.10	 	Additional Investors	  	 	32	 
		 	4.11	 	Massachusetts Business Trust	  	 	32	 

  

			
	SCHEDULE A	  	Schedule of Investors
	SCHEDULE B	  	Schedule of Common Holders

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 SEVENTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

This SEVENTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (the “Agreement”) is made as of the 26th day of July,
2019, by and among URBAN COMPASS, INC., a Delaware corporation (the “Company”), the investors listed on Schedule A hereto, each of which is herein referred to as an “Investor” and collectively as the
“Investors”, and the holders of Common Stock (as defined below) listed on Schedule B hereto, each of which is herein referred to as a “Common Holder” and collectively as the “Common Holders”.

 RECITALS 

WHEREAS, certain of the Investors (the “Existing Investors”) hold shares of the Company’s Series A Preferred
Stock, par value $0.0001 per share (the “Series A Preferred Stock”), shares of the Company’s Series B Preferred Stock, par value $0.0001 per share (the “Series B Preferred
Stock”), shares of the Company’s Series C Preferred Stock, par value $0.0001 per share (the “Series C Preferred Stock”), shares of the Company’s Series D Preferred Stock, par value $0.0001 per share (the
“Series D Preferred Stock”), shares of the Company’s Series E Preferred Stock, par value $0.0001 per share (the “Series E Preferred Stock”), shares of the Company’s Series F
Preferred Stock, par value $0.0001 per share (the “Series F Preferred Stock”) and/or shares of Common Stock, issued upon conversion thereof and possess information rights, rights of first offer and other rights
pursuant to that certain Sixth Amended and Restated Investors’ Rights Agreement dated as of October 22, 2018 by and among the Company and such Existing Investors (the “Prior Agreement”); 

WHEREAS, certain Investors (the “Series G Investors”) are parties to that certain Series G Preferred Stock Purchase
Agreement, dated as of July 25, 2019 (as amended from time to time, the “Series G Agreement”), which provides that, as a condition to the closing of the sale of the Series G Preferred Stock to them, this Agreement must be
executed and delivered by such Series G Investors and the Company; and 
 WHEREAS, to induce the Series G Investors to enter into the
Series G Agreement and purchase shares of the Company’s Series G Preferred Stock, par value $0.0001 per share (the “Series G Preferred Stock”) thereunder, the undersigned, representing the requisite parties necessary to amend
and restate the Prior Agreement, desire to amend and restate the Prior Agreement and to accept the rights created pursuant hereto in lieu of the rights created under the Prior Agreement. 

NOW, THEREFORE, in consideration of the mutual promises and covenants set forth herein, the parties hereto hereby agree that the Prior
Agreement shall be superseded and replaced in its entirety by this Agreement, and further agree as follows: 

  
 1 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 NOW, THEREFORE, THE PARTIES HEREBY AGREE AS FOLLOWS: 

1. Definitions. For purposes of this Agreement: 

(a) The term “Act” means the Securities Act of 1933, as amended. 

(b) The term “Affiliate” means, with respect to (i) any Person, any other Person who or which, directly or indirectly,
controls, is controlled by, or is under common control with such specified Person, including, without limitation, any general partner, managing member, officer, director or manager of such Person and any venture capital or other investment fund now
or hereafter existing that is controlled by one or more general partners or managing members of, or is under common investment management or shares the same investment advisor with, such Person, and (ii) in the case of a Fidelity Investor, an
investment company registered under the Investment Company Act advised or sub-advised by Fidelity or any affiliated investment advisor of Fidelity, one or more mutual funds, pension funds, pooled investment
vehicles or institutional clients advised or sub-advised by Fidelity or any affiliated investment advisor of Fidelity, in each case, registered under the Investment Advisers Act of 1940. For all purposes
hereunder, (A) CLCRKC, LLC shall be deemed to be an “Affiliate” of each of Discovery Global Focus Master Fund, Ltd. and DG URBAN-C LP and (B) each Fidelity Investor shall be deemed to be an
“Affiliate” of each other Fidelity Investor, and an entity that is an “Affiliate” of a Fidelity Investor shall not be deemed to be an “Affiliate” of any other Fidelity Investor unless such entity is a Fidelity Investor
(and, for the avoidance of doubt, an “Affiliate” of such entity shall not be deemed an “Affiliate” of any Fidelity Investor solely by virtue of being an “Affiliate” of such entity). 

(c) The term “Board” means the Company’s Board of Directors, as constituted from time to time. 

(d) The term “business day” means any day that is not a Saturday, a Sunday or other day on which banks are required or
authorized to be closed in the City of New York. 
 (e) The term “Class A Common Stock” means shares of
the Company’s class A common stock, par value $0.0001 per share. 
 (f) The term “Class B Common
Stock” means shares of the Company’s class B common stock, par value $0.0001 per share. 
 (g) The term “Common
Stock” means shares of Class A Common Stock and Class B Common Stock. 
 (h) The term “Fidelity” means
Fidelity Management & Research Company, and any affiliated or successor investment advisor or subadvisor thereof to the Fidelity Investors. 

(i) The term “Fidelity Investors” shall mean those Investors, or permitted transferees of Registrable Securities held by
Fidelity Investors, that are advisory or subadvisory clients of Fidelity. 
 (j) The term “Form S-3” means such form under the Act as in effect on the date hereof or any registration form under the Act subsequently adopted by the SEC that permits inclusion or incorporation of substantial information by
reference to other documents filed by the Company with the SEC. 

  
 2 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (k) The term “Free Writing Prospectus” means a free-writing prospectus, as
defined in Rule 405. 
 (l) The term “Holder” means any Person owning or having the right to acquire Registrable Securities
or any assignee thereof in accordance with Section 2.10 of this Agreement; provided, however, that the Common Holders shall not be deemed to be Holders for purposes of Section 2.11. 

(m) The term “Initial Offering” means the Company’s first firm commitment underwritten public offering of its Common
Stock under the Act. 
 (n) The term “Investment Company Act” means the Investment Company Act of 1940, as amended. 

(o) The term “1934 Act” means the Securities Exchange Act of 1934, as amended. 

(p) The term “Person” shall mean any individual, corporation, partnership, trust, limited liability company, association or
other entity. 
 (q) The term “Preferred Stock” shall have the meaning set forth in the Restated Certificate. 

(r) The term “QIA” shall mean Al Rayyan Holding LLC, a limited liability company organized and existing under the laws of the
Qatar Financial Center, and DIC Company Limited, an exempted company organized and existing under the laws of the Cayman Islands, collectively, together with their Affiliates and permitted transferees of Registrable Securities held by Al Rayyan
Holding LLC and DIC Company Limited and their Affiliates. 
 (s) The terms “register,” “registered,” and
“registration” refer to a registration effected by preparing and filing a registration statement or similar document in compliance with the Act, and the declaration or ordering of effectiveness of such registration statement or
document. 
 (t) The term “Registrable Securities” means (i) the Common Stock issuable or issued upon conversion of the
Company’s Series A Preferred Stock (including all Series A Preferred Stock acquired in connection with the Offer (as defined below)), Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series
F Preferred Stock (the Common Stock issuable or issued upon conversion of the Company’s Series F Preferred Stock, the “Series F Registrable Securities”), and Series G Preferred Stock (the Common Stock issuable or issued upon
conversion of the Company’s Series G Preferred Stock, the “Series G Registrable Securities”), (ii) any shares of the Common Stock held or subsequently acquired by SoftBank, (iii) the Common Stock issued to the Common
Holders; provided, however, that such shares of Common Stock shall not be deemed Registrable Securities for the purposes of Section 2.11, (iv) solely for purposes of Section 3.4, the Common Stock issued upon exercise of those
certain Common Stock Purchase Warrants, dated as of December 13, 2013, issued by the Company to each of Thrive Capital Partners III, L.P. and Claremount TW, L.P., (v) solely for the purposes of Sections 3.4 and 4.7, any shares of the Common
Stock acquired in 

  
 3 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 
connection with that certain Offer to Purchase dated as of May 23, 2017 (such shares, the “Tender Offer Shares”) (such Offer to Purchase, the “Offer”),
provided, that, such Tender Offer Shares shall be deemed Registrable Securities for the purposes of Section 4.7 hereof solely in connection with amendments and waivers of Sections 3.1 and 3.4 hereof, and (vi) any Common Stock of the
Company issued as (or issuable upon the conversion or exercise of any warrant, right or other security that is issued as) a dividend or other distribution with respect to, or in exchange for, or in replacement of, the shares referenced in (i), (ii),
(iii), (iv) or (v) above, excluding in all cases, however, any Registrable Securities sold by a Person in a transaction (a) which is not the acquisition of the Tender Offer Shares in connection with the Offer, and (b) in which such
Person’s rights under Section 2 of this Agreement are not assigned. In addition, the number of shares of Registrable Securities outstanding shall equal the aggregate of the number of shares of Common Stock outstanding that are, and the
number of shares of Common Stock issuable pursuant to then exercisable or convertible securities that are, Registrable Securities. 
 (u) The
term “Restated Certificate” shall mean the Company’s Eleventh Amended and Restated Certificate of Incorporation, as amended and/or restated from time to time. 

(v) The term “Rule 144” shall mean Rule 144 under the Act. 

(w) The term “Rule 144(b)(1)(i)” shall mean subsection (b)(1)(i) of Rule 144 under the Act as it applies to Persons who have
held shares for more than one (1) year. 
 (x) The term “Rule 405” shall mean Rule 405 under the Act. 

(y) The term “SEC” shall mean the Securities and Exchange Commission. 

(z) The term “SoftBank” shall mean SoftBank Vision Fund (AIV M1) L.P. and its Affiliates. 

(aa) The term “Voting Agreement” means the Company’s Seventh Amended and Restated Voting Agreement, as may be amended
and/or restated from time to time. 
 (bb) The term “Wellington” shall mean Wellington Management Company LLP, and any
affiliated or successor investment advisor or subadvisor thereof to the Wellington Investors. 
 (cc) The term “Wellington
Investors” shall mean those Investors, or permitted transferees of Registrable Securities held by Wellington Investors, that are advisory or subadvisory clients of Wellington. 

2. Registration Rights. The Company covenants and agrees as follows: 

2.1 Request for Registration. 

(a) Subject to the conditions of this Section 2.1, if the Company shall receive at any time after the earlier of
(i) July 26, 2023 or (ii) six (6) months after the effective date of the Initial Offering, a written request from the Holders of at least fifty percent (50%) of 

  
 4 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 
the Registrable Securities then outstanding (for purposes of this Section 2.1, the “Initiating Holders”) that the Company file a registration statement under the Act
covering the registration of Registrable Securities with an anticipated aggregate offering price of at least $10,000,000, then the Company shall, within twenty (20) days of the receipt thereof, give written notice of such request to all
Holders, and subject to the limitations of this Section 2.1, as soon as reasonably practicable, and in any event within sixty (60) days after the date such request is given by the Initiating Holders, file a Form S-1 registration statement under the Act covering all Registrable Securities that the Initiating Holders request to be registered and use its commercially reasonable efforts to effect, as soon as practicable after
such filing, the registration under the Act of all Registrable Securities that the Holders request to be registered in a written request received by the Company within twenty (20) days of the mailing of the Company’s notice pursuant to
this Section 2.1(a). 
 (b) If the Initiating Holders intend to distribute the Registrable Securities covered by their request by means
of an underwriting, they shall so advise the Company as a part of their request made pursuant to this Section 2.1, and the Company shall include such information in the written notice referred to in Section 2.1(a). In such event the right
of any Holder to include its Registrable Securities in such registration shall be conditioned upon such Holder’s participation in such underwriting and the inclusion of such Holder’s Registrable Securities in the underwriting (unless
otherwise mutually agreed by a majority in interest of the Initiating Holders and such Holder) to the extent provided herein. All Holders proposing to distribute their securities through such underwriting shall enter into an underwriting agreement
in customary form with the underwriter or underwriters selected for such underwriting by the Company (which underwriter or underwriters shall be reasonably acceptable to those Initiating Holders holding a majority of the Registrable Securities then
held by all Initiating Holders). Notwithstanding any other provision of this Section 2.1, if the underwriter advises the Company that marketing factors require a limitation on the number of securities underwritten (including Registrable
Securities), then the Company shall so advise all Holders of Registrable Securities that would otherwise be underwritten pursuant hereto, and the number of shares that may be included in the underwriting shall be allocated to the Holders of such
Registrable Securities pro rata based on the number of Registrable Securities held by all such Holders (including the Initiating Holders). In no event shall any Registrable Securities be excluded from such underwriting unless all other securities
are first excluded. Any Registrable Securities excluded or withdrawn from such underwriting shall be withdrawn from the registration. 
 (c)
Notwithstanding the foregoing, the Company shall not be required to effect a registration pursuant to this Section 2.1: 
 (i) in any
particular jurisdiction in which the Company would be required to execute a general consent to service of process in effecting such registration, unless the Company is already subject to service in such jurisdiction and except as may be required
under the Act; or 
 (ii) after the Company has effected two (2) registrations pursuant to this Section 2.1, and such
registrations have been declared or ordered effective; or 

  
 5 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (iii) during the period starting with the date sixty (60) days prior to the
Company’s good faith estimate of the date of the filing of and ending on a date one hundred eighty (180) days following the effective date of a Company-initiated registration subject to
Section 2.2 below, provided that the Company is actively employing in good faith its commercially reasonable efforts to cause such registration statement to become effective; or 

(iv) if the Initiating Holders propose to dispose of Registrable Securities that may be registered on
Form S-3 pursuant to Section 2.3 hereof. 
 (d) For purposes of Section 2.1, a
registration shall not be counted as “effected” (i) if, as a result of an exercise of the underwriter’s cutback provisions in Section 2.1(b), fewer than fifty percent (50%) of the total number of Registrable Securities that
Holders have requested to be included in such registration statement are actually included, or (ii) the Holders bear the expenses of such registration as though it were withdrawn at the request of the Holders of a majority of the Registrable
Securities pursuant to Section 2.6. 
 2.2 Company Registration. 

(a) If (but without any obligation to do so) the Company proposes to register (including for this purpose a registration effected by the
Company for stockholders other than the Holders) any of its stock or other securities under the Act in connection with the public offering of such securities (other than (i) a registration relating to a demand pursuant to Section 2.1 of
this Agreement, (ii) a registration relating solely to the sale of securities of participants in a Company stock plan, (iii) a registration relating to a corporate reorganization or transaction under Rule 145 of the Act, (iv) a
registration on any form that does not include substantially the same information as would be required to be included in a registration statement covering the sale of the Registrable Securities, or (v) a registration in which the only Common
Stock being registered is Common Stock issuable upon conversion of debt securities that are also being registered), the Company shall, at such time, promptly give each Holder written notice of such registration. Upon the written request of each
Holder given within twenty (20) days after mailing of such notice by the Company in accordance with Section 4.5 of this Agreement, the Company shall, subject to the provisions of Section 2.2(c) of this Agreement, cause to be
registered under the Act all of the Registrable Securities that each such Holder requests to be registered. 
 (b) Right to Terminate
Registration. The Company shall have the right to terminate or withdraw any registration initiated by it under this Section 2.2 prior to the effectiveness of such registration whether or not any Holder has elected to include securities in
such registration. The expenses of such withdrawn registration shall be borne by the Company in accordance with Section 2.6 hereof. 

(c) Underwriting Requirements. In connection with any offering involving an underwriting of shares of the Company’s capital stock,
the Company shall not be required under this Section 2.2 to include any of the Holders’ securities in such underwriting unless they accept the terms of the underwriting (so long as such terms are customary) as agreed upon between the
Company and the underwriters selected by the Company (or by other Persons entitled to select the underwriters) and enter into an underwriting agreement in customary form 

  
 6 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 
with such underwriters, and then only in such quantity as the underwriters determine in their sole discretion will not jeopardize the success of the offering by the Company. If the total amount
of securities, including Registrable Securities, requested by stockholders to be included in such offering exceeds the amount of securities sold other than by the Company that the underwriters determine in their sole discretion is compatible with
the success of the offering, then the Company shall be required to include in the offering only that number of such securities, including Registrable Securities, that the underwriters determine in their sole discretion will not jeopardize the
success of the offering. In the event that the underwriters determine that less than all of the Registrable Securities requested to be registered can be included in such offering, then the Registrable Securities that are included in such offering
shall be apportioned pro rata among the selling Holders based on the number of Registrable Securities held by all selling Holders or in such other proportions as shall mutually be agreed to by all such selling Holders. Notwithstanding the foregoing,
in no event shall (i) any Registrable Securities be excluded from such offering unless all other stockholders’ securities have been first excluded from the offering, and (ii) the amount of securities of the selling Holders included in
the offering be reduced below thirty percent (30%) of the total amount of securities included in such offering, unless such offering is the Initial Offering, in which case the selling Holders may be excluded if the underwriters make the
determination described above and no other stockholder’s securities are included in such offering. For purposes of the preceding sentence concerning apportionment, for any selling stockholder that is a Holder of Registrable Securities and that
is a venture capital or other investment fund, partnership or corporation, the affiliated venture capital or other investment funds, partners, members, retired partners and stockholders of such Holder, or the estates and family members of any such
partners, members and retired partners and any trusts for the benefit of any of the foregoing Persons shall be deemed to be a single “selling Holder,” and any pro rata reduction with respect to such “selling Holder” shall be
based upon the aggregate amount of Registrable Securities owned by all such related entities and individuals. 
 2.3 Form S-3 Registration. In case the Company shall receive from the Holders of at least thirty percent (30%) of the Registrable Securities (for purposes of this Section 2.3, the “S-3 Initiating Holders”) a written request or requests that the Company effect a registration on Form S-3 and any related qualification or compliance with
respect to all or a part of the Registrable Securities owned by such Holder or Holders, the Company shall: 
 (a) promptly give written
notice of the proposed registration, and any related qualification or compliance, to all other Holders; 
 (b) as soon as reasonably
practicable, and in any event within thirty (30) days after the date such request is given by the S-3 Initiating Holders, file a Form S-3 registration statement
under the Act covering all Registrable Securities that the S-3 Initiating Holders request to be registered; and 

(c) use its commercially reasonable efforts to effect, as soon as practicable following such filing, such registration and all such
qualifications and compliances as may be so requested and as would permit or facilitate the sale and distribution of all or such portion of such Holders’ Registrable Securities as are specified in such request, together with all or such portion
of the Registrable Securities of any other Holders joining in such request as are specified in a written request given within twenty (20) days after receipt of such written notice from the Company; provided, however, that the
Company shall not be obligated to effect any such registration, qualification or compliance, pursuant to this Section 2.3: 

  
 7 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (i) if Form S-3 is not available for such
offering by the Holders; 
 (ii) if the Holders, together with the holders of any other securities of the Company entitled to inclusion in
such registration, propose to sell Registrable Securities and such other securities (if any) at an aggregate price to the public (net of any underwriters’ discounts or commissions) of less than $2,000,000; 

(iii) if the Company has, within the twelve (12) month period preceding the date of such request, already effected two
(2) registrations on Form S-3 pursuant to this Section 2.3; provided that for purposes of Section 2.3, a registration shall not be counted as “effected” if (A), as a result
of an exercise of the underwriter’s cutback provisions in Section 2.2(c), fewer than fifty percent (50%) of the total number of Registrable Securities that Holders have requested to be included in such registration statement are actually
included, or (B) the Holders bear the expenses of such registration as though it were withdrawn at the request of the Holders of a majority of the Registrable Securities pursuant to Section 2.6; 

(iv) in any particular jurisdiction in which the Company would be required to qualify to do business or to execute a general consent to
service of process in effecting such registration, qualification or compliance; 
 (v) if the Company, within thirty (30) days of
receipt of the request of such S-3 Initiating Holders, gives notice to such S-3 Initiating Holders of its bona fide intention to effect the filing of a registration
statement with the SEC within one hundred twenty (120) days of receipt of such request (other than a registration effected solely to qualify an employee benefit plan or to effect a business combination pursuant to Rule 145), provided
that the Company is actively employing in good faith its commercially reasonable efforts to cause such registration statement to become effective; or 

(vi) during the period starting with the date thirty (30) days prior to the Company’s good faith estimate of the date of the filing
of and ending on a date ninety (90) days following the effective date of a Company-initiated registration subject to Section 2.2 of this Agreement, provided that the Company is actively
employing in good faith its commercially reasonable efforts to cause such registration statement to become effective. 
 (d) If the S-3 Initiating Holders intend to distribute the Registrable Securities covered by their request by means of an underwriting, they shall so advise the Company as a part of their request made pursuant to this
Section 2.3 and the Company shall include such information in the written notice referred to in Section 2.3(a). The provisions of Section 2.1(b) of this Agreement shall be applicable to such request (with the substitution of
Section 2.3 for references to Section 2.1 and the substitution of S-3 Initiating Holders for references to Initiating Holders). 

  
 8 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (e) Subject to the foregoing, the Company shall file a registration statement covering the
Registrable Securities and other securities so requested to be registered as soon as practicable after receipt of the request or requests of the S-3 Initiating Holders. Registrations effected pursuant to this
Section 2.3 shall not be counted as requests for registration effected pursuant to Section 2.1 of this Agreement. 
 2.4
Obligations of the Company. Whenever required under this Section 2 to effect the registration of any Registrable Securities, the Company shall, as expeditiously as reasonably possible: 

(a) prepare and file with the SEC a registration statement with respect to such Registrable Securities and use its commercially reasonable
efforts to cause such registration statement to become effective, and, upon the request of the Holders of a majority of the Registrable Securities registered thereunder, keep such registration statement effective for a period of up to one hundred
eighty (180) days or, if earlier, until the distribution contemplated in the registration statement has been completed; 
 (b) prepare
and file with the SEC such amendments and supplements to such registration statement and the prospectus used in connection with such registration statement as may be necessary to comply with the provisions of the Act with respect to the disposition
of all securities covered by such registration statement; 
 (c) furnish to the Holders such number of copies of a prospectus, including a
preliminary prospectus and any Free Writing Prospectus, in conformity with the requirements of the Act, and such other documents as they may reasonably request in order to facilitate the disposition of Registrable Securities owned by them; 

(d) use its commercially reasonable efforts to register and qualify the securities covered by such registration statement under such other
securities or Blue Sky laws of such jurisdictions as shall be reasonably requested by the Holders, provided that the Company shall not be required in connection therewith or as a condition thereto to qualify to do business or to file a
general consent to service of process in any such states or jurisdictions; 
 (e) in the event of any underwritten public offering, enter
into and perform its obligations under an underwriting agreement, in usual and customary form, with the managing underwriter of such offering; 

(f) notify each Holder of Registrable Securities covered by such registration statement at any time when a prospectus or Free Writing
Prospectus (to the extent prepared by or on behalf of the Company) relating thereto is required to be delivered under the Act of the happening of any event as a result of which the prospectus included in such registration statement, as then in
effect, includes an untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading in the light of the circumstances then existing, and, at the request
of any such Holder, the Company will, as soon as reasonably practicable, file and furnish to all such Holders a supplement or amendment to such prospectus or Free Writing Prospectus (to the extent prepared by or on behalf of the Company) so that, as
thereafter delivered to the purchasers of such Registrable Securities, such prospectus will not contain an untrue statement of a material fact or omit to state any fact necessary to make the statements therein not misleading in light of the
circumstances under which they were made; 

  
 9 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (g) cause all such Registrable Securities registered pursuant to this Section 2 to be
listed on a national exchange or trading system and on each securities exchange and trading system on which similar securities issued by the Company are then listed; and 

(h) provide a transfer agent and registrar for all Registrable Securities registered pursuant to this Agreement and a CUSIP number for all
such Registrable Securities, in each case not later than the effective date of such registration. 
 Notwithstanding the provisions of this
Section 2, if the Company shall furnish to all Holders requesting a registration statement pursuant to this Section 2 a certificate signed by the Company’s Chief Executive Officer or Chairman of the Board stating that in the good
faith judgment of the Board, it would be seriously detrimental to the Company and its stockholders for such registration statement to become effected at such time or remain effective for as long as such registration statement would otherwise be
required to remain effective, because such action would (i) materially impede, delay or interfere with any material pending or proposed financing, acquisition, corporate reorganization or other similar transaction involving the Company for
which the Board has authorized negotiations; (ii) materially and adversely impair the consummation of any pending or proposed material offering or sale of any class of securities by the Company; or (iii) require disclosure of material
nonpublic information that, if disclosed at such time, would be materially harmful to the interests of the Company and its stockholders (provided, however, that during any such period all executive officers and directors of the Company
are also prohibited from selling securities of the Company (or any security of any of the Company’s subsidiaries or affiliates)), then the Company shall have the right to postpone or suspend the filing, effectiveness or use of, or trading
under, such registration statement for a period of not more than ninety (90) days after receipt of the request of the Initiating Holders or S-3 Initiating Holders is given; provided that the
Company may not invoke this right more than once in any twelve (12) month period. 
 In the event of the suspension of effectiveness of
any registration statement pursuant to this Section 2.4, the applicable time period during which such registration statement is to remain effective shall be extended by that number of days equal to the number of days the effectiveness of such
registration statement was suspended. 
 2.5 Information from Holder. It shall be a condition precedent to the obligations of the
Company to take any action pursuant to this Section 2 with respect to the Registrable Securities of any selling Holder that such Holder shall furnish to the Company such information regarding itself, the Registrable Securities held by it, and
the intended method of disposition of such securities as shall be reasonably required to effect the registration of such Holder’s Registrable Securities. 

2.6 Expenses of Registration. All expenses other than underwriting discounts and commissions incurred in connection with registrations,
filings or qualifications pursuant to Sections 2.1, 2.2 and 2.3 of this Agreement, including, without limitation, all registration, filing 

  
 10 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 
and qualification fees, printers’ and accounting fees, fees and disbursements of counsel for the Company and the reasonable fees and disbursements of one counsel for the selling Holders (not
to exceed $50,000) shall be borne by the Company. Notwithstanding the foregoing, the Company shall not be required to pay for any expenses of any registration proceeding begun pursuant to Section 2.1 or 2.3 of this Agreement if the registration
request is subsequently withdrawn at the request of the Holders of a majority of the Registrable Securities to be registered (in which case all participating Holders shall bear such expenses pro rata based upon the number of Registrable Securities
that were to be included in the withdrawn registration) unless the Holders of a majority of the Registrable Securities agree to forfeit their right to one registration pursuant to Section 2.1 or Section 2.3, as the case may be;
provided, however, that if at the time of such withdrawal, the Holders have learned of a material adverse change in the condition, business or prospects of the Company from that known to the Holders at the time of their request and
have withdrawn the request with reasonable promptness following disclosure by the Company of such material adverse change, then the Holders shall not be required to pay any of such expenses and shall retain their rights pursuant to Sections 2.1
and 2.3 of this Agreement. 
 2.7 Delay of Registration. No Holder shall have any right to obtain or seek an injunction restraining or
otherwise delaying any such registration as the result of any controversy that might arise with respect to the interpretation or implementation of this Section 2. 

2.8 Indemnification. In the event any Registrable Securities are included in a registration statement under this Section 2: 

(a) To the extent permitted by law, the Company will indemnify and hold harmless each Holder, the partners, members, officers, directors and
stockholders of each Holder, legal counsel, accountants and investment advisors for each Holder, any underwriter (as defined in the Act) for such Holder and each Person, if any, who controls such Holder or underwriter within the meaning of the Act
or the 1934 Act, against any losses, claims, damages or liabilities (joint or several) to which they may become subject under the Act, the 1934 Act, any state securities laws or any rule or regulation promulgated under the Act, the 1934 Act or any
state securities laws, insofar as such losses, claims, damages, or liabilities (or actions or proceedings, whether commenced or threatened, in respect thereof) arise out of or are based upon any of the following statements, omissions or violations
(collectively, a “Violation”): (i) any untrue or alleged untrue statement of a material fact contained in such registration statement, including any preliminary prospectus, final prospectus, or Free Writing Prospectus contained
therein or any amendments or supplements thereto, any issuer information (as defined in Rule 433 of the Act) filed or required to be filed pursuant to Rule 433(d) under the Act or any other document incident to such registration prepared by or on
behalf of the Company or used or referred to by the Company, (ii) the omission or alleged omission of a material fact required to be stated in such registration statement, or necessary to make the statements therein not misleading or
(iii) any violation or alleged violation by the Company of the Act, the 1934 Act, any state securities laws or any rule or regulation promulgated under the Act, the 1934 Act or any state securities laws, and the Company will reimburse each such
Holder, underwriter, controlling Person or other aforementioned Person for any legal or other expenses reasonably incurred by them in connection with investigating or defending any such loss, claim, damage, liability, action or proceeding as such
expenses are incurred; provided, however, that the 

  
 11 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 
indemnity agreement contained in this Section 2.8(a) shall not apply to amounts paid in settlement of any such loss, claim, damage, liability, action or proceeding if such settlement is
effected without the consent of the Company (which consent shall not be unreasonably withheld), nor shall the Company be liable in any such case for any such loss, claim, damage, liability, action or proceeding to the extent that it arises out of or
is based upon a Violation that occurs in reliance upon, and in conformity with, written information furnished expressly for use in connection with such registration by any such Holder, underwriter, controlling Person or other aforementioned Person.

 (b) To the extent permitted by law, each selling Holder, severally and not jointly, will indemnify and hold harmless the Company, each of
its directors, each of its officers who has signed the registration statement, each Person, if any, who controls the Company within the meaning of the Act, legal counsel and accountants for the Company, any underwriter, any other Holder selling
securities in such registration statement and any controlling Person of any such underwriter or other Holder, against any losses, claims, damages or liabilities (joint or several) to which any of the foregoing Persons may become subject, under the
Act, the 1934 Act, any state securities laws or any rule or regulation promulgated under the Act, the 1934 Act or any state securities laws, insofar as such losses, claims, damages or liabilities (or actions or proceedings, whether commenced or
threatened, in respect thereof) arise out of or are based upon any Violation, in each case to the extent (and only to the extent) that such Violation occurs in reliance upon and in conformity with written information furnished by such Holder
expressly for use in connection with such registration; and each such Holder will reimburse any Person intended to be indemnified pursuant to this Section 2.8(b) for any legal or other expenses reasonably incurred by such Person in connection
with investigating or defending any such loss, claim, damage, liability, action or proceeding as such expenses are incurred; provided, however, that the indemnity agreement contained in this Section 2.8(b) shall not apply to
amounts paid in settlement of any such loss, claim, damage, liability, action or proceeding if such settlement is effected without the consent of the Holder (which consent shall not be unreasonably withheld), and provided that in no event
shall any indemnity under this Section 2.8(b), when combined with any amounts paid or payable by such Holder pursuant to Section 2.8(d), exceed the net proceeds from the offering received by such Holder. 

(c) Promptly after receipt by an indemnified party under this Section 2.8 of notice of the commencement of any action or proceeding
(including any governmental action or proceeding) for which a party may be entitled to indemnification, such indemnified party will, if a claim in respect thereof is to be made against any indemnifying party under this Section 2.8, deliver to
the indemnifying party a written notice of the commencement thereof and the indemnifying party shall have the right to participate in and, to the extent the indemnifying party so desires, jointly with any other indemnifying party similarly noticed,
to assume the defense thereof with counsel mutually satisfactory to the parties; provided, however, that an indemnified party (together with all other indemnified parties that may be represented without conflict by one counsel) shall
have the right to retain one (1) separate counsel, with the fees and expenses to be paid by the indemnifying party, if representation of such indemnified party by the counsel retained by the indemnifying party would be inappropriate due to
actual or potential differing interests between such indemnified party and any other party represented by such counsel in such proceeding. The failure to deliver written notice to the indemnifying party within a reasonable time of the commencement
of any such action or proceeding, if materially 

  
 12 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 
prejudicial to its ability to defend such action or proceeding, shall relieve such indemnifying party of liability to the indemnified party under this Section 2.8 to the extent of such
material prejudice, but the omission to so deliver written notice to the indemnifying party will not relieve such indemnifying party of any liability that it may have to any indemnified party otherwise than under this Section 2.8. 

(d) If the indemnification provided for in this Section 2.8 is held by a non-appealable order
from a court of competent jurisdiction to be unavailable to an indemnified party with respect to any loss, liability, claim, damage or expense referred to herein, then the indemnifying party, in lieu of indemnifying such indemnified party hereunder,
shall contribute to the amount paid or payable by such indemnified party as a result of such loss, liability, claim, damage or expense in such proportion as is appropriate to reflect the relative fault of the indemnifying party on the one hand and
the indemnified party on the other hand in connection with the statements or omissions that resulted in such loss, liability, claim, damage or expense, as well as any other relevant equitable considerations; provided, however, that
(i) no contribution by any Holder, when combined with any amounts paid by such Holder pursuant to Section 2.8(b), shall exceed the net proceeds from the offering received by such Holder and (ii) no Person guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the Act) will be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation; and provided further that in no event shall a
Holder’s liability pursuant to this Section 2.8(d), when combined with the amounts paid or payable by such Holder pursuant to Section 2.8(b), exceed the proceeds from the offering received by such Holder (net of any expenses paid by
such Holder). The relative fault of the indemnifying party and the indemnified party shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to
state a material fact relates to information supplied by the indemnifying party or by the indemnified party and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission.

 (e) Notwithstanding the foregoing, to the extent that the provisions on indemnification and contribution contained in the underwriting
agreement entered into in connection with the underwritten public offering are in conflict with the foregoing provisions, the provisions in the underwriting agreement shall control. 

(f) The obligations of the Company and Holders under this Section 2.8 shall survive the completion of any offering of Registrable
Securities in a registration statement under this Section 2 and otherwise. 
 2.9 Reports Under the 1934 Act. With a view to
making available to the Holders the benefits of Rule 144 and any other rule or regulation of the SEC that may at any time permit a Holder to sell securities of the Company to the public without registration or pursuant to a registration on Form
S-3, the Company agrees to: 
 (a) make and keep adequate current public information available, as
those terms are understood and defined in Rule 144, at all times after the effective date of the Initial Offering; 

  
 13 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (b) file with the SEC in a timely manner all reports and other documents required of the
Company under the Act and the 1934 Act; and 
 (c) furnish to any Holder, so long as the Holder owns any Registrable Securities, forthwith
upon request (i) a written statement by the Company that it has complied with the reporting requirements of Rule 144 (at any time after ninety (90) days after the effective date of the first registration statement filed by the
Company), the Act and the 1934 Act (at any time after it has become subject to such reporting requirements), or that it qualifies as a registrant whose securities may be resold pursuant to Form S-3 (at
any time after it so qualifies), (ii) a copy of the most recent annual or quarterly report of the Company and such other reports and documents so filed by the Company and (iii) such other information as may be reasonably requested to avail
any Holder of any rule or regulation of the SEC that permits the selling of any such securities without registration or pursuant to such form. 

2.10 Assignment of Registration Rights. The rights to cause the Company to register Registrable Securities pursuant to this
Section 2 may be assigned (but only with all related obligations) by a Holder to a transferee or assignee of such securities that (a) is an Affiliate, subsidiary, parent, partner, limited partner, retired partner, member or stockholder of
a Holder, (b) is a Holder’s family member or trust for the benefit of an individual Holder, or (c) after such assignment or transfer, holds at least two hundred fifty thousand (250,000) shares of Registrable Securities (appropriately
adjusted for any stock split, dividend, combination or other recapitalization) or, if less, all of the Registrable Securities held by such Holder; provided: (i) the Company is, within a reasonable time after such transfer, furnished with
written notice of the name and address of such transferee or assignee and the securities with respect to which such registration rights are being assigned; (ii) such transferee or assignee agrees in writing to be bound by and subject to the
terms and conditions of this Agreement, including, without limitation, the provisions of Section 2.12 of this Agreement; and (iii) such assignment shall be effective only if immediately following such transfer the further disposition of
such securities by the transferee or assignee is restricted under the Act. 
 2.11 Limitations on Priority Registration Rights. From
and after the date of this Agreement, the Company shall not, without the prior written consent of the Preferred Majority (as defined in the Restated Certificate), whether by amendment of this Agreement or otherwise, enter into any agreement with any
holder or prospective holder of any securities of the Company that would provide to such holder or prospective holder the right to include securities in any registration on other than either a pro rata basis with respect to the Common Stock
(a) issuable or issued upon conversion of such series of Preferred Stock or (b) issued as (or issuable upon the conversion or exercise of any warrant, right or other security that is issued as) a dividend or other distribution with respect
to, or in exchange for, or in replacement of the shares referenced in (a), or on a subordinate basis after all Holders of such series of Preferred Stock have had the opportunity to include in the registration and offering all shares of Registrable
Securities that they wish to so include; provided, that additional Investors purchasing Preferred Stock after the date hereof may be added as Investors in accordance with Section 4 hereof. 

  
 14 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 2.12 “Market
Stand-Off” Agreement. 
 (a) Each Holder hereby agrees that it will not,
without the prior written consent of the managing underwriter, during the period commencing on the date of the final prospectus relating to the Initial Offering and ending on the date specified by the Company and the managing underwriter (such
period not to exceed one hundred eighty (180) days) (the “Lock-Up Period”) (i) lend, offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any
option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock
held immediately prior to the effectiveness of the registration statement for the Initial Offering, or (ii) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership
of the Common Stock, whether any such transaction described in clause (i) or (ii) above is to be settled by delivery of Common Stock or other securities, in cash or otherwise. The foregoing provisions of this Section 2.12 shall apply
only to the Initial Offering, shall not apply to the sale of any shares to an underwriter pursuant to an underwriting agreement, shall not apply to shares acquired in the Initial Offering or in the open market following the Initial Offering, and
shall only be applicable to the Holders if all executive officers and directors of the Company and greater than one percent (1%) of the Company’s outstanding Common Stock (after giving effect to conversion into Common Stock of all outstanding
Preferred Stock and all other securities exchangeable or convertible into shares of Common Stock) (each, a “1% Stockholder”) are subject to the same restrictions. The underwriters in connection with the Initial Offering are intended
third-party beneficiaries of this Section 2.12 and shall have the right, power and authority to enforce the provisions hereof as though they were a party hereto. Each Holder further agrees to execute such
agreements as may be reasonably requested by the underwriters in the Initial Offering that are consistent with this Section 2.12 or that are necessary to give further effect thereto. 

If, prior to the expiration of the Lock-Up Period, the underwriters consent to the release of any
securities held by any executive officers or directors of the Company or 1% Stockholders from the restrictions set forth in this Section 2.12 (any such release, a “Triggering Release” and, such parties receiving such release,
the “Triggering Release Parties”), then a number of the securities held by each Investor who is a Major Investor (as defined below) on the date hereof, or who becomes a Major Investor by virtue of its purchase of Series G Preferred
Stock pursuant to the Series G Agreement, in either case, regardless of whether such Investor fails to hold a sufficient number of shares of Registrable Securities to constitute a “Major Investor” hereunder at any point in the future (each
such Investor, a “Lock-Up Major Investor”) shall also be released from the restrictions set forth in this Section 2.12, such number of securities being the total number of securities held
by such Lock-Up Major Investor on the date of the Triggering Release multiplied by a fraction, the numerator of which shall be the number of securities released pursuant to the Triggering Release and the
denominator of which shall be the total number of securities held by the Triggering Release Parties on such date. 
 In the event of any
conflict between the provisions of this Section 2.12 and Section 10.3 (or such other section providing for a lock-up) of the Company’s Amended and Restated Bylaws, as they may be amended from
time to time, the provisions of this Section 2.12 shall govern with respect to the Holders. 

  
 15 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 In order to enforce the foregoing covenant, the Company may impose stop-transfer instructions with respect to the Registrable Securities of each Holder (and the shares or securities of every other Person subject to the foregoing restriction) until the end of such period. 

(b) Each Holder agrees that a legend reading substantially as follows shall be placed on all certificates representing all shares or
securities of the Company of each Holder (and the shares or securities of every other Person subject to the restriction contained in this Section 2.12): 

THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO A LOCK-UP PERIOD AFTER THE EFFECTIVE DATE
OF THE ISSUER’S REGISTRATION STATEMENT FILED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AS SET FORTH IN AN AGREEMENT BETWEEN THE COMPANY AND THE ORIGINAL HOLDER OF THESE SECURITIES, A COPY OF WHICH MAY BE OBTAINED AT THE ISSUER’S
PRINCIPAL OFFICE. SUCH LOCK-UP PERIOD IS BINDING ON TRANSFEREES OF THESE SHARES. 
 2.13
Termination of Registration Rights. No Holder shall be entitled to exercise any right provided for in this Section 2: (a) after five (5) years following the consummation of the Initial Offering, (b) as to any Holder, such time
after the Initial Offering at which such Holder holds one percent (1%) or less of the Company’s outstanding Common Stock and all Registrable Securities held by such Holder (together with any Affiliate of the Holder with whom such Holder must
aggregate its sales under Rule 144) can be sold in any three (3) month period without registration in compliance with Rule 144 or (c) after the consummation of a Liquidation Event, as that term is defined in the Restated
Certificate, excluding a Liquidation Event of the nature described in Article IV(B), subsection 2(e)(i)(E) of the Restated Certificate. 
 3.
Covenants of the Company. 
 3.1 Delivery of Financial Statements. 

(a) The Company shall deliver to (A) each Investor (or transferee of an Investor) that holds at least 250,000 shares of Registrable
Securities (appropriately adjusted for any stock split, dividend, combination or other recapitalization), and (B) QIA for as long as it holds any shares of Registrable Securities (each party referenced in (A) and (B), a “Major
Investor”): 
 (i) as soon as practicable, but in any event within ninety (90) days after the end of each fiscal year of the
Company, an income statement for such fiscal year, a balance sheet of the Company and statement of stockholders’ equity as of the end of such year, and a statement of cash flows for such year, such
year-end financial reports to be in reasonable detail, prepared in accordance with generally accepted accounting principles (“GAAP”), and audited and certified by independent public
accountants of nationally recognized standing selected by the Company; 

  
 16 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (ii) as soon as practicable, but in any event within forty-five (45) days after the end
of each fiscal year of the Company, an unaudited income statement for such fiscal year, an unaudited balance sheet of the Company and unaudited statement of stockholders’ equity as of the end of such year, and an unaudited statement of cash
flows for such year, such year-end financial reports to be in reasonable detail, prepared in accordance with GAAP (except that such financial statements may (A) be subject to normal year-end audit adjustments and (B) not contain all notes thereto that may be required in accordance with GAAP); 

(iii) as soon as practicable, but in any event within forty-five (45) days after the end of each quarter of each fiscal year of the
Company, an unaudited income statement and statement of cash flows for such fiscal quarter and an unaudited balance sheet and a statement of stockholders’ equity as of the end of such fiscal quarter, all prepared in accordance with GAAP (except
that such financial statements may (A) be subject to normal year-end audit adjustments and (B) not contain all notes thereto that may be required in accordance with GAAP); 

(iv) as soon as practicable, but in any event at least thirty (30) days prior to the end of each fiscal year, a budget and business plan
for the next fiscal year, prepared on a monthly basis, including balance sheets, income statements and statements of cash flows for such months and, as soon as prepared, any other budgets or revised budgets prepared by the Company; 

(v) as soon as practicable, but in any event within forty-five (45) days after the end of each fiscal quarter of the Company, a statement
showing the number of shares of each class and series of capital stock and securities convertible into or exercisable for shares of capital stock outstanding at the end of the period, the Common Stock issuable upon conversion or exercise of any
outstanding securities convertible or exercisable for Common Stock and the exchange ratio or exercise price applicable thereto, and the number of shares of issued stock options and stock options not yet issued but reserved for issuance, if any, all
in sufficient detail as to permit the Major Investors to calculate their respective percentage equity ownership in the Company; 
 (vi) such
other information relating to the financial condition, business or corporate affairs of the Company as the Major Investor may from time to time request; provided, however, that the Company shall not be obligated under this
subsection (vi) to provide information if (a) access to such information would reasonably be expected to adversely affect the attorney-client privilege between the Company and its counsel, (b) it deems such information reasonably and
in good faith to be trade secrets or similar confidential information (unless covered by an enforceable confidentiality agreement, in form acceptable to the Company), or (c) the Board determines in good faith that the provision of such
information would adversely affect the Company with respect to a transaction, the primary purpose of which is not to raise capital for the Company, to which both the Company and the requesting Major Investor are, or may reasonably become, parties.

  
 17 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (b) Notwithstanding anything else in this Section 3.1 to the contrary, the Company may
cease providing the information set forth in this Section 3.1 during the period starting with the date thirty (30) days before the Company’s good-faith estimate of the date of filing of a registration statement if it reasonably
concludes it must do so to comply with the SEC rules applicable to such registration statement and related offering; provided that the Company’s covenants under this Section 3.1 shall be reinstated at such time as the Company is no
longer actively employing its commercially reasonable efforts to cause such registration statement to become effective. 
 3.2
Inspection. The Company shall permit each Major Investor, at such Major Investor’s expense, to visit and inspect the Company’s properties, to examine its books of account and records and to discuss the Company’s affairs,
finances and accounts with its officers, all at such reasonable times as may be requested by the Major Investor; provided, however, that the Company shall not be obligated pursuant to this Section 3.2 to provide access to any
information (a) if access to such information would reasonably be expected to adversely affect the attorney-client privilege between the Company and its counsel, (b) it deems such information reasonably and in good faith to be trade
secrets or similar confidential information (unless covered by an enforceable confidentiality agreement, in form acceptable to the Company), or (c) if the Board (or a duly designated special committee thereof) determines in good faith that the
provision of access to such information would adversely affect the Company with respect to a transaction, the primary purpose of which is not to raise capital for the Company, to which both the Company and the requesting Major Investor are, or may
reasonably become, parties. 
 3.3 Termination of Information and Inspection Covenants. The covenants set forth in Sections 3.1
and 3.2 shall terminate and be of no further force or effect upon the earliest to occur of (a) the consummation of the Initial Offering, (b) when the Company first becomes subject to the periodic reporting requirements of
Sections 12(g) or 15(d) of the 1934 Act, whichever event shall first occur and (c) the consummation of a Liquidation Event, as that term is defined in the Restated Certificate, excluding a Liquidation Event of the nature described in
Article IV(B), subsection 2(e)(i)(E) of the Restated Certificate. 
 3.4 Right of First Offer. Subject to the terms and conditions
specified in this Section 3.4, the Company hereby grants to each Major Investor a right of first offer with respect to future sales by the Company of its Shares (as hereinafter defined). For purposes of this Section 3.4, the term
“Major Investor” includes any general partners and Affiliates of a Major Investor. A Major Investor shall be entitled to apportion the right of first offer hereby granted it among itself and its partners and Affiliates in such
proportions as it deems appropriate. Each time the Company proposes to offer any shares of, or securities convertible into or exchangeable or exercisable for any shares of, its capital stock (“Shares”), the Company shall first make
an offering of such Shares to each Major Investor in accordance with the following provisions:  

(a) The Company shall deliver a notice in accordance with Section 4.5 (“Notice”) to the Major Investors stating
(i) its bona fide intention to offer such Shares, (ii) the number of such Shares to be offered and (iii) the price and terms upon which it proposes to offer such Shares. 

  
 18 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (b) By written notification received by the Company within twenty (20) calendar days
after the giving of Notice, each Major Investor may elect to purchase, at the price and on the terms specified in the Notice, up to that portion of such Shares that equals the proportion that the number of shares of Common Stock that are Registrable
Securities issued and held by such Major Investor (assuming full conversion and exercise of all convertible and exercisable securities then outstanding) bears to the total number of shares of Common Stock of the Company then outstanding (assuming
full conversion and exercise of all convertible and exercisable securities then outstanding). At the expiration of such twenty (20) calendar day period, the Company shall promptly, in writing, notify each Major Investor that elects to purchase
all the shares available to it (a “Fully-Exercising Investor”) of any other Major Investor’s failure to do likewise. During the ten (10) calendar day period commencing after the Company has given such notice to the
Fully-Exercising Investors, subject, in the case of each of SoftBank and QIA, to the Ownership Cap (as defined below), each Fully-Exercising Investor may elect to purchase that portion of the Shares for which
Major Investors were entitled to subscribe, but which were not subscribed for by the Major Investors, that is equal to the proportion that the number of shares of Registrable Securities issued and held by such
Fully-Exercising Investor bears to the total number of shares of Registrable Securities held by all Fully-Exercising Investors desiring to purchase such unsubscribed Shares. 

(c) If all Shares that Major Investors are entitled to obtain pursuant to Section 3.4(b) of this Agreement are not elected to be obtained
as provided in Section 3.4(b) of this Agreement, the Company may, during the ninety (90) day period following the expiration of the period provided in Section 3.4(b) of this Agreement, offer the remaining unsubscribed portion of such
Shares to any Person or Persons at a price not less than that, and upon terms no more favorable to the offeree than those, specified in the Notice. If the Company does not enter into an agreement for the sale of the Shares within such period, or if
such agreement is not consummated within sixty (60) days of the execution thereof, the right provided hereunder shall be deemed to be revived and such Shares shall not be offered unless first reoffered to the Major Investors in accordance
herewith. 
 (d) The right of first offer in this Section 3.4 shall not be applicable to (i) Excluded Issuances (as defined in the
Restated Certificate), or (ii) the issuance and sale of Series G Preferred Stock pursuant to the Series G Agreement. In addition to the foregoing, the right of first offer in this Section 3.4 shall not be applicable with respect to any
Major Investor in any subsequent offering of Shares if (i) at the time of such offering, the Major Investor is not an “accredited investor,” as that term is then defined in Rule 501(a) of the Act and (ii) such offering of Shares
is otherwise being offered only to accredited investors. 
 (e) The rights provided in this Section 3.4 may not be assigned or
transferred by any Major Investor; provided, however, that a Major Investor that is a venture capital or other investment fund may assign or transfer such rights to its Affiliates. 

(f) Notwithstanding the foregoing or anything to the contrary set forth in this Section 3.4, neither SoftBank nor QIA shall be permitted
to purchase Shares pursuant to the last sentence of Section 3.4(b) or assign its rights to purchase Shares pursuant to the proviso of Section 3.4(e) during such time when (and only to the extent that) (i) SoftBank and its Affiliates
or QIA, as applicable, meet or exceed the Ownership Cap (as defined below) or (ii) such acquisition of Shares would cause SoftBank and its Affiliates or QIA, as applicable, to exceed the Ownership Cap; provided, however, that, for
the avoidance of doubt, SoftBank (and 

  
 19 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 
its Affiliates, if applicable) and QIA, as applicable, shall be permitted to purchase up to that number of Shares pursuant to the last sentence of Section 3.4(b) and the proviso of
Section 3.4(e) that would allow SoftBank and its Affiliates or QIA, as applicable, to hold an aggregate number of shares of the Company’s voting capital stock, following such purchase, equal to the Ownership Cap. For purposes of this
Agreement, the “Ownership Cap” shall mean then-outstanding shares of voting capital stock of the Company representing forty percent (40%) of the voting power of all outstanding shares of voting capital stock of the Company. For the
avoidance of doubt, the Ownership Cap shall be calculated separately with respect to SoftBank and QIA. 
 (g) The covenants set forth in
this Section 3.4 shall terminate and be of no further force or effect upon the consummation of (i) the Initial Offering or (ii) a Liquidation Event, as that term is defined in the Restated Certificate, excluding a Liquidation Event of
the nature described in Article IV(B), subsection 2(e)(i)(E) of the Restated Certificate. 
 (h) For purposes of this Section 3.4, all
references to the “Company” shall mean the Company and any Controlled Subsidiary (as defined below), and the provisions of Section 3.4 shall apply mutatis mutandis to the issuance of any Shares of a Controlled Subsidiary; provided,
however, that, for the avoidance of doubt, no issuance of Shares by a Controlled Subsidiary to the Company (or a parent thereof) shall be subject to this Section 3.4. “Controlled Subsidiary” means any subsidiary which is
wholly-owned by the Company or which the Company directly or indirectly controls. 
 3.5 Directors’ and
Officers’ Insurance. The Company has as of the date hereof obtained from financially sound and reputable insurers directors and officers liability insurance in an amount and on terms and conditions satisfactory to the Board,
including the Series E Director (as defined in the Restated Certificate), and will use its commercially reasonable efforts to cause such insurance policy to be maintained until such time as the Board, including the Series E Director, determines that
such insurance should be discontinued. 
 3.6 Observer Rights. 

(a) For so long as SoftBank owns at least 1,667,205 shares of Preferred Stock (as adjusted for stock splits, stock dividends, combinations,
recapitalizations or the like) or an equivalent amount of Common Stock issued upon conversion thereof, the Company shall invite a representative of SoftBank (each such representative, a “SoftBank Board Observer”), who shall
initially be Hatim Sukhla, to attend all meetings of its Board in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents and other materials that it provides to its directors;
provided, however, that such representative shall agree to hold in confidence all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such
representative from any meeting or portion thereof if access to such information or attendance at such meeting (a) would adversely affect the attorney-client privilege between the Company and its counsel
or (b) would result in disclosure of trade secrets to such representative or a conflict of interest. Any SoftBank Board Observer shall be required to enter into a confidentiality agreement with the Company prior to the exercise of the rights
contained in this Section 3.6(a). 

  
 20 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (b) For so long as QIA owns at least 250,000 shares of Preferred Stock (as adjusted for
stock splits, stock dividends, combinations, recapitalizations or the like) or an equivalent amount of Common Stock issued upon conversion thereof, the Company shall invite a representative of QIA (each such representative, a “QIA Board
Observer”), to attend all meetings of its Board in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents and other materials that it provides to its directors;
provided, however, that such representative shall agree to hold in confidence all information so provided; and provided further, that the Company reserves the right to withhold any information or portion thereof and to
exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting (a) would adversely affect the attorney-client privilege between the Company and
its counsel or (b) would result in disclosure of trade secrets to such representative (c) would represent a conflict of interest or (d) would result in the disclosure of sensitive personal information of U.S. Persons. Any QIA Board
Observer shall be required to enter into a reasonable and customary confidentiality agreement with the Company prior to the exercise of the rights contained in this Section 3.6(b). 

3.7 Committee Representation. The Company shall allow the Series E Director to serve on any and all committees of the Board. 

3.8 Proprietary Information and Inventions Agreements. The Company shall require all employees and consultants with access to
confidential information to execute and deliver a Proprietary Information and Inventions Agreement in substantially the form approved by the Board or a consulting agreement containing substantially similar proprietary rights assignment and
confidentiality provisions. 
 3.9 Employee Agreements. Unless approved by the Board, all future employees of the Company who shall
purchase, or receive options to purchase, shares of Common Stock following the date hereof shall be required to execute stock purchase or option agreements providing for (a) vesting of shares over a four (4) year period with the first
twenty five percent (25%) of such shares vesting following twelve (12) months of continued employment or services, and the remaining shares vesting in equal monthly installments over the following thirty six (36) months thereafter and
(b) a one hundred and eighty (180)-day lockup period in connection with the Initial Offering. The Company shall retain a right of first refusal on transfers of shares issued pursuant to the exercise of
such options until the Initial Offering and the right to repurchase unvested shares at cost. 
 3.10 Indemnification Matters. The
Company hereby acknowledges that one (1) or more of the directors nominated to serve on the Board by the Investors (each a “Fund Director”) may have certain rights to indemnification, advancement of expenses and/or insurance
provided by one or more of the Investors and certain of their affiliates (collectively, the “Fund Indemnitors”). The Company hereby agrees (a) that it is the indemnitor of first resort (i.e., its obligations to any such Fund
Director are primary and any obligation of the Fund Indemnitors to advance expenses or to provide indemnification for the same expenses or liabilities incurred by such Fund Director are secondary), (b) that it shall be required to advance the full
amount of expenses incurred by such Fund Director and shall be liable for the full amount of all expenses, judgments, penalties, fines and amounts paid in settlement by or on behalf of any such Fund Director to the extent legally permitted and as
required by the Restated Certificate or Bylaws of 

  
 21 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 
the Company (or any agreement between the Company and such Fund Director), without regard to any rights such Fund Director may have against the Fund Indemnitors, and, (c) that it irrevocably
waives, relinquishes and releases the Fund Indemnitors from any and all claims against the Fund Indemnitors for contribution, subrogation or any other recovery of any kind in respect thereof. The Company further agrees that no advancement or payment
by the Fund Indemnitors on behalf of any such Fund Director with respect to any claim for which such Fund Director has sought indemnification from the Company shall affect the foregoing and the Fund Indemnitors shall have a right of contribution
and/or be subrogated to the extent of such advancement or payment to all of the rights of recovery of such Fund Director against the Company. 

3.11 Confidentiality. Each Investor agrees, severally and not jointly, to use the same degree of care, but no less than a commercially
reasonable degree of care, as such Investor uses with respect to information of a similar nature about other companies in which such Investor invests for any information obtained pursuant to this Agreement or otherwise as a stockholder of the
Company which the Company identifies in writing as being proprietary or confidential and such Investor acknowledges that it will not, unless otherwise required by law or the rules of any national securities exchange, association or marketplace,
disclose such information without the prior written consent of the Company except such information that (a) was in the public domain prior to the time it was furnished to such Investor, (b) is or becomes (through no willful improper action
or inaction by such Investor) generally available to the public, (c) was in its possession or known by such Investor without restriction prior to receipt from the Company, (d) was rightfully disclosed to such Investor by a third party
without restriction or (e) was independently developed without any use of the Company’s confidential information. Notwithstanding the foregoing, each Investor may disclose such proprietary or confidential information to (i), if such
Investor is a limited partnership or limited liability company, corporation, limited company or similar entity, any Affiliate, former partners or members who retained an economic interest in such Investor, current or prospective partner of the
partnership or any subsequent partnership under common investment management, limited partner, general partner, member, management company or investment advisor of such Investor (or any employee or representative of any of the foregoing), (ii) legal
counsel, accountants or other representatives for such Investor who are bound by reasonable and customary nondisclosure agreements or other confidentiality obligations, or (iii) lenders or prospective lenders if a nondisclosure agreement is in
place with such lender or prospective lender (each of the foregoing Persons, a “Permitted Disclosee”). Furthermore, nothing contained herein shall prevent any Investor or any Permitted Disclosee from (i) entering into any
business, entering into any agreement with a third party, or investing in or engaging in investment discussions with any other company (whether or not competitive with the Company), provided that such Investor or Permitted Disclosee does not,
except as permitted in accordance with this Section 3.11, disclose or otherwise make use of any proprietary or confidential information of the Company in connection with such activities, or (ii) making any disclosures required by law,
rule, regulation or court or other governmental order, including, without limitation, with respect to any Investor that is a registered investment company within the meaning of the Investment Company Act or an Affiliate thereof (each, a
“Regulated Investor”), disclosures consistent with such Regulated Investor’s required investment reporting practices. Additionally, and notwithstanding any provision to the contrary in this Section 3.11, unless required by
law, rule, regulation or court or other governmental order, including, without limitation, with respect to any Regulated Investor, 

  
 22 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 
disclosures consistent with such Regulated Investor’s required investment reporting practices, in no event shall any Investor (or the Permitted Disclosees of such Investor), without the
written consent of the Company, disclose, either publicly or to any third party who is not a Permitted Disclosee (A) the price such Investor paid for any capital stock of the Company held by such Investor, (B) the value such Investor
attributes to such capital stock or any portion of its investment in the Company, or (C) any component of the analysis such Investor developed or reviewed in determining such value ((A) through (C) of the foregoing sentence, the
“Restricted Information”). Each Investor shall be responsible for the disclosure of any Restricted Information by its Permitted Disclosees or any Person to whom such Investor disclosed such Restricted Information in breach of the
preceding sentence. Each Investor (other than a Regulated Investor with respect to disclosures consistent with such Regulated Investor’s required investment reporting practices) represents and warrants that it is not currently required by law,
rule, regulation or court or other governmental order to disclose Restricted Information publicly, and each Investor covenants and agrees that such Investor shall not Transfer (as defined in the Company’s Amended and Restated Bylaws) any
securities of the Company to any Affiliate that would be legally compelled to publicly disclose Restricted Information without the Company’s prior written consent, except that a Regulated Investor may Transfer securities of the Company to any
Affiliate that is required to make similar disclosures consistent with such Regulated Investor’s required investment reporting practices. 

3.12 Applicable ABAC/Sanctions/Money Laundering Laws. 

(a) For the purposes of this Section 3.12 of this Agreement: 

(i) “Affiliate” means, in relation to the Company, a direct or indirect subsidiary of the Company, a holding company of the
Company and any other subsidiary of that holding company. 
 (ii) “Applicable ABAC Laws” means all US federal, state and
local laws, regulations, orders and/or official government requirements, including all laws, regulations, orders or official government requirements of any branch of the US federal government, the government of any state or of any political
subdivision thereof, and all laws, regulations, orders or official government requirements of any other countries or political subdivision thereof, applying to the Company, any of its Affiliates, an Associated Person of either the Company or any of
its Affiliates, and/or SoftBank prohibiting bribery and other related forms of corruption, including, fraud, tax evasion, insider dealing and market manipulation. 

(iii) “Applicable Money Laundering Laws” means all US federal, state and local laws, regulations, orders and/or official
government requirements, including all laws, regulations, orders or official government requirements of any branch of the US federal government, the government of any state or of any political subdivision thereof, and all laws, regulations, orders
or official government requirements of any other countries or political subdivision thereof, applying to the Company, any of its Affiliates, an Associated Person of either the Company or any of its Affiliates, and/or SoftBank prohibiting money
laundering and any acts or attempted acts to conceal or disguise the identity of illegally obtained proceeds. 

  
 23 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (iv) “Associated Person” means, in relation to a company or other entity,
an individual or entity (including a director, officer, employee, consultant, agent or other representative) who or that is acting or performing or has acted or performed services for or on behalf of that company or other entity but only with
respect to actions or the performance of services for or on behalf of that company or other entity. 
 (v) “BIS” means the
Bureau of Industry and Security of the US Department of Commerce. 
 (vi) “EU” means the European Union. 

(vii) “Government Official” means (A) an officer or employee of any national, regional, local or other component of
government; (B) a director, officer or employee of any entity in which a government or any component of a government possesses a majority or controlling interest; (C) a candidate for public office; (D) a political party or political
party official; (E) an officer or employee of a public international organization (e.g., the European Commission or World Bank); and (F) any individual who is acting in an official capacity for any government, component of a government,
political party or public international organization, even if such individual is acting in that capacity temporarily and without compensation. 

(viii) “OFAC” means the Office of Foreign Assets Control of the US Department of the Treasury. 

(ix) “Sanctioned Country” means Cuba, Iran, North Korea, Sudan, Syria, and the Crimea region of Ukraine, the government
(including any branch, agency, or instrumentality of such government) or Government Officials of any such jurisdiction, any person owned or controlled, directly or indirectly, by the foregoing, and any person acting or purporting to act, directly or
indirectly, for or on behalf of the foregoing. 
 (x) “Sanctions” refers to the following economic or financial sanctions,
trade embargoes, export controls, and anti-boycott laws and regulations: 
 (1) United Nations sanctions imposed pursuant to any United
Nations Security Council Resolution; 
 (2) US sanctions administered by OFAC, the US Department of State, the US Department of Commerce, or
any other US Government authority or department, US export controls administered by BIS, the US Department of Commerce, US Department of State, Nuclear Regulatory Commission, or US Department of Energy, and US antiboycott provisions administered by
the US Department of Commerce or US Department of the Treasury; 
 (3) EU restrictive measures implemented pursuant to any EU Council or
Commission Regulation or Decision adopted pursuant to a Common Position in furtherance of the EU’s Common Foreign and Security Policy; 

  
 24 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (4) UK sanctions adopted by the Terrorist-Asset Freezing etc Act 2010 or other legislation
and statutory instruments enacted pursuant to the United Nations Act 1946 or the European Communities Act 1972 or enacted by or pursuant to other laws; and 

(5) any other trade, economic or financial sanctions laws, regulations, embargoes, export controls or restrictive trade measures administered,
enacted or enforced by any authority, government, or official institution as applicable to the Company, any of its Affiliates or any Associated Persons or either the Company or any of its Affiliates or to SoftBank or any transaction in which the
Company or any of its Affiliates is engaged. 
 (xi) “Sanctions List” refers to the “Specially Designated Nationals
and Blocked Persons” list, including the EO 13599 list, Foreign Sanctions Evaders list, and the “Sectoral Sanctions Identifications List” maintained by OFAC, the Entity list and Denied Persons list maintained by BIS, the
“Consolidated List of Persons, Groups and Entities Subject to EU Financial Sanctions” maintained by the European Union, the lists of persons set out under Annexes III, V, and VI to Council Regulation 833/2014 as amended, the
“Consolidated List of Financial Sanctions Targets” maintained by Her Majesty’s Treasury, or any similar list maintained by the United States, European Union, United Kingdom, or United Nations, each as amended, supplemented or
substituted from time to time. 
 (xii) “Sanctioned Person” refers to any individual who or entity that is: 

(1) specifically listed in any Sanctions List; or 

(2) owned or controlled by any individual or entity referred to in any Sanctions List, or government or Government Official of any Sanctioned
Country. 
 (xiii) “UK” means the United Kingdom. 

(xiv) “US” means the United States of America. 

(b) The Company covenants and agrees: 

(i) Neither the Company, any of its Affiliates, nor any Associated Person when acting for or on behalf of either the Company or any of its
Affiliates shall directly or indirectly offer, promise, give or authorize any payment or offer, promise, give or authorize the giving of anything else of value to a Government Official or individual employed by another entity in the private sector
that would violate any of the Applicable ABAC Laws, or engage in any other conduct that would violate any of the Applicable ABAC Laws, Applicable Money Laundering Laws or Sanctions after the effective date of this Agreement. 

(ii) Neither the Company, any of its Affiliates nor any Associated Person when acting for or on behalf of either the Company or any of its
Affiliates shall use any funds received from SoftBank directly or indirectly (a) for the benefit of activities or parties subject to, in violation of, or penalized under Sanctions, (b) in violation of Sanctions or (c) for any Sanctioned
Person or for the benefit of any Sanctioned Person, or (d) in any way that would violate the Applicable Money Laundering Laws. 

  
 25 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (iii) If it has not already done so, the Company and its Affiliates shall adopt and
implement within ninety (90) days of executing this Agreement policies and procedures designed to prevent the Company, its Affiliates as well as any Associated Person when acting for or on behalf of either the Company or any of its Affiliates
from engaging in any activity, practice or conduct that would violate or be penalized or restricted under any Applicable ABAC Laws, Applicable Money Laundering Laws or Sanctions. Such policies and procedures shall be consistent with the guidance
that has been provided by government authorities in the United States of America, as well as any other countries or political subdivision thereof in which the Company has operations, having authority to administer and prosecute violations of such
laws and regulations. 
 (iv) If it has not already done so, the Company shall within forty five (45) days of executing this Agreement
(1) ensure that it has a suitably qualified and appropriately resourced chief compliance officer or individual tasked with performing the functions of a chief compliance officer, in either case, vested with authority to make compliance reports
directly to the Board or an appropriate committee of the Board; and (2) take such other steps as those having authority to prosecute violations of any of the Applicable ABAC Laws, Applicable Money Laundering Laws or Sanctions have recommended
to ensure that the compliance function of companies and entities subject to their jurisdiction is operating in an appropriate manner. 
 (v)
The Company and its Affiliates shall keep and maintain books and records reflecting accurately and in reasonable detail transactions involving the Company and its Affiliates and, if they have not already done so, implement financial controls
designed to ensure that payments will be made by or on behalf of the Company and its Affiliates only in accordance with management instructions. 

(vi) The Company shall confirm in writing to SoftBank, upon request and no more than once each year, that it and its Affiliates have complied
with the undertakings set forth in this Section 3.12. 
 (vii) If the Company or any of its Affiliates suspects or comes to believe
that either the Company, any of its Affiliates or any Associated Person when acting for or on behalf of the Company or any of its Affiliates have violated or are subject to penalties or restrictions under any of the Applicable ABAC Laws, Applicable
Money Laundering Laws and/or Sanctions, it shall notify SoftBank promptly in writing of its suspicion or belief. 
 (viii) Notwithstanding
anything else in this Agreement, the Company and its Affiliates and their respective directors, officers and employees shall cooperate in good faith with SoftBank if SoftBank decides to seek to determine whether the Company, its Affiliates and/or
any Associated Persons of either the Company or any of its Affiliates have complied with the undertakings set forth in this Section 3.12. The cooperation required by the foregoing shall include permitting SoftBank or the authorized
representative(s) of SoftBank to 

  
 26 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 
audit the books and records of the Company and its Affiliates as well as review and make copies of correspondence and other documents, however sent or received, possessed by the Company or its
Affiliates pertaining to compliance with the undertakings set forth in this Section 3.12. If so requested by SoftBank, the Company and its Affiliates shall answer any questions put to them or requests made of them by SoftBank as well as its or
their authorized representative(s) pertaining to compliance with the undertakings set forth in this Section 3.12 and shall encourage their Associated Persons to do the same. SoftBank will, however, not seek to review any information or
materials protected by the attorney-client privilege or the attorney work product doctrine, as those concepts are understood under U.S. law; provided, further, that the Company shall use its best efforts to provide access to SoftBank to the
underlying substance of such information without such loss of attorney-client or attorney work product privilege. 
 (ix) The Company, its
Affiliates and any Associated Person when acting for or on behalf of either the Company or any of its Affiliates shall not violate or engage in conduct restricted or penalized under any of the Applicable ABAC Laws, Applicable Money Laundering Laws
or Sanctions and the Company shall indemnify and hold harmless SoftBank from and against any and all direct liabilities, damages, costs and expenses (including reasonable legal expenses) that are finally awarded by a court or governmental body with
competent jurisdiction (or agreed to in writing by the Company in settlement) and caused by or attributable to any violation of Applicable ABAC Laws, Applicable Money Laundering Laws or Sanctions by the Company, any of its Affiliates or any
Associated Person when acting for or on behalf of either the Company or any of its Affiliates. 
 3.13 Successor Indemnification. If
the Company or any of its successors or assignees consolidates with or merges into any other Person and is not the continuing or surviving corporation or entity of such consolidation or merger, then to the extent necessary, proper provision shall be
made so that the successors and assignees of the Company assume the obligations of the Company with respect to indemnification of members of the Board as in effect immediately before such transaction, whether such obligations are contained in the
Company’s Bylaws, the Restated Certificate or elsewhere, as the case may be. 
 3.14 Tax Covenants. 

(a) For so long as SoftBank or QIA, as applicable, owns equity in the Company, the Company shall not be liquidated, merged, converted into a
limited liability company, or otherwise enter into a transaction pursuant to which the Company ceases to exist as an entity treated as a corporation for U.S. federal income tax purposes (and state and local tax purposes, where applicable) without
the prior written approval of SoftBank or QIA, as applicable. 
 (b) The Company (and its applicable withholding agents and paying agents)
shall be entitled to deduct and withhold taxes on any payments on the Registrable Securities to the extent required by applicable tax law; provided that, if the Company determines that an amount is required to be deducted and withheld, at least
fifteen (15) days prior to the date the applicable payment is scheduled to be made, the Company shall (i) provide SoftBank and QIA, as applicable, with written notice of the intent to deduct and withhold, which notice shall include the
basis for the withholding and an estimate of the amount proposed to be deducted and withheld, and (ii) provide SoftBank and QIA, as applicable, with a reasonable opportunity to provide forms or other evidence that would reduce or eliminate such
amounts of withholding, and shall otherwise reasonably cooperate to minimize any such withholding. 

  
 27 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (c) The Company, SoftBank and QIA agree that it is their intention that (i) the
Registrable Securities shall be treated as stock that is not “preferred stock” within the meaning of Section 305 of the Internal Revenue Code of 1986, as amended (the “Code”), and the Treasury Regulations issued
thereunder, and (ii) SoftBank and QIA, as applicable, shall not be required to include in income as a dividend for U.S. federal income tax purposes any income or gain in respect of the Registrable Securities on account of the accrual of
dividends thereon (including any deemed dividends or as a result of any discount) unless and until such dividends are declared and paid in cash. The Company, SoftBank and QIA agree to take no positions or actions inconsistent with such
treatment (including on any IRS Form 1099), unless, pursuant to an opinion of counsel reasonably satisfactory to each of (i) the Company, (ii) SoftBank, and (iii) QIA, such position or action is otherwise required by a change in
applicable law after October 22, 2018. 
 (d) The Company shall, upon the prior written request of SoftBank or QIA, as applicable, use
commercially reasonable efforts to cooperate with SoftBank and QIA, as applicable, to structure any redemption of the Registrable Securities permitted under the terms of the Restated Certificate to be treated as a payment in exchange for stock
pursuant to Section 302 of the Code. 
 (e) The Company shall provide prompt notice to SoftBank and QIA, as applicable, following any
“determination date” (as defined in Treasury Regulation Section 1.897-2(c)(1)) on which the Company becomes a “United States real property holding corporation” within the meaning of
Section 897(c)(2) of the Code. In addition, upon any written request by SoftBank or QIA, as applicable, the Company shall provide SoftBank or QIA, as applicable, with a written statement informing SoftBank or QIA, as applicable, whether
its interest in the Company constitutes a “United States real property interest” within the meaning of Section 897(c)(2) of the Code. The Company’s determination shall comply with the requirements of Treasury Regulation Section 1.897-2(h)(1) or any successor regulation, and the Company shall provide timely notice to the Internal Revenue Service, in accordance with and to the extent required by Treasury Regulation Section 1.897-2(h)(2) or any successor regulation, that such statement has been made. The Company’s written statement to SoftBank or QIA, as applicable, shall be delivered within 15 days of the
written request therefor made by SoftBank or QIA, as applicable. The Company’s obligation to furnish such written statement shall continue notwithstanding the fact that a class of the Company’s stock may be regularly traded on an
established securities market or the fact that there is no Preferred Stock of the Company then outstanding. 
 3.15 Termination of Certain
Covenants. The covenants set forth in Sections 3.5, 3.6, 3.7, 3.8, 3.9, 3.14(b) and 3.14(d) shall terminate and be of no further force or effect upon the consummation of (a) the Initial Offering or (b) a Liquidation Event, as that
term is defined in the Restated Certificate. The covenant set forth in Section 3.14(c) shall terminate and be of no further force or effect upon the consummation of (a) the Initial Offering or (b) a Liquidation Event; provided,
that, in each case, QIA is not a Holder of Preferred Stock at such 

  
 28 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 
time. The covenants set forth in Section 3.12 shall terminate and be of no further force or effect (i) upon the consummation of an Initial Offering or a Liquidation Event, in either
case, if SoftBank fails to hold at least five percent (5%) of the then outstanding voting equity of the Company (or surviving entity, in the case of a Liquidation Event) immediately following the consummation of such Initial Offering or Liquidation
Event, as applicable (the “Minimum Ownership Threshold”) or (ii) if SoftBank holds the Minimum Ownership Threshold immediately following the consummation of such Initial Offering or Liquidation Event, immediately at such time
thereafter as SoftBank fails to hold the Minimum Ownership Threshold. 
 4. Miscellaneous. 

4.1 Successors and Assigns. Except as otherwise provided herein, the terms and conditions of this Agreement shall inure to the benefit
of and be binding upon the respective successors and assigns of the parties (including transferees of any shares of Registrable Securities). Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties
hereto or their respective successors and permitted assigns any rights, remedies, obligations or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. 

4.2 Governing Law. This Agreement shall be governed by and construed in accordance with the General Corporation Law of the State of
Delaware as to matters within the scope thereof, and as to all other matters shall be governed by and construed in accordance with the internal laws of the State of New York, without regard to conflicts of law principles thereof. 

4.3 Counterparts; Facsimile. This Agreement may be executed by electronic signature and in two (2) or more counterparts, each of
which shall be deemed an original, but all of which together shall constitute one (1) and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including pdf or any electronic signature complying with the U.S.
federal ESIGN Act of 2000, e.g., www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes. 

4.4 Titles and Subtitles. The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in
construing or interpreting this Agreement. 
 4.5 Notices. All notices and other communications given or made pursuant hereto shall be
in writing and shall be deemed effectively given upon the earlier to occur of actual receipt or: (a) upon personal delivery to the party to be notified, (b) when sent by confirmed electronic mail or facsimile if sent during normal business
hours of the recipient; if not sent during normal business hours, then on the next business day, (c) five (5) days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (d) one
(1) day after deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification of receipt. All notices and other communications shall be sent only to the respective Parties at the addresses set
forth on Schedule A or Schedule B, or the signature pages hereto, as applicable, or to such e-mail address, facsimile number or other 

  
 29 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 
addresses as shall be specified by notice given in accordance with this Section 4.5). If notice is given to the Company, it shall be sent to the address on the Company’s signature page;
a copy (which shall not constitute notice) shall also be given to Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP, 220 West 42nd Street, 21st Floor, New York, NY 10036, Attention: Steven Baglio, Esq. 
 4.6 Expenses. If any
action at law or in equity is necessary to enforce or interpret the terms of this Agreement, the prevailing party shall be entitled to reasonable attorneys’ fees, costs and necessary disbursements in addition to any other relief to which such
party may be entitled. 
 4.7 Entire Agreement; Amendments and Waivers. This Agreement (including the Exhibits hereto, if any)
constitutes the full and entire understanding and agreement among the parties with regard to the subjects hereof and thereof. Except as set forth below, any term of this Agreement may be amended and the observance of any term of this Agreement may
be waived (either generally or in a particular instance and either retroactively or prospectively) only with the written consent of the (a) the Company, (b) Common Holders holding a majority of the Registrable Securities held by Common
Holders who are then providing services to the Company as employees or consultants in good standing (with it being understood that a non-natural Person that holds shares and is affiliated with a Common Holder
will be deemed to be providing services to the Company as an employee or consultant in good standing if such Common Holder is providing services to the Company as employee or consultant in good standing), and (c) Investors holding a majority of
the Registrable Securities held by Investors. For the avoidance of doubt, the SoftBank Voting Covenants (as defined in the Voting Agreement) shall apply to the written consent described in the foregoing sentence. Notwithstanding the foregoing: 

(i) Subject to the following clauses (iii) through (vi), this clause (i), the provisions of Section 3.1, Section 3.2,
Section 3.3 and Sections 3.4(a) through (e), and (g) may not be amended or waived (either generally or in a particular instance and either retroactively or prospectively) without the written consent of the Company and the Major Investors
holding a majority of the Registrable Securities then held by all of the Major Investors; provided, however, that any waiver of the provisions of Section 3.4 shall only be effective (a) with respect to the Major Investors
holding shares of Series F Registrable Securities (solely with respect to the Series F Registrable Securities held by such Major Investors) if such written consent includes the written consent of the Major Investors holding at least two-thirds (2/3) of the Series F Registrable Securities held by all Major Investors, and (b) with respect to the Major Investors holding shares of Series G Registrable Securities (solely with respect to the
Series G Registrable Securities held by such Major Investors) if such written consent includes the written consent of the Major Investors holding at least two-thirds (2/3) of the Series G Registrable
Securities held by all Major Investors. For the avoidance of doubt, the SoftBank Voting Covenants shall not apply to the written consent described in the foregoing sentence. 

(ii) This clause (ii) and Section 2.11 may not be amended or waived (either generally or in a particular instance and either
retroactively or prospectively) without the written consent of the Preferred Majority (as defined in the Restated Certificate). For the avoidance of doubt, the SoftBank Voting Covenants shall apply to the written consent described in the foregoing
sentence. 

  
 30 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (iii) This clause (iii), Section 1(t)(ii), Section 2.12, Section 3.1,
Section 3.2, Section 3.3, Section 3.4 (for so long as SoftBank is a Major Investor), Section 3.5 (for so long as SoftBank is entitled to nominate the Series E Director pursuant to the Voting Agreement), Section 3.6(a),
Section 3.7 (for so long as SoftBank is entitled to nominate the Series E Director pursuant to the Voting Agreement), Section 3.10, Section 3.11, Section 3.12, Section 3.13, Section 3.14, the first sentence of
Section 3.15 (to the extent it applies to Section 3.5, 3.6(a) or 3.7), the last sentence of Section 3.15, all references to the SoftBank Voting Covenants and the definitions of “SoftBank,” “Minimum Ownership
Threshold,” and “Ownership Cap” may not amended or waived (either generally or in a particular instance and either retroactively or prospectively) in a manner adverse to SoftBank without the written consent of SoftBank. For
the avoidance of doubt, the SoftBank Voting Covenants shall not apply to the written consent described in the foregoing sentence. 
 (iv)
For so long as any Wellington Investor holds any shares of Registrable Securities, (A) the definitions of “Wellington” and “Wellington Investors” may be amended or waived (either generally or in a particular instance and
either retroactively or prospectively) only with the written consent of the Wellington Investors holding a majority of the Registrable Securities then held by all of the Wellington Investors, and (B) Section 2.12 may be amended or waived
(either generally or in a particular instance and either retroactively or prospectively) in a manner adverse to the Wellington Investors only with the written consent of the Wellington Investors holding a majority of the Registrable Securities then
held by all of the Wellington Investors. 
 (v) For so long as any Fidelity Investor holds any shares of Registrable Securities,
(A) the definitions of “Affiliate” (as it relates to a Fidelity Investor), “Fidelity” and “Fidelity Investor” may be amended or waived (either generally or in a particular instance and either retroactively or
prospectively) only with the written consent of the Fidelity Investors holding a majority of the Registrable Securities then held by all of the Fidelity Investors, (B) Section 2.12 may be amended or waived (either generally or in a
particular instance and either retroactively or prospectively) in a manner adverse to the Fidelity Investors only with the written consent of the Fidelity Investors holding a majority of the Registrable Securities then held by all of the Fidelity
Investors and (C) the definition of “Regulated Investor” and Section 3.11 (as it relates to a Regulated Investor) may be amended or waived (either generally or in a particular instance and either retroactively or prospectively)
only with the written consent of the Fidelity Investors holding a majority of the Registrable Securities then held by all of the Fidelity Investors. 

(vi) For so long as QIA is a Major Investor, Section 3.1(a)(B), Section 3.4, Section 3.6(b), Section 3.14, the first
sentence of Section 3.15 (to the extent it applies to Section 3.6(b) and Section 3.14(b) and (d)), the second sentence of Section 3.15 (to the extent it applies to Section 3.14(c)), this clause (vi), and the definitions of
“QIA,” and “Ownership Cap” may not amended or waived (either generally or in a particular instance and either retroactively or prospectively) in a manner adverse to QIA without the written consent of QIA. 

  
 31 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (vii) The consent of the Common Holders shall not be required for any amendment or waiver if
such amendment or waiver does not apply to the Common Holders. 
 (viii) No waiver of the rights of the Investors hereunder shall require
the consent of the Company. 
 (ix) Any amendment or waiver that applies to an Investor or Holder in a different fashion than it applies to
other Investors or Holders, respectively, shall require the written consent of such Investor or Holder to be effective as to such Investor or Holder. The Company shall give prompt written notice of any amendment, termination or waiver hereunder to
any party to this Agreement that did not consent in writing thereto. 
 Any amendment or waiver effected in accordance with this paragraph shall be binding
upon each holder of any (or the applicable) Registrable Securities, each future holder of all such Registrable Securities and the Company. Notwithstanding the foregoing, any provision hereof may be waived by a party on such party’s own
behalf, without the written consent of any other party. Upon the effectiveness of this Agreement, the Prior Agreement shall be superseded and replaced in its entirety by this Agreement and shall be of no further force or effect. 

4.8 Severability. Whenever possible, each provision of this Agreement shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Agreement shall be held to be prohibited by or invalid under applicable law, such provision shall be ineffective only to the extent of such prohibition or invalidity, without invalidating the
remainder of such provision or the remaining provisions of this Agreement. 
 4.9 Aggregation of Stock. All shares of Registrable
Securities held or acquired by Affiliates shall be aggregated together for the purpose of determining the availability of any rights under this Agreement. 

4.10 Additional Investors. Notwithstanding Section 4.7, no consent shall be necessary to (a) add additional Investors as
signatories to this Agreement and (b) update Schedule A accordingly, provided that such Investors have purchased Preferred Stock from the Company and the terms of this Agreement are not otherwise amended. 

4.11 Massachusetts Business Trust. A copy of the Agreement and Declaration of Trust of each Fidelity Investor, or any affiliate thereof,
is on file with the Secretary of State of the Commonwealth of Massachusetts and notice is hereby given that this Agreement is executed on behalf of the trustees of such Fidelity Investor or any affiliate thereof as trustees and not individually and
that the obligations of this Agreement are not binding on any of the trustees, officers or stockholders of such Fidelity Investor or any affiliate thereof individually but are binding only upon such Fidelity Investor or any affiliate thereof and its
assets and property. 
 [Remainder of page intentionally left blank] 

  
 32 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first
above written. 
  

			
	URBAN COMPASS, INC.
		
	By:	 	 /s/ Robert Reffkin

			
	Name:	 	Robert Reffkin
	Title:	 	Chief Executive Officer

 
			
		
	Address:	 	90 5th Avenue, 3rd Floor
		 	New York, NY 10011

 SIGNATURE PAGE TO SEVENTH
AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

FOR URBAN COMPASS, INC. (SERIES G) 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first
above written. 
  

			
	COMMON HOLDERS:
	
	 /s/ Robert Reffkin

	Robert Reffkin
	
	 /s/ Benis Reffkin

	Benis Reffkin
	
	 /s/ Ruth Reffkin

	Ruth Reffkin
	
	 /s/ Ori Allon

	Ori Allon
	
	ALLON FAMILY TRUST III HOLDINGS, LLC
		
	By:	 	 /s/ Itai Lemberger

	Name: Itai Lemberger
	Title: Manager
	
	THE COMPASS 2015 GRAT
		
	By:	 	 /s/ Robert Reffkin

	Name: Robert Reffkin
	Title: Trustee
		
	By:	 	 /s/ Elida Reyes

	Name: Elida Reyes
	Title: Trustee
	
	THE COMPASS 2017 GRAT
		
	By:	 	 /s/ Robert Reffkin

	Name: Robert Reffkin
	Title: Trustee
		
	By:	 	 /s/ Elida Reyes

	Name: Elida Reyes
	Title: Trustee

  

SIGNATURE PAGE TO SEVENTH AMENDED AND
RESTATED INVESTORS’ RIGHTS AGREEMENT 
 FOR
URBAN COMPASS, INC. (SERIES G) 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first
above written. 
  

			
	COMMON HOLDERS:
	
	THE RR1 TRUST
		
	By:	 	 /s/ Elida Reyes

	Name: Elida Reyes
	Title: Trustee
	
	THE RR2 TRUST
		
	By:	 	 /s/ Elida Reyes

	Name: Elida Reyes
	Title: Trustee
	
	THE RR3 TRUST
		
	By:	 	 /s/ Elida Reyes

	Name: Elida Reyes
	Title: Trustee
	
	THE ELIDA REYES FAMILY TRUST
		
	By:	 	 /s/ Ruth Reffkin

	Name: Ruth Reffkin
	Title: Trustee

 
			
	
	Address:

  

SIGNATURE PAGE TO SEVENTH AMENDED AND
RESTATED INVESTORS’ RIGHTS AGREEMENT 
 FOR
URBAN COMPASS, INC. (SERIES G) 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 URBAN COMPASS, INC. 

COUNTERPART SIGNATURE PAGE TO THE 

SEVENTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

The undersigned hereby agrees to be bound by and subject to all of the terms and conditions of the Seventh Amended and Restated
Investors’ Rights Agreement dated as of July 26, 2019 by and among the Company, the Investors set forth on Schedule A thereto and the Common Holders set forth on Schedule B thereto (as amended, the “Investors’ Rights
Agreement”), as a “Common Holder” and a “Holder” thereunder and all of the benefits and obligations of the Investors’ Rights Agreement shall inure to the undersigned as a “Common Holder” and a
“Holder” thereunder. The undersigned hereby authorizes the Company to attach this counterpart signature page to the Investors’ Rights Agreement and update Schedule A thereto. Capitalized terms used but not defined herein shall have
the meanings ascribed thereto in the Investors’ Rights Agreement. 
 Date: April 14, 2020  

 

			
	COMMON HOLDER:
	
	RUTH REFFKIN FAMILY TRUST
		
	By:	 	 /s/ Christen Edward Joseph Lee

			
	Name:	 	Christen Edward Joseph Lee
	Title:	 	Trustee
	
	Address: 90 Fifth Avenue, 3rd Floor New York, NY 10011

  

SIGNATURE PAGE TO SEVENTH AMENDED AND
RESTATED INVESTORS’ RIGHTS AGREEMENT 
 FOR
URBAN COMPASS, INC. (SERIES G) 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first
above written. 
  

			
	INVESTOR:
	
	HADLEY HARBOR MASTER INVESTORS (CAYMAN) L.P.
	
	By: Wellington Management Company LLP, as investment adviser
		
	By:	 	 /s/ Emily Babalas

	Name: Emily Babalas
	Title: Managing Director & Counsel

 
			
	
	Address:
	Email Address:

  

SIGNATURE PAGE TO SEVENTH AMENDED AND
RESTATED INVESTORS’ RIGHTS AGREEMENT 
 FOR
URBAN COMPASS, INC. (SERIES G) 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above written. 

 

			
	INVESTOR:
	
	SOFTBANK VISION FUND (AIV M1) L.P.
	
	By: SB Investment Advisers (UK) Limited, acting as Manager of SoftBank Vision Fund (AIV M1) L.P.
		
	By:	 	 /s/ Ruwan Weerasekera

	Name: Ruwan Weerasekera
	Title: Director
	
	Email Address:
	
	and
	
	A copy (which shall not constitute notice) shall also be sent to:

  

SIGNATURE PAGE TO SEVENTH AMENDED AND
RESTATED INVESTORS’ RIGHTS AGREEMENT 
 FOR
URBAN COMPASS, INC. (SERIES G) 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above written. 

 

			
	 INVESTORS:

	
	 AL RAYYAN HOLDING LLC

		
	 By:
	 	 /s/ Ahmed Ali Al Hammadi

	 Name: Ahmed Ali Al Hammadi

	 Title: Director

	
	DIC COMPANY LIMITED

		
	 By:
	 	 /s/ Ahmed Ali Al Hammadi

	 Name: Ahmed Ali Al Hammadi

	 Title: Director

  

SIGNATURE PAGE TO SEVENTH AMENDED AND
RESTATED INVESTORS’ RIGHTS AGREEMENT 
 FOR
URBAN COMPASS, INC. (SERIES G) 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above written. 

 

			
	 INVESTOR:

	
	CANADA PENSION PLAN INVESTMENT BOARD
		
	 By:
	 	 /s/ Leon Pedersen

	 Name: Leon Pedersen

	 Title: Managing Director

		 	
		
	 By:
	 	 /s/ Caitlin Walsh

	 Name: Caitlin Walsh

	 Title: Senior Portfolio Manager

	
	Address:

  

SIGNATURE PAGE TO SEVENTH AMENDED AND
RESTATED INVESTORS’ RIGHTS AGREEMENT 
 FOR
URBAN COMPASS, INC. (SERIES G) 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above written. 

 

			
	INVESTORS:
	
	GLYNN EMERGING OPPORTUNITY FUND, L.P.

	
	By: Glynn Capital Management LLC
	Its: General Partner
		
	By:	 	 /s/ John Glynn

	Name: John Glynn
	Title: Managing Director
	
	GLYNN EMERGING OPPORTUNITY FUND II, L.P.
	
	By: Glynn Management Evergreen LLC
	Its: General Partner
		
	By:	 	 /s/ David Glynn

	Name: David Glynn
	Title: Managing Director
	
	GLYNN EMERGING OPPORTUNITY FUND II-A, L.P.
	
	By: Glynn Management Evergreen LLC
	Its: General Partner
		
	By:	 	 /s/ David Glynn

	Name: David Glynn
	Title: Managing Director
	
	Address:

  

SIGNATURE PAGE TO SEVENTH AMENDED AND
RESTATED INVESTORS’ RIGHTS AGREEMENT 
 FOR
URBAN COMPASS, INC. (SERIES G) 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above written. 

 

			
	INVESTORS:
	
	COORDINATES DF INVESTMENTS, LLC
		
	By:	 	 /s/ Pat Robertson

	Name: Pat Robertson
	Title: Authorized Signatory
	
	Address:

  

SIGNATURE PAGE TO SEVENTH AMENDED AND
RESTATED INVESTORS’ RIGHTS AGREEMENT 
 FOR
URBAN COMPASS, INC. (SERIES G) 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above written. 

 

			
	INVESTORS:
	
	DISCOVERY GLOBAL FOCUS MASTER FUND, LTD.
		
	By:	 	 /s/ Adam Schreck

	Name: Adam Schreck
	Title: General Counsel
	
	DG URBAN-C LP
		
	By:	 	 /s/ Adam Schreck

	Name: Adam Schreck
	Title: General Counsel
	
	CLCRKC, LLC
		
	By:	 	 /s/ Robert K. Citrone

	Name: Robert K. Citrone
	Title: Authorized Person

  

SIGNATURE PAGE TO SEVENTH AMENDED AND
RESTATED INVESTORS’ RIGHTS AGREEMENT 
 FOR
URBAN COMPASS, INC. (SERIES G) 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 Urban Compass, Inc. 

Counterpart Signature Page to 

Seventh Amended and Restated Investors’ Rights Agreement 

Pursuant to Section 4.10 of the Seventh Amended and Restated Investors’ Rights Agreement dated as of July 26, 2019 by and
among Urban Compass, Inc. (the “Company”) the Investors listed on Schedule A thereto, and the Common Holders listed on Schedule B thereto (as amended from time to time, the “Investors’ Rights
Agreement”), and in consideration of the sale and issuance of shares of the Company’s Series G Preferred Stock to the undersigned, the undersigned hereby agrees to be bound by and to observe all of the terms and conditions of the
Investors’ Rights Agreement and all of the benefits of the Investors’ Rights Agreement shall inure to the undersigned as an Investor thereunder. The undersigned hereby authorizes the Company to attach this counterpart signature page to the
Investors’ Rights Agreement. Capitalized terms used but not defined herein shall have the meanings ascribed thereto in the Investors’ Rights Agreement. 

Dated as of     October 4    , 2019 

 

			
	INVESTOR:
	
	TORCH OPPORTUNITY I LLC – SERIES 3
	
	By: Torch Opportunity I GP LLC, its managing member
		
	By:	 	 /s/ Jonathan Keidan

	Name: Jonathan Keidan
	Title: Managing Member

 
			
	
	Address:
	
	Email Address(es):

  

SIGNATURE PAGE TO SEVENTH AMENDED AND
RESTATED INVESTORS’ RIGHTS AGREEMENT 
 FOR
URBAN COMPASS, INC. (SERIES G) 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 Urban Compass, Inc. 

Counterpart Signature Page to 

Seventh Amended and Restated Investors’ Rights Agreement 

Pursuant to Section 4.10 of the Seventh Amended and Restated Investors’ Rights Agreement dated as of July 26, 2019 by and among
Urban Compass, Inc. (the “Company”) the Investors listed on Schedule A thereto, and the Common Holders listed on Schedule B thereto (as amended from time to time, the “Investors’ Rights
Agreement”), and in consideration of the sale and issuance of 38,893 shares of the Company’s Series G Preferred Stock to the undersigned for the aggregate purchase price of $5,999,984.22, the undersigned hereby agrees to be bound by
and to observe all of the terms and conditions of the Investors’ Rights Agreement and all of the benefits of the Investors’ Rights Agreement shall inure to the undersigned as an Investor thereunder. The undersigned hereby authorizes the
Company to attach this counterpart signature page to the Investors’ Rights Agreement. Capitalized terms used but not defined herein shall have the meanings ascribed thereto in the Investors’ Rights Agreement. 

Dated as of     October 4    , 2019 

 

			
	INVESTOR:
	
	ALVARIUM COMPASS LP
	
	Alvarium Compass LP an Isle of Man limited partnership, acting by Alvarium Compass GP Limited, its General Partner
		
	By:	 	 /s/ Mark Veale

 
			
	Name:	 	Mark Veale
	Title:	 	Director
		 	For and on behalf of Park Limited

 
			
	
	Address:

  

SIGNATURE PAGE TO SEVENTH AMENDED AND
RESTATED INVESTORS’ RIGHTS AGREEMENT 
 FOR
URBAN COMPASS, INC. (SERIES G) 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 Urban Compass, Inc. 

Counterpart Signature Page to 

Seventh Amended and Restated Investors’ Rights Agreement 

Pursuant to Section 4.10 of the Seventh Amended and Restated Investors’ Rights Agreement dated as of July 26, 2019 by and among
Urban Compass, Inc. (the “Company”) the Investors listed on Schedule A thereto, and the Common Holders listed on Schedule B thereto (as amended from time to time, the “Investors’ Rights
Agreement”), and in consideration of the sale and issuance of 12,964 shares of the Company’s Series G Preferred Stock to the undersigned for the aggregate purchase price of $1,999,943.32, the undersigned hereby agrees to be bound by
and to observe all of the terms and conditions of the Investors’ Rights Agreement and all of the benefits of the Investors’ Rights Agreement shall inure to the undersigned as an Investor thereunder. The undersigned hereby authorizes the
Company to attach this counterpart signature page to the Investors’ Rights Agreement. Capitalized terms used but not defined herein shall have the meanings ascribed thereto in the Investors’ Rights Agreement. 

Dated as of     October 8    , 2019 

 

			
	INVESTOR:
	
	WILLET 12 SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

 
			
		
	By:	 	 /s/ Jan Łukasz Wejchert

			
	Name:	 	Jan Łukasz Wejchert
	Title:	 	President of the Board

  

SIGNATURE PAGE TO SEVENTH AMENDED AND
RESTATED INVESTORS’ RIGHTS AGREEMENT 
 FOR
URBAN COMPASS, INC. (SERIES G) 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 Urban Compass, Inc. 

Counterpart Signature Page to 

Seventh Amended and Restated Investors’ Rights Agreement 

Pursuant to Section 4.10 of the Seventh Amended and Restated Investors’ Rights Agreement dated as of July 26, 2019 by and among
Urban Compass, Inc. (the “Company”) the Investors listed on Schedule A thereto, and the Common Holders listed on Schedule B thereto (as amended from time to time, the “Investors’ Rights
Agreement”), and in consideration of the sale and issuance of 6,482 shares of the Company’s Series G Preferred Stock to the undersigned for the aggregate purchase price of $999,971.66, the undersigned hereby agrees to be bound by and
to observe all of the terms and conditions of the Investors’ Rights Agreement and all of the benefits of the Investors’ Rights Agreement shall inure to the undersigned as an Investor thereunder. The undersigned hereby authorizes the
Company to attach this counterpart signature page to the Investors’ Rights Agreement. Capitalized terms used but not defined herein shall have the meanings ascribed thereto in the Investors’ Rights Agreement. 

Dated as of     November 7    , 2019 

 

			
	INVESTOR:
	
	AVG – FV COMPASS 2019 TRUST
		
	By:	 	 /s/ Anton Simunovic

	Name: Anton Simunovic
	Title: Trustee

 
			
	
	Address:

  

SIGNATURE PAGE TO SEVENTH AMENDED AND
RESTATED INVESTORS’ RIGHTS AGREEMENT 
 FOR
URBAN COMPASS, INC. (SERIES G) 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 Urban Compass, Inc. 

Counterpart Signature Page to 

Seventh Amended and Restated Investors’ Rights Agreement 

Pursuant to Section 4.10 of the Seventh Amended and Restated Investors’ Rights Agreement dated as of July 26, 2019 by and among
Urban Compass, Inc. (the “Company”) the Investors listed on Schedule A thereto, and the Common Holders listed on Schedule B thereto (as amended from time to time, the “Investors’ Rights
Agreement”), and in consideration of the sale and issuance of 6,482 shares of the Company’s Series G Preferred Stock to the undersigned for the aggregate purchase price of $999,971.66, the undersigned hereby agrees to be bound by and
to observe all of the terms and conditions of the Investors’ Rights Agreement and all of the benefits of the Investors’ Rights Agreement shall inure to the undersigned as an Investor thereunder. The undersigned hereby authorizes the
Company to attach this counterpart signature page to the Investors’ Rights Agreement. Capitalized terms used but not defined herein shall have the meanings ascribed thereto in the Investors’ Rights Agreement. 

Dated as of     January 28    , 2020 

 

			
	HADLEY HARBOR MASTER INVESTORS (CAYMAN) L.P.
	
	By: Wellington Management Company LLP, as investment adviser
		
	By:	 	 /s/ Emily Babalas

	Name: Emily D. Babalas
	Title: Managing Director & Counsel

  

SIGNATURE PAGE TO SEVENTH AMENDED AND
RESTATED INVESTORS’ RIGHTS AGREEMENT 
 FOR
URBAN COMPASS, INC. (SERIES G) 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 URBAN COMPASS, INC. 

COUNTERPART SIGNATURE PAGE TO THE 

SEVENTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

The undersigned hereby agrees to be bound by and subject to all of the terms and conditions of the Seventh Amended and Restated
Investors’ Rights Agreement dated as of July 26, 2019 by and among the Company, the Investors set forth on Schedule A thereto and the Common Holders set forth on Schedule B thereto (as amended, the “Investors’
Rights Agreement”), as a “Common Holder” and a “Holder” thereunder and all of the benefits and obligations of the Investors’ Rights Agreement shall inure to the undersigned as a “Common Holder” and a
“Holder” thereunder. The undersigned hereby authorizes the Company to attach this counterpart signature page to the Investors’ Rights Agreement and update Schedule A thereto. Capitalized terms used but not defined herein shall
have the meanings ascribed thereto in the Investors’ Rights Agreement. 
 Date: 5/21/20 

 

			
	COMMON HOLDER:
	
	THE ELIDA REYES FAMILY TRUST
		
	By:	 	 /s/ Ruth Reffkin

 
			
	Name:	 	Ruth Reffkin
	Title:	 	Trustee
	
	Address:

  

SIGNATURE PAGE TO SEVENTH AMENDED AND
RESTATED INVESTORS’ RIGHTS AGREEMENT 
 FOR
URBAN COMPASS, INC. (SERIES G) 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 SCHEDULE A 

SCHEDULE OF INVESTORS 
 Atomico IV
(Guernsey), L.P. 
 Daniel Landver 
 Alta Park Fund, LP 

National Philanthropic Trust 
 SoftBank Vision Fund (AIV M1) L.P.

 FIAM Target Date Blue Chip Growth Commingled Pool1 

Fidelity Blue Chip Growth Commingled Pool2 

Fidelity Securities Fund: Fidelity Flex Large Cap Growth Fund3 

Fidelity Securities Fund: Fidelity Blue Chip Growth K6 Fund4 

Fidelity Securities Fund: Fidelity Blue Chip Growth Fund5 

Fidelity Securities Fund: Fidelity Series Blue Chip Growth Fund6 

Fidelity Securities Fund: Fidelity Small Cap Growth K6 Fund7 

Fidelity Capital Trust: Fidelity Flex Small Cap Fund—Small Cap Growth Subportfolio8 

Fidelity Securities Fund: Fidelity Small Cap Growth Fund9 

Hadley Harbor Master Investors (Cayman) L.P. 
 Advance/Newhouse
Investment Partnership 
 Thrive Capital Partners III, L.P. 

Claremount TW, L.P. 
 Andrew Marks 2011 Irrevocable Trust 

Corigin (CPEG Urban Compass LLC) 
 Adebayo O. Ogunlesi 

Urban Compass Investment, LLC 
  

	1 	 The stock certificate representing the shares that this Investor holds are registered in the name of its
nominee, FLAPPER CO fbo FIAM Target Date Blue Chip Growth Commingled Pool. 

	2 	 The stock certificate representing the shares that this Investor holds are registered in the name of its
nominee, Mag & Co fbo Fidelity Blue Chip Growth Commingled Pool. 

	3 	 The stock certificate representing the shares that this Investor holds are registered in the name of its
nominee, Booth & Co fbo Fidelity Securities Fund: Fidelity Flex Large Cap Growth Fund. 

	4 	 The stock certificate representing the shares that this Investor holds are registered in the name of its
nominee, Booth & Co FBO Fidelity Securities Fund: Fidelity Blue Chip Growth K6 Fund. 

	5 	 The stock certificate representing the shares that this Investor holds are registered in the name of its
nominee, M Gardiner & Co fbo Fidelity Securities Fund: Fidelity Blue Chip Growth Fund. 

	6 	 The stock certificate representing the shares that this Investor holds are registered in the name of its
nominee, WAVECHART + CO fbo Fidelity Securities Fund: Fidelity Series Blue Chip Growth Fund. 

	7 	 The stock certificate representing the shares that this Investor holds are registered in the name of its
nominee, Powhatan & Co., LLC fbo Fidelity Securities Fund: Fidelity Small Cap Growth K6 Fund. 

	8 	 The stock certificate representing the shares that this Investor holds are registered in the name of its
nominee, ISLANDMOORING CO FBO Fidelity Capital Trust: Fidelity Flex Small Cap Fund - Small Cap Growth Subportfolio. 

	9 	 The stock certificate representing the shares that this Investor holds are registered in the name of its
nominee, Mag & Co fbo Fidelity Securities Fund: Fidelity Small Cap Growth Fund. 

  
 S-1 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 William & Ophelia Rudin Family Investment Fund LLC 

FF Angel IV, LLC 
 Bernstein Family 1998 Trust 

Point 406 Ventures II, L.P. 
 The Marc R. Benioff Revocable Trust
U/A/D 12/3/2004 
 Joe Gleberman 
 Cap-Meridian Ventures 
 John Rowan 

Henry Cornell 
 Andrew H. Tisch 1995 Issue Trust No. 2 

Meyers Family Trust 
 Stephen Dannhauser 

Uhuru Capital 
 Weiss Family Partners 

Jason Landver 
 Alexander H. Tisch 2011 Trust 

Andrew H. Tisch 
 Lacey A. Tisch 2011 Trust 

Ray McGuire 
 Roger Weiss 

Greer Family Partners 
 Alex Sloane 

Christen Lee 
 William Lewis 

Kenneth Chenault 
 Lightning Fund I LLC 

James Sholem 
 Jonathan Keidan 

Michael Eisenberg 
 Ethan Silverstein 

Jay Kwan 
 ASP Ventures, LLC 

AAT Investments LLC 
 Denis Tolkachev 

Yusef Kassim 
 Gavin P. Myers Irrevocable Trust 

Josh Wolfe 
 Kristopher Brown 

Evan Layne 
 David Jasper 

Roey Eyal 
 Peter Pinto 

Kevin A Tanzer 
 JV Kodali 

Netta Korin 
 Miriam Lemberger 

  
 S-2 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 Shawn R. Carpenter Living Trust 

SV Booth Investments III LLC 
 The Emily T. Sussman 2011 Trust

 The Carolyn T. Sussman 2011 Trust 
 Richard Witten 

Ofer Maor 
 Tamir Carmi 

Nir Caspi 
 ASKME Investments LLC 

Cie-Jai Brown 
 LF Urban
Compass LLC 
 TNG UC LLC 
 Ball Pond Capital, LLC 

George Loening 
 MEO Urban Compass, LLC 

Libitzky Holdings L.P. 
 Ram Island Holdings LLC 

Justin Ehrlich 
 Franklin Equity Associates LLC 

Juan Uribe 
 Arn Tellem 

Rafay Farooqui 
 Circle Walk Partners LLC 

Pan Brothers Capital Management Group, LLC 
 David B. Keidan 2010
Family Long Term Trust 
 Cheer Land Investments Group Limited 

The Joseph Straus Jr. GST Subject Trust FBO James A. Straus 

Shawn-Pavan M. Golhar 
 Prudence Compass, LLC 

Regal Trust dated April 2, 2014      

William P Reedy Trust 
 Linda Johnson 

Andrew C. Hecht 
 Institutional Venture Partners XV, L.P. 

Institutional Venture Partners XV Executive Fund, L.P. 

Institutional Venture Partners XIII, L.P. 
 Parkhead Investments
S.A. 
 Jonathan Christodoro 
 Galaxy Acquisitions LLC 

Ramsey Smith 
 James Simmons 

Atomico IV, L.P. 
 Point 406 Ventures 2016 Opportunities Fund,
L.P. 
 Simone Nardi 
 Itai Lemberger 

Lemberger UC 2018 Trust 

  
 S-3 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 Keidan Path I, LP 

Keidan Path II LP 
 Keidan Path III, LP 

RAK Family Trust LLC 
 HS Investments 1 Limited 

Osprey Point Investments XXVII, LLC 
 Alexander M. Meyers Gift
Trust Dated December 15, 2016 
 Katelyn E. Meyers Gift Trust Dated December 15, 2016 

Paige E. Meyers Gift Trust Dated December 15, 2016 
 Ryan C.
Meyers Gift Trust Dated December 15, 2016 
 Growth Capital Fund I, L.P. 

LCP VIII Holdings, L.P. 
 Victor Sigoura 

SP UC LLC 
 Lead Edge Capital III, LP 

CLCRKC, LLC 
 DG URBAN-C
LP 
 Discovery Global Focus Master Fund, Ltd. 
 Glynn Emerging
Opportunity Fund, L.P. 
 Glynn Emerging Opportunity Fund II, L.P. 

Glynn Emerging Opportunity Fund II-A, L.P. 

JBDB Compass LLC 
 James Berkeley 

DIC Company Limited 
 Al Rayyan Holding LLC 

Canada Pension Plan Investment Board 
 Link Trustees (Jersey)
Limited in their capacity as trustee of the 9583165 International Pension Trust 
 AVGF—FV Urban Compass 2018, LLC 

Coordinates DF Investments, LLC 
 Torch Opportunity I
LLC—Series 3 
 Alvarium Compass LP 
 Willet 12
Spółka Z Ograniczoną Odpowiedzialnością 
 AVG – FV Compass 2019 Trust 

  
 S-4 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 SCHEDULE B 

SCHEDULE OF COMMON HOLDERS 
 Robert
Reffkin 
 Ori Allon 
 Ugo Di Girolamo 

Michael Weiss 
 Alexandre Petcherski 

Paul Groudas 
 The COMPASS 2015 GRAT 

David Snider 
 Liming Zhao 

Gordon Golub 
 Zachary Ozer 

LCP VII Holdings, L.P. 
 Growth Capital Fund I, L.P. 

Keidan Path II LP 
 CLCRKC, LLC 

The COMPASS 2017 GRAT 
 The RR1 Trust 

The RR2 Trust 
 Benis Reffkin 

Ruth Reffkin 
 The Elida Reyes Family Trust 

The RR3 Trust 
 Compass HTC Investors, LLC 

Ruth Reffkin Family TrustEX-10.2

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 EXHIBIT 10.2 

URBAN COMPASS, INC. 
 THIRD
AMENDED & RESTATED 2012 STOCK INCENTIVE PLAN 
  

	1.	 Purpose 

The purpose of this Third Amended & Restated 2012 Stock Incentive Plan (the “Plan”) of Urban Compass, Inc., a
Delaware corporation (the “Company”), is to advance the interests of the Company’s stockholders by enhancing the Company’s ability to attract, retain and motivate persons who are expected to make important
contributions to the Company and by providing such persons with equity ownership opportunities and performance-based incentives that are intended to better align the interests of such persons with those of the Company’s stockholders. Except
where the context otherwise requires, the term “Company” shall include any of the Company’s present or future parent or subsidiary corporations as defined in Sections 424(e) or (f) of the Internal Revenue Code
of 1986, as amended, and any regulations thereunder (the “Code”) and any other business venture (including, without limitation, joint venture or limited liability company) in which the Company has a controlling interest, as
determined by the Board of Directors of the Company (the “Board”); provided, however, that such other business ventures shall be limited to entities that, where required by Section 409A of the Code, are
eligible issuers of service recipient stock (as defined in Treas. Reg. Section 1.409A-1(b)(5)(iii)(E), or applicable successor regulation). 

 

	2.	 Eligibility 

All of the Company’s employees, officers and directors, as well as consultants and advisors to the Company (as such terms consultants and
advisors are defined and interpreted for purposes of Rule 701 under the Securities Act of 1933, as amended (the “Securities Act”) (or any successor rule)) are eligible to be granted Awards under the Plan. Each person who is
granted an Award under the Plan is deemed a “Participant.” “Award” means Options (as defined in Section 5), SARs (as defined in Section 6), Restricted Stock (as defined in Section 7),
Restricted Stock Units (as defined in Section 7) and Other Stock-Based Awards (as defined in Section 8). 
  

	3.	 Administration and Delegation 

(a) Administration by the Board. The Plan will be administered by the Board. The Board shall have authority to grant Awards and to
adopt, amend and repeal such administrative rules, guidelines and practices relating to the Plan as it shall deem advisable. The Board may construe and interpret the terms of the Plan and any Award agreements entered into under the Plan. The Board
may correct any defect, supply any omission or reconcile any inconsistency in the Plan or any Award in the manner and to the extent it shall deem expedient to carry the Plan into effect and it shall be the sole and final judge of such expediency.
All decisions by the Board shall be made in the Board’s sole discretion and shall be final and binding on all persons having or claiming any interest in the Plan or in any Award. 

(b) Appointment of Committees. To the extent permitted by applicable law, the Board may delegate any or all of its powers under the Plan
to one or more committees or subcommittees of the Board (each, a “Committee”). All references in the Plan to the “Board” shall mean the Board or a Committee of the Board to the extent that the
Board’s powers or authority under the Plan have been delegated to such Committee. 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

	4.	 Stock Available for Awards 

(a) Number of Shares. Subject to adjustment under Section 9, Awards may be made under the Plan for up to 1,960,000 shares of common
stock, $0.0001 par value per share, of the Company (the “Common Stock”), any or all of which Awards may be in the form of Incentive Stock Options (as defined in Section 5(b)). If any Award expires or is terminated,
surrendered or canceled without having been fully exercised, is forfeited in whole or in part (including as the result of shares of Common Stock subject to such Award being repurchased by the Company at the original issuance price pursuant to a
contractual repurchase right), or results in any Common Stock not being issued, the unused Common Stock covered by such Award shall again be available for the grant of Awards under the Plan. Further, shares of Common Stock tendered to the Company by
a Participant to exercise an Award or to satisfy tax withholding obligations arising with respect to an Award shall be added to the number of shares of Common Stock available for the grant of Awards under the Plan. However, in the case of Incentive
Stock Options, the two immediately preceding sentences shall be subject to any limitations under the Code. Shares issued under the Plan may consist in whole or in part of authorized but unissued shares or treasury shares. 

(b) Substitute Awards. In connection with a merger or consolidation of an entity with the Company or the acquisition by the Company of
property or stock of an entity, the Board may grant Awards in substitution for any options or other stock or stock-based awards granted by such entity or an affiliate thereof. Substitute Awards may be granted on such terms as the Board deems
appropriate in the circumstances, notwithstanding any limitations on Awards contained in the Plan. Substitute Awards shall not count against the overall share limit set forth in Section 4(a), except as may be required by reason of
Section 422 and related provisions of the Code. 
  

	5.	 Stock Options 

(a) General. The Board may grant options to purchase Common Stock (each, an “Option”) and determine the number
of shares of Common Stock to be covered by each Option, the exercise price of each Option and the conditions and limitations applicable to the exercise of each Option, including conditions relating to applicable federal or state securities laws, as
it considers necessary or advisable. 
 (b) Incentive Stock Options. An Option that the Board intends to be an “incentive stock
option” as defined in Section 422 of the Code (an “Incentive Stock Option”) shall only be granted to employees of Urban Compass, Inc., any of Urban Compass, Inc.’s present or future parent or subsidiary
corporations as defined in Sections 424(e) or (f) of the Code, and any other entities the employees of which are eligible to receive Incentive Stock Options under the Code, and shall be subject to and shall be construed consistently with the
requirements of Section 422 of the Code. An Option that is not intended to be an Incentive Stock Option shall be designated a “Nonstatutory Stock Option.” The Company shall have no liability to a Participant, or any
other party, if an Option (or any part thereof) that is intended to be an Incentive Stock Option is not an Incentive Stock Option or if the Company converts an Incentive Stock Option to a Nonstatutory Stock Option. 

  
 2 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (c) Exercise Price. The Board shall establish the exercise price of each Option and
specify the exercise price in the applicable Option agreement. The exercise price shall be not less than 100% of the fair market value per share of Common Stock, as determined by (or in a manner approved by) the Board (“Fair Market
Value”), on the date the Option is granted. “Fair Market Value” of a share of Common Stock for purposes of the Plan will be determined as follows: 

(1) if the Common Stock is not publicly traded, the Board will determine the Fair Market Value for purposes of the Plan using any measure of
value it determines to be appropriate (including, as it considers appropriate, relying on appraisals) in a manner consistent with the valuation principles under Code Section 409A, except as the Board may expressly determine otherwise; 

(2) if the Common Stock trades on a national securities exchange, the closing sale price (for the primary trading session) on the date of
grant; or 
 (3) if the Common Stock does not trade on any such exchange, the average of the closing bid and asked prices as reported by an
authorized OTCBB market data vendor as listed on the OTCBB website (otcbb.com) on the date of grant. 
 For any date that is not a trading
day, the Fair Market Value of a share of Common Stock for such date will be determined by using the closing sale price or average of the bid and asked prices, as appropriate, for the immediately preceding trading day and with the timing in the
formulas above adjusted accordingly. The Board can substitute a particular time of day or other measure of “closing sale price” or “bid and asked prices” if appropriate because of exchange or market procedures or can, in its sole
discretion, use weighted averages either on a daily basis or such longer period as complies with Code Section 409A. 
 The Board has
sole discretion to determine the Fair Market Value for purposes of the Plan, and all Awards are conditioned on the participants’ agreement that the Administrator’s determination is conclusive and binding even though others might make a
different determination. 
 (d) Duration of Options. Each Option shall be exercisable at such times and subject to such terms and
conditions as the Board may specify in the applicable option agreement; provided, however, that no Option will be granted with a term in excess of 10 years. 

(e) Exercise of Options. 

Options may be exercised by delivery to the Company of a notice of exercise in a form of notice (which may be electronic) approved by the
Company, together with payment in full (in a manner specified in Section 5(f)) of the exercise price for the number of shares for which the Option is exercised. Shares of Common Stock subject to the Option will be delivered by the Company as
soon as practicable following exercise. 

  
 3 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (f) Payment Upon Exercise. Common Stock purchased upon the exercise of an Option
granted under the Plan shall be paid for as follows: 
 (1) in cash or by check, payable to the order of the Company; 

(2) when the Common Stock is registered under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), except as may
otherwise be provided in the applicable Option agreement or approved by the Board, in its sole discretion, by (i) delivery of an irrevocable and unconditional undertaking by a creditworthy broker to deliver promptly to the Company sufficient
funds to pay the exercise price and any required tax withholding or (ii) delivery by the Participant to the Company of a copy of irrevocable and unconditional instructions to a creditworthy broker to deliver promptly to the Company cash or a
check sufficient to pay the exercise price and any required tax withholding; 
 (3) when the Common Stock is registered under the Exchange
Act and to the extent provided for in the applicable Option agreement or approved by the Board, in its sole discretion, by delivery (either by actual delivery or attestation) of shares of Common Stock owned by the Participant valued at their Fair
Market Value, provided (i) such method of payment is then permitted under applicable law, (ii) such Common Stock, if acquired directly from the Company, was owned by the Participant for such minimum period of time, if any, as may be
established by the Board in its discretion and (iii) such Common Stock is not subject to any repurchase, forfeiture, unfulfilled vesting or other similar requirements; 

(4) to the extent provided for in the applicable Nonstatutory Stock Option agreement or approved by the Board in its sole discretion, by
delivery of a notice of “net exercise” to the Company, as a result of which the Participant would pay the exercise price for the portion of the Option being exercised by cancelling a portion of the Option for such number of shares as is
equal to the exercise price divided by the excess of the Fair Market Value on the date of exercise over the Option exercise price per share. 

(5) to the extent permitted by applicable law and provided for in the applicable Option agreement or approved by the Board, in its sole
discretion, by (i) delivery of a promissory note of the Participant to the Company on terms determined by the Board, or (ii) payment of such other lawful consideration as the Board may determine; or 

(6) by any combination of the above permitted forms of payment. 

  
 4 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

	6.	 Stock Appreciation Rights 

(a) General. The Board may grant Awards consisting of stock appreciation rights (“SARs”) entitling the holder,
upon exercise, to receive an amount of Common Stock or cash or a combination thereof (such form to be determined by the Board) determined by reference to appreciation, from and after the date of grant, in the Fair Market Value of a share of Common
Stock over the measurement price established pursuant to Section 6(b). The date as of which such appreciation is determined shall be the exercise date. 

(b) Measurement Price. The Board shall establish the measurement price of each SAR and specify it in the applicable SAR agreement. The
measurement price shall not be less than 100% of the Fair Market Value on the date the SAR is granted. 
 (c) Duration of SARs. Each
SAR shall be exercisable at such times and subject to such terms and conditions as the Board may specify in the applicable SAR agreement; provided, however, that no SAR will be granted with a term in excess of 10 years. 

(d) Exercise of SARs. SARs may be exercised by delivery to the Company of a notice of exercise in a form (which may be electronic)
approved by the Company, together with any other documents required by the Board. 
  

	7.	 Restricted Stock; Restricted Stock Units 

(a) General. The Board may grant Awards entitling recipients to acquire shares of Common Stock (“Restricted
Stock”), subject to the right of the Company to repurchase all or part of such shares at their issue price or other stated or formula price (or to require forfeiture of such shares if issued at no cost) from the recipient in the event
that conditions specified by the Board in the applicable Award are not satisfied prior to the end of the applicable restriction period or periods established by the Board for such Award. The Board may also grant Awards entitling the recipient to
receive shares of Common Stock or cash to be delivered at the time such Award vests (“Restricted Stock Units”) (Restricted Stock and Restricted Stock Units are each referred to herein as a “Restricted Stock
Award”). 
 (b) Terms and Conditions for All Restricted Stock Awards. The Board shall determine the terms and conditions
of a Restricted Stock Award, including the conditions for vesting and repurchase (or forfeiture) and the issue price, if any. 
 (c)
Additional Provisions Relating to Restricted Stock. 
 (1) Dividends. Unless otherwise provided in the applicable Award
agreement, any dividends (whether paid in cash, stock or property) declared and paid by the Company with respect to shares of Restricted Stock (“Accrued Dividends”) shall be paid to the Participant only if and when such
shares become free from the restrictions on transferability and forfeitability that apply to such shares. Each payment of Accrued Dividends will be made no later than the end of the calendar year in which the dividends are paid to stockholders of
that class of stock or, if later, the 15th day of the third month following the lapsing of the restrictions on transferability and the forfeitability provisions applicable to the underlying shares of Restricted Stock. 

  
 5 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (2) Stock Certificates. The Company may require that any stock certificates issued in
respect of shares of Restricted Stock, as well as dividends or distributions paid on such Restricted Stock, shall be deposited in escrow by the Participant, together with a stock power endorsed in blank, with the Company (or its designee). At the
expiration of the applicable restriction periods, the Company (or such designee) shall deliver the certificates no longer subject to such restrictions to the Participant or if the Participant has died, to his or her Designated Beneficiary.
“Designated Beneficiary” means (i) the beneficiary designated, in a manner determined by the Board, by a Participant to receive amounts due or exercise rights of the Participant in the event of the Participant’s
death or (ii) in the absence of an effective designation by a Participant, “Designated Beneficiary” the Participant’s estate. 

(d) Additional Provisions Relating to Restricted Stock Units. 

(1) Settlement. Upon the vesting of and/or lapsing of any other restrictions (i.e., settlement) with respect to each Restricted Stock
Unit, the Participant shall be entitled to receive from the Company one share of Common Stock or (if so provided in the applicable Award agreement) an amount of cash equal to the Fair Market Value of one share of Common Stock. The Board may, in its
discretion, provide that settlement of Restricted Stock Units shall be deferred, on a mandatory basis or at the election of the Participant in a manner that complies with Section 409A of the Code. 

(2) Voting Rights. A Participant shall have no voting rights with respect to any Restricted Stock Units. 

(3) Dividend Equivalents. The Award agreement for Restricted Stock Units may provide Participants with the right to receive an amount
equal to any dividends or other distributions declared and paid on an equal number of outstanding shares of Common Stock (“Dividend Equivalents”). Dividend Equivalents may be paid currently or credited to an account for the
Participants, may be settled in cash and/or shares of Common Stock and may be subject to the same restrictions on transfer and forfeitability as the Restricted Stock Units with respect to which paid, in each case to the extent provided in the
applicable Award agreement. 
  

	8.	 Other Stock-Based Awards 

(a) General. Other Awards of shares of Common Stock, and other Awards that are valued in whole or in part by reference to, or are
otherwise based on, shares of Common Stock or other property, may be granted hereunder to Participants (“Other Stock-Based-Awards”). Such Other Stock-Based Awards shall also be available as a form of payment in the settlement
of other Awards granted under the Plan or as payment in lieu of compensation to which a Participant is otherwise entitled. Other Stock-Based Awards may be paid in shares of Common Stock or cash, as the Board shall determine. 

(b) Terms and Conditions. Subject to the provisions of the Plan, the Board shall determine the terms and conditions of each Other
Stock-Based Award, including any purchase price applicable thereto. 

  
 6 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

	9.	 Adjustments for Changes in Common Stock and Certain Other Events 

(a) Changes in Capitalization. In the event of any stock split, reverse stock split, stock dividend, recapitalization, combination of
shares, reclassification of shares, spin-off or other similar change in capitalization or event, or any dividend or distribution to holders of Common Stock other than an ordinary cash dividend, (i) the
number and class of securities available under the Plan, (ii) the number and class of securities and exercise price per share of each outstanding Option, (iii) the share and per-share provisions and
the measurement price of each outstanding SAR, (iv) the number of shares subject to and the repurchase price per share subject to each outstanding Restricted Stock Award and (v) the share and
per-share-related provisions and the purchase price, if any, of each outstanding Other Stock-Based Award, shall be equitably adjusted by the Company (or substituted Awards may be made, if applicable) in the
manner determined by the Board. Without limiting the generality of the foregoing, in the event the Company effects a split of the Common Stock by means of a stock dividend and the exercise price of and the number of shares subject to an outstanding
Option are adjusted as of the date of the distribution of the dividend (rather than as of the record date for such dividend), then an optionee who exercises an Option between the record date and the distribution date for such stock dividend shall be
entitled to receive, on the distribution date, the stock dividend with respect to the shares of Common Stock acquired upon such Option exercise, notwithstanding the fact that such shares were not outstanding as of the close of business on the record
date for such stock dividend. 
 (b) Reorganization Events. 

(1) Definition. A “Reorganization Event” shall mean: (a) any merger or consolidation of the Company with or
into another entity as a result of which all of the Common Stock of the Company is converted into or exchanged for the right to receive cash, securities or other property or is cancelled, (b) any transfer or disposition of all of the Common
Stock of the Company for cash, securities or other property pursuant to a share exchange or other transaction or (c) any liquidation or dissolution of the Company. 

(2) Consequences of a Reorganization Event on Awards Other than Restricted Stock. 

(i) In connection with a Reorganization Event, the Board may take any one or more of the following actions as to all or any (or any portion
of) outstanding Awards other than Restricted Stock on such terms as the Board determines (except to the extent specifically provided otherwise in an applicable Award agreement or another agreement between the Company and the Participant):
(i) provide that such Awards shall be assumed, or substantially equivalent Awards shall be substituted, by the acquiring or succeeding corporation (or an affiliate thereof), (ii) upon written notice to a Participant, provide that all of
the Participant’s unexercised Awards will terminate immediately prior to the consummation of such Reorganization Event unless exercised by the Participant (to the extent then exercisable) within a specified period following the date of such
notice, (iii) provide that outstanding Awards shall become exercisable, realizable, or deliverable, or restrictions applicable to an Award shall lapse, in whole or in part prior to or upon such Reorganization Event, (iv) in the event of a
Reorganization Event under the terms of which holders of Common Stock will receive upon 

  
 7 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 
consummation thereof a cash payment for each share surrendered in the Reorganization Event (the “Acquisition Price”), make or provide for a cash payment to Participants
with respect to each Award held by a Participant equal to (A) the number of shares of Common Stock subject to the vested portion of the Award (after giving effect to any acceleration of vesting that occurs upon or immediately prior to such
Reorganization Event) multiplied by (B) the excess, if any, of (I) the Acquisition Price over (II) the exercise, measurement or purchase price of such Award and any applicable tax withholdings, in exchange for the termination of such
Award, (v) provide that, in connection with a liquidation or dissolution of the Company, Awards shall convert into the right to receive liquidation proceeds (if applicable, net of the exercise, measurement or purchase price thereof and any
applicable tax withholdings) and (vi) any combination of the foregoing. In taking any of the actions permitted under this Section 9(b)(2), the Board shall not be obligated by the Plan to treat all Awards, all Awards held by a Participant,
or all Awards of the same type, identically. 
 (ii) Notwithstanding the terms of Section 9(b)(2)(i), in the case of outstanding
Restricted Stock Units that are subject to Section 409A of the Code: (i) if the applicable Restricted Stock Unit agreement provides that the Restricted Stock Units shall be settled upon a “change in control event” within the
meaning of Treasury Regulation Section 1.409A-3(i)(5)(i), and the Reorganization Event constitutes such a “change in control event”, then no assumption or substitution shall be permitted
pursuant to Section 9(b)(2)(i)(i) and the Restricted Stock Units shall instead be settled in accordance with the terms of the applicable Restricted Stock Unit agreement; and (ii) the Board may only undertake the actions set forth in
clauses (iii), (iv) or (v) of Section 9(b)(2)(i) if the Reorganization Event constitutes a “change in control event” as defined under Treasury Regulation Section 1.409A-3(i)(5)(i) and
such action is permitted or required by Section 409A of the Code; if the Reorganization Event is not a “change in control event” as so defined or such action is not permitted or required by Section 409A of the Code, and the
acquiring or succeeding corporation does not assume or substitute the Restricted Stock Units pursuant to clause (i) of Section 9(b)(2)(i), then the unvested Restricted Stock Units shall terminate immediately prior to the consummation of
the Reorganization Event without any payment in exchange therefor. 
 (iii) For purposes of Section 9(b)(2)(i)(i), an Award (other than
Restricted Stock) shall be considered assumed if, following consummation of the Reorganization Event, such Award confers the right to purchase or receive pursuant to the terms of such Award, for each share of Common Stock subject to the Award
immediately prior to the consummation of the Reorganization Event, the consideration (whether cash, securities or other property) received as a result of the Reorganization Event by holders of Common Stock for each share of Common Stock held
immediately prior to the consummation of the Reorganization Event (and if holders were offered a choice of consideration, the type of consideration chosen by the holders of a majority of the outstanding shares of Common Stock); provided,
however, that if the consideration received as a result of the Reorganization Event is not solely common stock of the acquiring or succeeding corporation (or an affiliate thereof), the Company may, with the consent of the acquiring or succeeding
corporation, provide for the consideration to be received upon the exercise or settlement of the Award to consist solely of such number of shares of common stock of the acquiring or succeeding corporation (or an affiliate thereof) that the Board
determined to be equivalent in value (as of the date of such determination or another date specified by the Board) to the per share consideration received by holders of outstanding shares of Common Stock as a result of the Reorganization Event. 

  
 8 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (3) Consequences of a Reorganization Event on Restricted Stock. Upon the occurrence
of a Reorganization Event other than a liquidation or dissolution of the Company, the repurchase and other rights of the Company with respect to outstanding Restricted Stock shall inure to the benefit of the Company’s successor and shall,
unless the Board determines otherwise, apply to the cash, securities or other property which the Common Stock was converted into or exchanged for pursuant to such Reorganization Event in the same manner and to the same extent as they applied to such
Restricted Stock; provided, however, that the Board may provide for termination or deemed satisfaction of such repurchase or other rights under the instrument evidencing any Restricted Stock or any other agreement between a Participant
and the Company, either initially or by amendment. Upon the occurrence of a Reorganization Event involving the liquidation or dissolution of the Company, except to the extent specifically provided to the contrary in the instrument evidencing any
Restricted Stock or any other agreement between a Participant and the Company, all restrictions and conditions on all Restricted Stock then outstanding shall automatically be deemed terminated or satisfied. 

 

	10.	 General Provisions Applicable to Awards. 

(a) Transferability of Awards. Awards (or any interest in an Award, including, prior to exercise, any interest in shares of Common Stock
issuable upon exercise of an Option or SAR) shall not be sold, assigned, transferred (including by establishing any short position, put equivalent position (as defined in Rule 16a-1 issued under the Exchange
Act) or call equivalent position (as defined in Rule 16a-1 issued under the Exchange Act)), pledged, hypothecated or otherwise encumbered by the person to whom they are granted, either voluntarily or by
operation of law, and, during the life of the Participant, shall be exercisable only by the Participant; except that Awards, other than Awards subject to Section 409A of the Code, may be transferred to family members (as defined in Rule
701(c)(3) under the Securities Act) through gifts or (other than Incentive Stock Options) domestic relations orders or to an executor or guardian upon the death or disability of the Participant. The Company shall not be required to recognize any
such permitted transfer until such time as such permitted transferee shall deliver to the Company a written instrument, as a condition to such transfer, in form and substance satisfactory to the Company confirming that such transferee shall be bound
by all of the terms and conditions of the Award. References to a Participant, to the extent relevant in the context, shall include references to authorized transferees. For the avoidance of doubt, nothing contained in this Section 10(a) shall
be deemed to restrict a transfer to the Company. 
 (b) Documentation. Each Award shall be evidenced in such form (written, electronic
or otherwise) as the Board shall determine. Each Award may contain terms and conditions in addition to those set forth in the Plan. 
 (c)
Board Discretion. Except as otherwise provided by the Plan, each Award may be made alone or in addition or in relation to any other Award. The terms of each Award need not be identical, and the Board need not treat Participants uniformly.

  
 9 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (d) Termination of Status. The Board shall determine the effect on an Award of the
disability, death, termination or other cessation of employment, authorized leave of absence or other change in the employment or other status of a Participant and the extent to which, and the period during which, the Participant, or the
Participant’s legal representative, conservator, guardian or Designated Beneficiary, may exercise rights under the Award.  

(e) Withholding. The Participant must satisfy all applicable federal, state, and local or other income and employment tax withholding
obligations before the Company will deliver stock certificates or otherwise recognize ownership of Common Stock under an Award. The Company may decide to satisfy the withholding obligations through additional withholding on salary or wages. If the
Company elects not to or cannot withhold from other compensation, the Participant must pay the Company the full amount, if any, required for withholding or have a broker tender to the Company cash equal to the withholding obligations. Payment of
withholding obligations is due before the Company will issue any shares on exercise, vesting or release from forfeiture of an Award or at the same time as payment of the exercise or purchase price unless the Company determines otherwise. If provided
for in an Award or approved by the Board in its sole discretion, a Participant may satisfy such tax obligations in whole or in part by delivery (either by actual delivery or attestation) of shares of Common Stock, including shares retained from the
Award creating the tax obligation, valued at their Fair Market Value; provided, however, except as otherwise provided by the Board, that the total tax withholding where stock is being used to satisfy such tax obligations cannot exceed the
Company’s minimum statutory withholding obligations (based on minimum statutory withholding rates for federal and state tax purposes, including payroll taxes, that are applicable to such supplemental taxable income). Shares used to satisfy tax
withholding requirements cannot be subject to any repurchase, forfeiture, unfulfilled vesting or other similar requirements. 
 (f)
Amendment of Award. 
 (1) The Board may amend, modify or terminate any outstanding Award, including but not limited to, substituting
therefor another Award of the same or a different type, changing the date of exercise or realization, and converting an Incentive Stock Option to a Nonstatutory Stock Option. The Participant’s consent to such action shall be required unless
(i) the Board determines that the action, taking into account any related action, does not materially and adversely affect the Participant’s rights under the Plan or (ii) the change is permitted under Section 9. 

(2) The Board may, without stockholder approval, amend any outstanding Award granted under the Plan to provide an exercise price per share that
is lower than the then-current exercise price per share of such outstanding Award. The Board may also, without stockholder approval, cancel any outstanding award (whether or not granted under the Plan) and grant in substitution therefor new Awards
under the Plan covering the same or a different number of shares of Common Stock and having an exercise price per share lower than the then-current exercise price per share of the cancelled award. 

  
 10 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (g) Conditions on Delivery of Stock. The Company will not be obligated to deliver any
shares of Common Stock pursuant to the Plan or to remove restrictions from shares previously issued or delivered under the Plan until (i) all conditions of the Award have been met or removed to the satisfaction of the Company, (ii) in the
opinion of the Company’s counsel, all other legal matters in connection with the issuance and delivery of such shares have been satisfied, including any applicable securities laws and regulations and any applicable stock exchange or stock
market rules and regulations, and (iii) the Participant has executed and delivered to the Company such representations or agreements as the Company may consider appropriate to satisfy the requirements of any applicable laws, rules or
regulations. 
 (h) Acceleration. The Board may at any time provide that any Award shall become immediately exercisable in whole or in
part, free of some or all restrictions or conditions, or otherwise realizable in whole or in part, as the case may be. 
  

	11.	 Miscellaneous. 

(a) No Right To Employment or Other Status. No person shall have any claim or right to be granted an Award by virtue of the adoption of
the Plan, and the grant of an Award shall not be construed as giving a Participant the right to continued employment or any other relationship with the Company. The Company expressly reserves the right at any time to dismiss or otherwise terminate
its relationship with a Participant free from any liability or claim under the Plan, except as expressly provided in the applicable Award. 

(b) No Rights As Stockholder. Subject to the provisions of the applicable Award, no Participant or Designated Beneficiary shall have any
rights as a stockholder with respect to any shares of Common Stock to be distributed with respect to an Award until becoming the record holder of such shares. 

(c) Effective Date and Term of Plan. The Plan shall become effective on the date on which it is adopted by the Board. No Awards shall be
granted under the Plan after the expiration of 10 years from the earlier of (i) the date on which the Plan was adopted by the Board or (ii) the date the Plan was approved by the Company’s stockholders, but Awards previously granted
may extend beyond that date. 
 (d) Amendment of Plan. The Board may amend, suspend or terminate the Plan or any portion thereof at
any time; provided that if at any time the approval of the Company’s stockholders is required as to any modification or amendment under Section 422 of the Code or any successor provision with respect to Incentive Stock Options, the
Board may not effect such modification or amendment without such approval. Unless otherwise specified in the amendment, any amendment to the Plan adopted in accordance with this Section 11(d) shall apply to, and be binding on the holders of,
all Awards outstanding under the Plan at the time the amendment is adopted, provided the Board determines that such amendment, taking into account any related action, does not materially and adversely affect the rights of Participants under the
Plan. 
 (e) Authorization of Sub-Plans (including Grants to
non-U.S. Employees). The Board may from time to time establish one or more sub-plans under the Plan for purposes of satisfying applicable securities, tax or other
laws of various jurisdictions. The Board shall establish such sub-plans by adopting supplements to the Plan containing (i) such limitations on the Board’s discretion under the Plan as the Board deems
necessary or desirable or (ii) such 

  
 11 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 
additional terms and conditions not otherwise inconsistent with the Plan as the Board shall deem necessary or desirable. All supplements adopted by the Board shall be deemed to be part of the
Plan, but each supplement shall apply only to Participants within the affected jurisdiction and the Company shall not be required to provide copies of any supplement to Participants in any jurisdiction which is not the subject of such supplement.

 (f) Compliance with Section 409A of the Code. Except as provided in individual Award agreements initially or by
amendment, if and to the extent (i) any portion of any payment, compensation or other benefit provided to a Participant pursuant to the Plan in connection with his or her employment termination constitutes “nonqualified deferred
compensation” within the meaning of Section 409A of the Code and (ii) the Participant is a specified employee as defined in Section 409A(a)(2)(B)(i) of the Code, in each case as determined by the Company in accordance with its
procedures, by which determinations the Participant (through accepting the Award) agrees that he or she is bound, such portion of the payment, compensation or other benefit shall not be paid before the day that is six months plus one day
after the date of “separation from service” (as determined under Section 409A of the Code) (the “New Payment Date”), except as Section 409A of the Code may then permit. The aggregate of any payments that
otherwise would have been paid to the Participant during the period between the date of separation from service and the New Payment Date shall be paid to the Participant in a lump sum on such New Payment Date, and any remaining payments will be paid
on their original schedule. 
 The Company makes no representations or warranty and shall have no liability to the Participant or any other person if any
provisions of or payments, compensation or other benefits under the Plan are determined to constitute nonqualified deferred compensation subject to Section 409A of the Code but do not to satisfy the conditions of that section. 

(g) Limitations on Liability. Notwithstanding any other provisions of the Plan, no individual acting as a director,
officer, other employee, or agent of the Company will be liable to any Participant, former Participant, spouse, beneficiary, or any other person for any claim, loss, liability, or expense incurred in connection with the Plan, nor will such
individual be personally liable with respect to the Plan because of any contract or other instrument he or she executes in his or her capacity as a director, officer, other employee, or agent of the Company. The Company will indemnify and hold
harmless each director, officer, other employee, or agent of the Company to whom any duty or power relating to the administration or interpretation of the Plan has been or will be delegated, against any cost or expense (including attorneys’
fees) or liability (including any sum paid in settlement of a claim with the Board’s approval) arising out of any act or omission to act concerning the Plan unless arising out of such person’s own fraud or bad faith. 

(h) Governing Law. The provisions of the Plan and all Awards made hereunder shall be governed by and interpreted in accordance with the
laws of the State of Delaware, excluding choice-of-law principles of the law of such state that would require the application of the laws of a jurisdiction other than
the State of Delaware. 

  
 12 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 URBAN COMPASS, INC. 

2012 STOCK INCENTIVE PLAN 

CALIFORNIA SUPPLEMENT 

Pursuant to Section 11(e) of the Plan, the Board has adopted this supplement for purposes of satisfying the requirements of
Section 25102(o) of the California Law: 
 Any Awards granted under the Plan to a Participant who is a resident of the State of
California on the date of grant (a “California Participant”) shall be subject to the following additional limitations, terms and conditions: 

1. Additional Limitations on Options. 
 (a)
Maximum Duration of Options. No Options granted to California Participants shall have a term in excess of 10 years measured from the Option grant date. 

(b) Minimum Exercise Period Following Termination. Unless a California Participant’s employment is terminated for cause (as defined
by applicable law, the terms of the Plan or option grant or a contract of employment), in the event of termination of employment of such Participant, such Participant shall have the right to exercise an Option, to the extent that such Participant is
entitled to exercise such Option on the date employment terminated, until the earlier of: (i) at least six months from the date of termination, if termination was caused by such Participant’s death or disability, (ii) at least 30 days
from the date of termination, if termination was caused other than by such Participant’s death or disability and (iii) the Option expiration date. 

2. Additional Limitations for Other Stock-Based Awards. The terms of all Awards granted to a California Participant under Section 8 of the Plan
shall comply, to the extent applicable, with Sections 260.140.42, 260.140.45 and 260.140.46 of the California Code of Regulations. 
 3. Additional
Limitations on Timing of Awards. No Award granted to a California Participant shall become exercisable, vested or realizable, as applicable to such Award, unless the Plan has been approved by the holders of a majority of the Company’s
outstanding voting securities by the later of (i) within 12 months before or after the date the Plan was adopted by the Board, or (ii) prior to or within 12 months of the granting of any Award to a California Participant. 

4. Additional Restriction Regarding Recapitalizations, Stock Splits, Etc. For purposes of Section 9 of the Plan, in the event of a stock split,
reverse stock split, stock dividend, recapitalization, combination, reclassification or other distribution of the Company’s securities underlying the Award without the receipt of consideration by the Company, the number of securities
purchasable, and in the case of Options, the exercise price of such Options, must be proportionately adjusted. 
 5. Additional Limitations on
Transferability of Awards. Notwithstanding the provisions of Section 10(a) of the Plan, an Award granted to a California Participant may not be transferred to an executor or guardian upon the disability of the Participant. 

 

  
 13 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 FIRST AMENDMENT TO THE URBAN COMPASS, INC. 

THIRD AMENDED & RESTATED 2012 STOCK INCENTIVE PLAN 

Urban Compass, Inc., a Delaware corporation (the “Corporation”), adopted the Corporation’s Third Amended and Restated
2012 Stock Incentive Plan on September 24, 2013 (the “Plan”). Unless otherwise defined herein, all capitalized terms shall have the meaning set forth in the Plan. 

Section 4(a) of the Plan shall be amended in its entirety to read as follows: 

“(a) Number of Shares. Subject to adjustment under Section 9, Awards may be made under the Plan for up to
2,960,000 shares of common stock, $0.0001 par value per share, of the Company (the “Common Stock”), any or all of which Awards may be in the form of Incentive Stock Options (as defined in Section 5(b)). If any Award
expires or is terminated, surrendered or canceled without having been fully exercised, is forfeited in whole or in part (including as the result of shares of Common Stock subject to such Award being repurchased by the Company at the original
issuance price pursuant to a contractual repurchase right), or results in any Common Stock not being issued, the unused Common Stock covered by such Award shall again be available for the grant of Awards under the Plan. Further, shares of Common
Stock tendered to the Company by a Participant to exercise an Award or to satisfy tax withholding obligations arising with respect to an Award shall be added to the number of shares of Common Stock available for the grant of Awards under the Plan.
However, in the case of Incentive Stock Options, the two immediately preceding sentences shall be subject to any limitations under the Code. Shares issued under the Plan may consist in whole or in part of authorized but unissued shares or treasury
shares.” 
 Except as expressly amended hereby, the Plan shall remain unchanged and in full force and effect and is hereby ratified and
confirmed. 
  

					
		 	Adopted by the Corporation’s Board of Directors:	  	April 23, 2014
			
		 	Adopted by the Corporation’s Stockholders:	  	May 16, 2014

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 SECOND AMENDMENT TO THE URBAN COMPASS, INC. 

THIRD AMENDED & RESTATED 2012 STOCK INCENTIVE PLAN 

Urban Compass, Inc., a Delaware corporation (the “Corporation”), adopted the Corporation’s Third Amended and Restated
2012 Stock Incentive Plan on September 24, 2013 (as amended, the “Plan”). Unless otherwise defined herein, all capitalized terms shall have the meaning set forth in the Plan. 

Section 4(a) of the Plan shall be amended in its entirety to read as follows: 

“(a) Number of Shares. Subject to adjustment under Section 9, Awards may be made under the Plan for up to
3,960,000 shares of common stock, $0.0001 par value per share, of the Company (the “Common Stock”), any or all of which Awards may be in the form of Incentive Stock Options (as defined in Section 5(b)). If any Award
expires or is terminated, surrendered or canceled without having been fully exercised, is forfeited in whole or in part (including as the result of shares of Common Stock subject to such Award being repurchased by the Company at the original
issuance price pursuant to a contractual repurchase right), or results in any Common Stock not being issued, the unused Common Stock covered by such Award shall again be available for the grant of Awards under the Plan. Further, shares of Common
Stock tendered to the Company by a Participant to exercise an Award or to satisfy tax withholding obligations arising with respect to an Award shall be added to the number of shares of Common Stock available for the grant of Awards under the Plan.
However, in the case of Incentive Stock Options, the two immediately preceding sentences shall be subject to any limitations under the Code. Shares issued under the Plan may consist in whole or in part of authorized but unissued shares or treasury
shares.” 
 Except as expressly amended hereby, the Plan shall remain unchanged and in full force and effect and is hereby ratified and
confirmed. 
  

					
		 	Adopted by the Corporation’s Board of Directors:	  	February 2, 2015
			
		 	Adopted by the Corporation’s Stockholders:	  	August 18, 2015

  

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 THIRD AMENDMENT TO THE URBAN COMPASS, INC. 

THIRD AMENDED & RESTATED 2012 STOCK INCENTIVE PLAN 

Urban Compass, Inc., a Delaware corporation (the “Corporation”), adopted the Corporation’s Third Amended and Restated
2012 Stock Incentive Plan on September 24, 2013 (as amended, the “Plan”). Unless otherwise defined herein, all capitalized terms shall have the meaning set forth in the Plan. 

Section 4(a) of the Plan shall be amended in its entirety to read as follows: 

“(a) Number of Shares. Subject to adjustment under Section 9, Awards may be made under the Plan for up to
4,560,000 shares of common stock, $0.0001 par value per share, of the Company (the “Common Stock”), any or all of which Awards may be in the form of Incentive Stock Options (as defined in Section 5(b)). If any Award
expires or is terminated, surrendered or canceled without having been fully exercised, is forfeited in whole or in part (including as the result of shares of Common Stock subject to such Award being repurchased by the Company at the original
issuance price pursuant to a contractual repurchase right), or results in any Common Stock not being issued, the unused Common Stock covered by such Award shall again be available for the grant of Awards under the Plan. Further, shares of Common
Stock tendered to the Company by a Participant to exercise an Award or to satisfy tax withholding obligations arising with respect to an Award shall be added to the number of shares of Common Stock available for the grant of Awards under the Plan.
However, in the case of Incentive Stock Options, the two immediately preceding sentences shall be subject to any limitations under the Code. Shares issued under the Plan may consist in whole or in part of authorized but unissued shares or treasury
shares.” 
 Except as expressly amended hereby, the Plan shall remain unchanged and in full force and effect and is hereby ratified and
confirmed. 
  

					
		 	Adopted by the Corporation’s Board of Directors:	  	February 3, 2016
			
		 	Adopted by the Corporation’s Stockholders:	  	March 11, 2016

  

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 FOURTH AMENDMENT TO THE URBAN COMPASS, INC. 

THIRD AMENDED & RESTATED 2012 STOCK INCENTIVE PLAN 

Urban Compass, Inc., a Delaware corporation (the “Corporation”), adopted the Corporation’s Third Amended and Restated
2012 Stock Incentive Plan on September 24, 2013 (as amended, the “Plan”). Unless otherwise defined herein, all capitalized terms shall have the meaning set forth in the Plan. 

Section 4(a) of the Plan shall be amended in its entirety to read as follows: 

“(a) Number of Shares. Subject to adjustment under Section 9, Awards may be made under the Plan for up to
5,370,467 shares of common stock, $0.0001 par value per share, of the Company (the “Common Stock”), any or all of which Awards may be in the form of Incentive Stock Options (as defined in Section 5(b)). If any Award
expires or is terminated, surrendered or canceled without having been fully exercised, is forfeited in whole or in part (including as the result of shares of Common Stock subject to such Award being repurchased by the Company at the original
issuance price pursuant to a contractual repurchase right), or results in any Common Stock not being issued, the unused Common Stock covered by such Award shall again be available for the grant of Awards under the Plan. Further, shares of Common
Stock tendered to the Company by a Participant to exercise an Award or to satisfy tax withholding obligations arising with respect to an Award shall be added to the number of shares of Common Stock available for the grant of Awards under the Plan.
However, in the case of Incentive Stock Options, the two immediately preceding sentences shall be subject to any limitations under the Code. Shares issued under the Plan may consist in whole or in part of authorized but unissued shares or treasury
shares.” 
 Except as expressly amended hereby, the Plan shall remain unchanged and in full force and effect and is hereby ratified and
confirmed. 
  

					
		 	Adopted by the Corporation’s Board of Directors:	  	February 1, 2017
			
		 	Adopted by the Corporation’s Stockholders:	  	March 30, 2017

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 FIFTH AMENDMENT TO THE URBAN COMPASS, INC. 

THIRD AMENDED & RESTATED 2012 STOCK INCENTIVE PLAN 

Effective January 19, 2018 

Urban Compass, Inc., a Delaware corporation (the “Corporation”), adopted the Corporation’s Third Amended and Restated
2012 Stock Incentive Plan on September 24, 2013 (as amended, the “Plan”). Unless otherwise defined herein, all capitalized terms shall have the meaning set forth in the Plan. 

Section 4(a) of the Plan shall be amended in its entirety to read as follows: 

“(a) Number of Shares. Subject to adjustment under Section 9, Awards may be made under the Plan for up to
6,442,642 shares of Class A Common Stock, $0.0001 par value per share, of the Company (the “Common Stock”), any or all of which Awards may be in the form of Incentive Stock Options (as defined in Section 5(b)). If
any Award expires or is terminated, surrendered or canceled without having been fully exercised, is forfeited in whole or in part (including as the result of shares of Common Stock subject to such Award being repurchased by the Company at the
original issuance price pursuant to a contractual repurchase right), or results in any Common Stock not being issued, the unused Common Stock covered by such Award shall again be available for the grant of Awards under the Plan. Further, shares of
Common Stock tendered to the Company by a Participant to exercise an Award or to satisfy tax withholding obligations arising with respect to an Award shall be added to the number of shares of Common Stock available for the grant of Awards under the
Plan. However, in the case of Incentive Stock Options, the two immediately preceding sentences shall be subject to any limitations under the Code. Shares issued under the Plan may consist in whole or in part of authorized but unissued shares or
treasury shares.” 
 Except as expressly amended hereby, the Plan shall remain unchanged and in full force and effect and is hereby
ratified and confirmed. 
  

					
		 	Adopted by the Corporation’s Board of Directors:	  	December 6, 2017
			
		 	    Adopted by the Corporation’s Stockholders:	  	December 6, 2017

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 SIXTH AMENDMENT TO THE URBAN COMPASS, INC. 

THIRD AMENDED & RESTATED 2012 STOCK INCENTIVE PLAN 

Effective October 22, 2018 

Urban Compass, Inc., a Delaware corporation (the “Corporation”), adopted the Corporation’s Third Amended and Restated
2012 Stock Incentive Plan on September 24, 2013 (as amended, the “Plan”). Unless otherwise defined herein, all capitalized terms shall have the meaning set forth in the Plan. 

Section 4(a) of the Plan shall be amended in its entirety to read as follows: 

“(a) Number of Shares. Subject to adjustment under Section 9, Awards may be made under the Plan for up to
7,700,640 shares of Class A Common Stock, $0.0001 par value per share, of the Company (the “Common Stock”), any or all of which Awards may be in the form of Incentive Stock Options (as defined in Section 5(b)). If
any Award expires or is terminated, surrendered or canceled without having been fully exercised, is forfeited in whole or in part (including as the result of shares of Common Stock subject to such Award being repurchased by the Company at the
original issuance price pursuant to a contractual repurchase right), or results in any Common Stock not being issued, the unused Common Stock covered by such Award shall again be available for the grant of Awards under the Plan. Further, shares of
Common Stock tendered to the Company by a Participant to exercise an Award or to satisfy tax withholding obligations arising with respect to an Award shall be added to the number of shares of Common Stock available for the grant of Awards under the
Plan. However, in the case of Incentive Stock Options, the two immediately preceding sentences shall be subject to any limitations under the Code. Shares issued under the Plan may consist in whole or in part of authorized but unissued shares or
treasury shares.” 
 Except as expressly amended hereby, the Plan shall remain unchanged and in full force and effect and is hereby
ratified and confirmed. 
  

					
		 	Adopted by the Corporation’s Board of Directors:	  	September 26, 2018
			
		 	    Adopted by the Corporation’s Stockholders:	  	October 16, 2018

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 SEVENTH AMENDMENT TO THE URBAN COMPASS, INC. 

THIRD AMENDED & RESTATED 2012 STOCK INCENTIVE PLAN 

Effective July 25, 2019 

Urban Compass, Inc., a Delaware corporation (the “Corporation”), adopted the Corporation’s Third Amended and Restated
2012 Stock Incentive Plan on September 24, 2013 (as amended, the “Plan”). Unless otherwise defined herein, all capitalized terms shall have the meaning set forth in the Plan. 

Section 4(a) of the Plan shall be amended in its entirety to read as follows: 

“(a) Number of Shares. Subject to adjustment under Section 9, Awards may be made under the Plan for up to
10,193,756 shares of Class A Common Stock, $0.0001 par value per share, of the Company (the “Common Stock”), any or all of which Awards may be in the form of Incentive Stock Options (as defined in Section 5(b)). If
any Award expires or is terminated, surrendered or canceled without having been fully exercised, is forfeited in whole or in part (including as the result of shares of Common Stock subject to such Award being repurchased by the Company at the
original issuance price pursuant to a contractual repurchase right), or results in any Common Stock not being issued, the unused Common Stock covered by such Award shall again be available for the grant of Awards under the Plan. Further, shares of
Common Stock tendered to the Company by a Participant to exercise an Award or to satisfy tax withholding obligations arising with respect to an Award shall be added to the number of shares of Common Stock available for the grant of Awards under the
Plan. However, in the case of Incentive Stock Options, the two immediately preceding sentences shall be subject to any limitations under the Code. Shares issued under the Plan may consist in whole or in part of authorized but unissued shares or
treasury shares.” 
 Except as expressly amended hereby, the Plan shall remain unchanged and in full force and effect and is hereby
ratified and confirmed. 
  

					
		 	Adopted by the Corporation’s Board of Directors:	  	July 25, 2019
			
		 	    Adopted by the Corporation’s Stockholders:	  	July 25, 2019

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 Exhibit D 

EIGHTH AMENDMENT TO THE URBAN COMPASS, INC. 

THIRD AMENDED & RESTATED 2012 STOCK INCENTIVE PLAN 

Effective March 12, 2020 

Urban Compass, Inc., a Delaware corporation (the “Corporation”), adopted the Corporation’s Third Amended and Restated
2012 Stock Incentive Plan on September 24, 2013 (as amended, the “Plan”). Unless otherwise defined herein, all capitalized terms shall have the meaning set forth in the Plan. 

Section 4(a) of the Plan shall be amended in its entirety to read as follows: 

“(a) Number of Shares. Subject to adjustment under Section 9, Awards may be made under the Plan for up to
11,916,118 shares of Class A Common Stock, $0.0001 par value per share, of the Company (the “Common Stock”), any or all of which Awards may be in the form of Incentive Stock Options (as defined in Section 5(b)). If
any Award expires or is terminated, surrendered or canceled without having been fully exercised, is forfeited in whole or in part (including as the result of shares of Common Stock subject to such Award being repurchased by the Company at the
original issuance price pursuant to a contractual repurchase right), or results in any Common Stock not being issued, the unused Common Stock covered by such Award shall again be available for the grant of Awards under the Plan. Further, shares of
Common Stock tendered to the Company by a Participant to exercise an Award or to satisfy tax withholding obligations arising with respect to an Award shall be added to the number of shares of Common Stock available for the grant of Awards under the
Plan. However, in the case of Incentive Stock Options, the two immediately preceding sentences shall be subject to any limitations under the Code. Shares issued under the Plan may consist in whole or in part of authorized but unissued shares or
treasury shares.” 
 Except as expressly amended hereby, the Plan shall remain unchanged and in full force and effect and is hereby
ratified and confirmed. 
  

					
		 	Adopted by the Corporation’s Board of Directors:	  	March 12, 2020
			
		 	        Adopted by the Corporation’s Stockholders:	  	March 12, 2020

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 NINTH AMENDMENT TO THE URBAN COMPASS, INC. 

THIRD AMENDED & RESTATED 2012 STOCK INCENTIVE PLAN 

Effective September 9, 2020 
 Urban Compass, Inc., a
Delaware corporation (the “Corporation”), adopted the Corporation’s Third Amended and Restated 2012 Stock Incentive Plan on September 24, 2013 (as amended, the “Plan”). Unless otherwise defined herein, all
capitalized terms shall have the meaning set forth in the Plan. 
 Section 4(a) of the Plan shall be amended in its entirety to read as
follows: 
 “(a) Number of Shares. Subject to adjustment under Section 9, Awards may be made under the Plan for up
to 13,916,118 shares of Class A Common Stock, $0.0001 par value per share, of the Company (the “Common Stock”), any or all of which Awards may be in the form of Incentive Stock Options (as defined in Section 5(b)).
If any Award expires or is terminated, surrendered or canceled without having been fully exercised, is forfeited in whole or in part (including as the result of shares of Common Stock subject to such Award being repurchased by the Company at the
original issuance price pursuant to a contractual repurchase right), or results in any Common Stock not being issued, the unused Common Stock covered by such Award shall again be available for the grant of Awards under the Plan. Further, shares of
Common Stock tendered to the Company by a Participant to exercise an Award or to satisfy tax withholding obligations arising with respect to an Award shall be added to the number of shares of Common Stock available for the grant of Awards under the
Plan. However, in the case of Incentive Stock Options, the two immediately preceding sentences shall be subject to any limitations under the Code. Shares issued under the Plan may consist in whole or in part of authorized but unissued shares or
treasury shares.” 
 Except as expressly amended hereby, the Plan shall remain unchanged and in full force and effect and is hereby ratified and
confirmed. 
 Adopted by the Corporation’s Board of Directors: September 9, 2020 

Adopted by the Corporation’s Stockholders: September 10, 2020 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 4 year vesting schedule, 1 year cliff 

URBAN COMPASS, INC. 

THIRD AMENDED & RESTATED 

2012 STOCK INCENTIVE PLAN 

NOTICE OF RESTRICTED STOCK UNIT AWARD 

You (“Recipient”) have been granted Restricted Stock Units (“RSUs”) representing shares of the Class A Common Stock of
Urban Compass, Inc. (the “Company”) on the following terms: 
  

					
	Name of Recipient:	  		  	«Name»
			
	Total Number of RSUs Granted:	  		  	«TotalRSUs»
			
	Date of Grant:	  		  	«DateGrant»
			
	Vesting Commencement Date:	  		  	«VestComDate»1
			
	Expiration Date:	  		  	«ExpirationDate»2
			
	Vesting:	  		  	You will receive a benefit with respect to the RSU only if it vests on or before the Expiration Date specified above. The “Vesting Date” of an RSU will be the first date on or before the Expiration Date upon which
the Vesting Requirement is satisfied with respect to that particular RSU.
			
	Vesting Requirement:	  		  	The Vesting Requirement will be satisfied in installments as to the RSUs as follows provided you remain in Service through the applicable Vesting Date: (i) with respect to the first 12/48ths of the RSUs subject to this award on
the 12 month anniversary of the Vesting Commencement Date specified above and (ii) with respect to an additional [1/48th of the RSUs subject to this award on each monthly] [3/48ths of the RSUs subject to this award on each quarterly]
anniversary of the Vesting Commencement Date thereafter for the next 36 months.
			
	Settlement:	  		  	Settlement of RSUs refers to the issuance of Shares once the RSU is vested. If an RSU vests as a result of satisfaction of the Vesting Requirement as described above, the Company will deliver one Share for each vested RSU subject to
this award at the time of settlement specified in Section 4 of the Restricted Stock Unit Agreement. No fractional RSUs or rights for fractional Shares shall be created pursuant to this Notice of Grant.

  
  

 

	1 	 Consider uniform vesting dates (for instance, the first of the month) and quarterly vesting dates to facilitate
settlement and limit the number of dates each year when withholding taxes have to be paid. 

	2 	 Ten years from the date of grant. 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 By signing below or otherwise accepting this award in a manner acceptable to the Company, you and the Company
agree that these RSUs are granted under and governed by the terms and conditions of this Notice of Restricted Stock Unit Award, the Third Amended & Restated 2012 Stock Incentive Plan (the “Plan”) and the Restricted Stock
Unit Agreement. These latter two documents are attached to, and made a part of, this Notice of Restricted Stock Unit Award. Capitalized terms not otherwise defined herein or in the Restricted Stock Unit Agreement shall have the meaning set forth in
the Plan. You hereby acknowledge that (i) this agreement supersedes any other agreements, representations or understandings (whether oral or written and whether express or implied) that relate to the subject matter hereof, including without
limitation, the Offer Letter; and (ii) the vesting of the RSUs pursuant to this Notice of Restricted Stock Unit Award is conditioned on the satisfaction of the Vesting Requirement. Section 10 of the Restricted Stock Unit
Agreement also includes important acknowledgements. 
  

							
	RECIPIENT:	 	URBAN COMPASS, INC.
				
	  
	 		 	By:	 	  

	Email Address:	 		 	Title:	 	  

				
	  
	 		 		 	
	Address for Mailing Stock Certificate (only applicable if the Company has certificated shares):	 		 		 	
				
	  
	 		 		 	

  

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 THE RSUS GRANTED PURSUANT TO THE NOTICE OF RESTRICTED STOCK UNIT AWARD AND THIS AGREEMENT AND THE SHARES
ISSUABLE THEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD, PLEDGED, OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT OR AN OPINION OF COUNSEL, SATISFACTORY TO THE
COMPANY AND ITS COUNSEL, THAT SUCH REGISTRATION IS NOT REQUIRED. 
 URBAN COMPASS, INC.

 AMENDED AND RESTATED 

2012 STOCK INCENTIVE PLAN 

RESTRICTED STOCK UNIT AGREEMENT 

SECTION 1. GRANT OF RESTRICTED STOCK UNITS. 

(a) Grant. On the terms and conditions set forth in the Notice of Restricted Stock Unit Award and this Agreement, the Company grants to
you on the Date of Grant the number of RSUs set forth in the Notice of Restricted Stock Unit Award. Each RSU represents the right to receive one Share on the terms and conditions set forth in this Agreement. 

(b) Consideration. No payment is required for the RSUs that have been granted to you. 

(c) Nature of Units; No Rights As a Stockholder. Your RSUs are mere bookkeeping entries and represent only the Company’s unfunded
and unsecured promise to issue Shares on a future date under specified conditions. As a holder of RSUs, you have no rights other than the rights of a general creditor of the Company. Your RSUs carry neither voting rights nor rights to cash
dividends. You have no rights as a stockholder of the Company unless and until your RSUs are settled pursuant to Section 4. 
 (d)
Stock Plan and Defined Terms. Your RSUs are granted pursuant to the Plan, a copy of which you acknowledge having received. The provisions of the Plan are incorporated into this Agreement by this reference. Certain capitalized terms are
defined in Section 10 of this Agreement. Capitalized terms not otherwise defined herein or in the Notice of Restricted Stock Unit Award shall have the meanings set forth in the Plan. 

SECTION 2. VESTING. 
 (a)
Generally. The RSUs vest in accordance with the vesting schedule set forth in the Notice of Restricted Stock Unit Award. You will receive a benefit with respect to the RSU only if the Vesting Requirement is satisfied on or before the
Expiration Date. Your RSUs will not vest (in whole or in part) if such requirement is not satisfied on or before the Expiration Date. 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (b) Termination of Service. If your Service terminates for any reason, all RSUs as to
which the Vesting Requirement has not been satisfied as of your termination date shall automatically terminate and be cancelled on the date that is 30 days after your termination date (such 30-day period, the
“Post-Termination Period”). Except as provided in Subsection (c) below and in this Section 2(b), you will not satisfy the Vesting Requirement for any additional RSUs after your Service has terminated for any reason.
Upon your termination of Service, any RSUs as to which the Vesting Requirement has been satisfied will remain outstanding until the first to occur of settlement or the Expiration Date. Upon a termination of one or more RSUs pursuant to this
Section 2, you will have no further right with respect to such RSUs or the Shares previously allocated thereto. 
 (c) Additional
Vesting Credit After Termination of Service. To the extent the Vesting Requirement is not fully satisfied when your Service terminates, the Board of Directors may, during the Post-Termination Period, take action to cause the Vesting Requirement
to be satisfied with respect to additional RSUs. In no event will the Vesting Requirement be satisfied after termination of your Service unless the Board of Directors takes affirmative action pursuant to the preceding sentence or unless expressly
provided in a written agreement between you and the Company. 
 (d) Expiration of RSUs. To the extent the Vesting Requirement is not
satisfied on or before the Expiration Date set forth in the Notice of Restricted Stock Unit Award, all RSUs as to which the Vesting Requirement had not been satisfied shall automatically terminate and be cancelled upon such date. 

(e) Part-Time Employment and Leaves of Absence. If you commence working on a part-time basis, then the Company may adjust the Vesting
Requirement set forth in the Notice of Restricted Stock Unit Award. If you go on a leave of absence, then, to the extent permitted by applicable law, the Company may adjust or suspend the Vesting Requirement set forth in the Notice of Restricted
Stock Unit Award. Except as provided in the preceding sentence, Service shall be deemed to continue for any purpose under this Agreement while you are on a bona fide leave of absence approved by the Company in writing. Service shall be deemed
to terminate when such leave ends, unless you immediately return to active work when such leave ends. 
 SECTION 3. RESTRICTIONS APPLICABLE TO RSUS.

 Except as otherwise provided in or pursuant to this Agreement or the Plan, these RSUs and the rights and privileges conferred hereby
shall not be sold, assigned, transferred, pledged, hypothecated, or otherwise disposed of by you prior to the settlement of the RSUs. However, you may designate a third party who, in the event of your death, shall thereafter be entitled to receive
any distribution of Shares to which you were entitled at the time of your death pursuant to this Agreement by delivering a written beneficiary designation to the Company’s headquarters on the prescribed form before your death. If you deliver no
such beneficiary designation or if your designated beneficiaries do not survive you, your estate will receive payments in respect of any vested RSUs. 

  
 2 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 SECTION 4. SETTLEMENT OF RSUS. 

(a) Settlement Date. Upon or following a Vesting Date with respect to a particular RSU, the Company will settle the RSU by one Share for
that RSU. RSUs shall be settled no later than March 15 of the calendar year following the calendar year in which a Vesting Date occurs. You will not be permitted, directly or indirectly, to select the calendar year of settlement. Settlement
means the delivery of the Shares vested under an RSU. Settlement of vested RSUs shall occur whether or not you are in Service at the time of settlement. 

(b) Form of Delivery. The form of any delivery of Shares (e.g., a stock certificate or electronic entry evidencing such shares) shall be
determined by the Company. 
 (c) Legality of Issuance. No Shares shall be issued to you upon settlement of these RSUs unless and
until the Company has determined that (i) you and the Company have taken any actions required to register the Shares under the Securities Act or to perfect an exemption from the registration requirements thereof; (ii) any applicable
listing requirement of any stock exchange or other securities market on which Stock is listed has been satisfied; and (iii) any other applicable provision of federal, State or foreign law has been satisfied. The Company shall have no liability
to issue Shares in respect of the RSUs unless it is able to do so in compliance with applicable law. 
 SECTION 5. TAXES. 

(a) Withholding Taxes. No consideration will be paid to you in respect of this award unless you have made arrangements satisfactory to
the Company and/or the Parent or Subsidiary employing you (your “Employer”) for the payment of all applicable federal, State, local and foreign income and employment withholding taxes which arise in connection with the vesting
and/or settlement of these RSUs (the “Withholding Taxes”). To the extent that you fail to make such arrangements with respect to these RSUs, then you will permanently forfeit such RSUs. At the discretion of the Company, these
arrangements may include (i) withholding from other compensation or amounts that are owed to you by your Employer, (ii) payment in cash, (iii) if the Stock is publicly traded, payment from the proceeds of the sale of shares through a
Company-approved broker through a voluntary sale or through a mandatory sale arranged by the Company (on your behalf and you hereby authorize such sales by this authorization), (iv) withholding a number of Shares that otherwise would be issued
to you when the RSUs are settled, or (v) any other method permitted by the Company. If the Withholding Taxes are satisfied pursuant to clause (iv), you will be deemed to have been issued the full number of Shares subject to the RSUs and the
Fair Market Value of the withheld Shares, determined as of the date when taxes otherwise would have been withheld in cash, will be applied to the Withholding Taxes and such amount will be remitted to appropriate tax authorities by the Company or
your Employer. You acknowledge that the responsibility for all Withholding Taxes is yours and may exceed the amount actually withheld by the Company or your Employer. 

(b) Section 409A. The settlement of these RSUs is intended to comply with the requirements of Code Section 409A
and shall be administered and interpreted in a manner that complies with such requirements so that this award is not subject to additional tax or interest under Code Section 409A. To the extent that any provision of this Agreement is ambiguous
as 

  
 3 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 
to its compliance with Code Section 409A, the provision shall be read in such a manner so that all payments hereunder comply with Code Section 409A. In this regard, to the extent
necessary to comply with Code Section 409A, any reference to your “termination of employment” or similar terms will mean your “separation from service” within the meaning of Code Section 409A(a)(2)(A)(i) (a
“Separation”). In addition, if this award is payable upon your Separation and you are a “specified employee” of the Company or any affiliate thereof within the meaning of Code Section 409A(a)(2)(B)(i) on the day of
your Separation, then no such payment shall be made prior to the date that is the earlier of (i) six months and one day after your Separation, or (ii) your death, but only to the extent such delay is necessary so that this award is not
subject to additional tax or interest under Code Section 409A. Each installment of your RSUs that vests is intended to constitute a separate payment for purposes of Code Section 409A. 

SECTION 6. RESTRICTIONS APPLICABLE TO SHARES. 

(a) Securities Law Restrictions. Regardless of whether the offering and sale of Shares under the Plan have been registered under the
Securities Act or have been registered or qualified under the securities laws of any State or other relevant jurisdiction, the Company at its discretion may impose restrictions upon the sale, pledge or other transfer of such Shares (including the
placement of appropriate legends on the stock certificates (or electronic equivalent) or the imposition of stop-transfer instructions) and may refuse (or may be required to refuse) to transfer Shares acquired
hereunder (or Shares proposed to be transferred in a subsequent transfer) if, in the judgment of the Company, such restrictions, legends or refusal are necessary or appropriate to achieve compliance with the Securities Act or other relevant
securities or other laws, including without limitation under Regulation S of the Securities Act or pursuant to another available exemption from registration. You (or the beneficiary or your personal representative in the event of your death or
incapacity, as the case may be) shall deliver to the Company any representations or other documents or assurances as the Company may deem necessary or reasonably desirable to ensure compliance with all applicable legal and regulatory requirements.

 (b) Market Stand-Off. In connection with any underwritten public offering by the Company of
its equity securities pursuant to an effective registration statement filed under the Securities Act, including the Company’s initial public offering, you or a Transferee shall not directly or indirectly sell, make any short sale of, loan,
hypothecate, pledge, offer, grant or sell any option or other contract for the purchase of, purchase any option or other contract for the sale of, or otherwise dispose of or transfer, or agree to engage in any of the foregoing transactions with
respect to, any Shares acquired under this Agreement without the prior written consent of the Company or its managing underwriter. Such restriction (the “Market Stand-Off”) shall be in effect
for such period of time following the date of the final prospectus for the offering as may be requested by the Company or such underwriter. In no event, however, shall such period exceed 180 days plus such additional period as may reasonably be
requested by the Company or such underwriter to accommodate regulatory restrictions on (i) the publication or other distribution of research reports or (ii) analyst recommendations and opinions, including (without limitation) the
restrictions set forth in Rule 2711(f)(4) of the National Association of Securities Dealers and Rule 472(f)(4) of the New York Stock Exchange, as amended, or any similar successor rules. The Market
Stand-Off shall in any event terminate two years after the date of 

  
 4 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 
the Company’s initial public offering. In the event of the declaration of a stock dividend, a spin-off, a stock split, an adjustment in conversion
ratio, a recapitalization or a similar transaction affecting the Company’s outstanding securities without receipt of consideration, any new, substituted or additional securities which are by reason of such transaction distributed with respect
to any Shares subject to the Market Stand-Off, or into which such Shares thereby become convertible, shall immediately be subject to the Market Stand-Off. In order to
enforce the Market Stand-Off, the Company may impose stop-transfer instructions with respect to the Shares acquired under this Agreement until the end of the applicable
stand-off period. The Company’s underwriters shall be beneficiaries of the agreement set forth in this Section 6(b). This Section 6(c) shall not apply to Shares registered in the public offering
under the Securities Act. 
 (c) Investment Intent at Grant. You represent and agree that the Shares to be acquired upon settlement of
these RSUs will be acquired for investment, and not with a view to the sale or distribution thereof. 
 (d) Investment Intent at
Settlement. In the event that the sale of Shares under the Plan is not registered under the Securities Act but an exemption is available that requires an investment representation or other representation, you shall represent and agree at the
time of issuance that the Shares being acquired upon settlement of these RSUs are being acquired for investment, and not with a view to the sale or distribution thereof, and shall make such other representations as are deemed necessary or
appropriate by the Company and its counsel, including, at the time of settlement, such representations as required by Regulation S of the Securities Act (if the Company is relying on such exemption). 

(e) Rights of the Company. The Company shall not be required to (i) transfer on its books any Shares that have been sold or
transferred in contravention of this Agreement or (ii) treat as the owner of Shares, or otherwise to accord voting, dividend or liquidation rights to, any Transferee to whom the Shares have been transferred in contravention of this Agreement.

 (f) Legends. All certificates evidencing the Shares issued under this Agreement shall bear the following legend: 

“THE SHARES REPRESENTED HEREBY (AND ANY INTEREST THEREIN) MAY NOT BE SOLD, ASSIGNED, TRANSFERRED, ENCUMBERED OR IN ANY MANNER DISPOSED OF,
EXCEPT IN COMPLIANCE WITH THE TERMS OF THE RESTRICTED STOCK UNIT AGREEMENT PURSUANT TO WHICH SUCH SHARES WERE ACQUIRED. THE SHARES ARE SUBJECT TO RESTRICTIONS ON TRANSFER AS SET FORTH IN SUCH RESTRICTED STOCK UNIT AGREEMENT. THE SECRETARY OF THE
COMPANY WILL UPON WRITTEN REQUEST FURNISH A COPY OF SUCH RESTRICTED STOCK UNIT AGREEMENT TO THE HOLDER HEREOF WITHOUT CHARGE.” 
 All certificates
evidencing Shares issued under this Agreement in an unregistered transaction shall bear the following legend (and such other restrictive legends as are required or deemed advisable under the provisions of any applicable law): 

  
 5 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 “THE SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF
1933, AS AMENDED (THE “ACT”) OR ANY SECURITIES LAWS OF ANY U.S. STATE, AND MAY NOT BE SOLD, REOFFERED, PLEDGED, ASSIGNED, ENCUMBERED OR OTHERWISE TRANSFERRED OR DISPOSED OF WITHOUT AN EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT OR AN
OPINION OF COUNSEL, SATISFACTORY TO THE COMPANY AND ITS COUNSEL, THAT SUCH REGISTRATION IS NOT REQUIRED. IN THE ABSENCE OF REGISTRATION OR THE AVAILABILITY (CONFIRMED BY OPINION OF COUNSEL) OF AN ALTERNATIVE EXEMPTION FROM REGISTRATION UNDER THE ACT
(INCLUDING WITHOUT LIMITATION IN ACCORDANCE WITH REGULATION S UNDER THE ACT), THESE SHARES MAY NOT BE SOLD, REOFFERED, PLEDGED, ASSIGNED, ENCUMBERED OR OTHERWISE TRANSFERRED OR DISPOSED OF. HEDGING TRANSACTIONS INVOLVING THESE SHARES MAY NOT BE
CONDUCTED UNLESS IN COMPLIANCE WITH THE ACT.” 
 (g) Removal of Legends. If, in the opinion of the Company and its counsel, any
legend placed on a stock certificate representing Shares issued under this Agreement is no longer required, the holder of such certificate shall be entitled to exchange such certificate for a certificate representing the same number of Shares but
without such legend. 
 (h) Administration. Any determination by the Company and its counsel in connection with any of the matters set
forth in this Section 6 shall be conclusive and binding on you and all other persons. 
 SECTION 7. ADJUSTMENT OF SHARES. 

In the event of any transaction described in Section 9(a) of the Plan, the terms of these RSUs (including, without limitation, the number
and kind of shares subject to these RSUs) shall be adjusted as set forth in Section 9(a) of the Plan. In the event that the Company is a party to a Reorganization Event or in the event of a sale of all or substantially all of the Company’s
assets, these RSUs shall be subject to the treatment provided by the Board of Directors in its sole discretion, as provided in Section 9(b) of the Plan; provided, however, that any action taken must either preserve the exemption
of your RSUs from Code Section 409A or comply with Code Section 409A. Any additional RSUs and any new, substituted or additional shares, cash or other property that become subject to this award as a result of any such transaction shall be
subject to the same conditions and restrictions as applicable to the RSUs to which they relate. 
 SECTION 8. CONVERSION OF SHARES TO NONVOTING SHARES.

 At such time as deemed necessary or advisable by the Company (including any officer of the Company and any employee on the
Company’s equity administration team or such other team that performs similar functions) to comply with Part 175.22 of the New York Real Estate Licensing Law, any similar or successor rule or statue of New York or any similar law, rule or
statute of any other jurisdiction (the “Regulation”), or at such time you notify the Company that you are subject to the Regulation, any Shares issued to you upon the settlement of 

  
 6 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 
these RSUs shall automatically be converted, with no further action by you, into an equal number of shares of nonvoting Class B Common Stock, $0.0001 par value per share, of the Company
(“Nonvoting Shares”). To effectuate such conversion to Nonvoting Shares, you hereby constitute and appoint each officer and director of the Company as your agent and attorney-in-fact for purposes of executing or approving such documents, and taking such actions, as may be deemed necessary or advisable by such agent and attorney-in-fact with respect to the conversion of such Shares. This power of attorney, being coupled with an interest, is irrevocable and shall survive your death, disability or incapacitation. 

SECTION 9. MISCELLANEOUS PROVISIONS. 
 (a)
No Retention Rights. Nothing in this Agreement or in the Plan shall confer upon you the right to remain in Service in any capacity for any period of specific duration or interfere with or otherwise restrict in any way the rights of the
Company (or any Parent or Subsidiary employing or retaining you) or you, which rights are hereby expressly reserved by each, to terminate your Service at any time and for any reason, with or without cause. 

(b) Notice. Any notice required by the terms of this Agreement shall be given in writing. It shall be deemed effective upon
(i) personal delivery, (ii) deposit with the United States Postal Service, by registered or certified mail, with postage and fees prepaid, (iii) deposit with Federal Express Corporation, with shipping charges prepaid or
(iv) deposit with any internationally recognized express mail courier service, with shipping charges prepaid. Notice shall be addressed to the Company at its principal executive office and to you at the address that you most recently provided
to the Company in accordance with this Section 9(b). In addition, to the extent required or permitted pursuant to rules established by the Company from time to time, notices may be delivered electronically. 

(c) Modifications and Waivers. No provision of this Agreement shall be modified, waived or discharged unless the modification, waiver or
discharge is agreed to in writing and signed by you and by an authorized officer of the Company (other than you). No waiver by either party of any breach of, or of compliance with, any condition or provision of this Agreement by the other party
shall be considered a waiver of any other condition or provision or of the same condition or provision at another time. 
 (d) Entire
Agreement. The Notice of Restricted Stock Unit Award, this Agreement and the Plan constitute the entire understanding between you and the Company regarding the subject matter hereof. They supersede any other agreements, representations or
understandings (whether oral or written and whether express or implied) that relate to the subject matter hereof, including without limitation, the Offer Letter. 

(e) Choice of Law. This Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware, as such
laws are applied to contracts entered into and performed in such State. 
 (f) Severability. Whenever possible, each provision of this
Agreement shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Agreement shall be held to be prohibited by or invalid under applicable law,

  
 7 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 
such provision shall be ineffective only to the extent of such prohibition or invalidity, without invalidating the remainder of such provision or the remaining provisions of this Agreement. 

(g) Successors and Assigns. Except as otherwise expressly provided to the contrary, the provisions of this Agreement shall inure to the
benefit of, and be binding upon, the Company and its successors and assigns and be binding upon you and your legal representatives, heirs, legatees, distributees, assigns and transferees by operation of law, whether or not any such person has become
a party to this Agreement or has agreed in writing to join herein and to be bound by the terms, conditions and restrictions hereof. 
 SECTION 10.
ACKNOWLEDGEMENTS. 
 In addition to the other terms, conditions and restrictions imposed on your RSUs and the Shares issuable upon
settlement of your RSUs pursuant to this Agreement and the Plan, you expressly acknowledge being subject to Section 6 (Restrictions Applicable to Shares, including without limitation the Market
Stand-Off), as well as the following provisions: 
 (a) Tax Consequences. You acknowledge that
there will be tax consequences upon vesting and/or settlement of the RSUs and/or disposition of the Shares, if any, received hereunder, and you should consult a tax adviser regarding your tax obligations prior to such event. You acknowledge that the
Company is not providing any tax, legal, or financial advice, nor is the Company making any recommendations regarding your participation in the Plan or acquisition or sale of Shares subject to this award. You are hereby advised to consult with your
own personal tax, legal, and financial advisors regarding your participation in the Plan. You further acknowledge that the Company (i) makes no representations or undertakings regarding the tax treatment of the award of RSUs, including, but not
limited to the grant, vesting, or settlement of the RSUs, the subsequent sale of Shares acquired pursuant to such RSUs, and the receipt of any dividends; and (ii) does not commit to and is under no obligation to structure the terms of the grant
of the RSUs to reduce or eliminate your tax liability or achieve any particular tax result. You agree that the Company does not have a duty to design or administer the RSUs, the Plan or its other compensation programs in a manner that minimizes your
tax liability. You shall not make any claim against the Company or its Board of Directors, officers, or employees related to tax matters arising from this award or your other compensation. 

(b) Electronic Delivery of Documents. You acknowledge and agree that the Company may, in its sole discretion, deliver all documents
relating the Company, the Plan or these RSUs and all other documents that the Company is required to deliver to its security holders (including, without limitation, disclosures that may be required by the Securities and Exchange Commission) by email
or other means of electronic transmission (including by posting them on a website maintained by the Company or a third party under contract with the Company). You acknowledge that you may incur costs in connection with any such delivery by means of
electronic transmission, including the cost of accessing the internet and printing fees, and that an interruption of internet access may interfere with his or her ability to access the documents. 

  
 8 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (c) Plan Discretionary. You understand and acknowledge that (i) the Plan is
entirely discretionary, (ii) the Company and your employer have reserved the right to amend, suspend or terminate the Plan at any time, (iii) the grant of the RSUs does not in any way create any contractual or other right to receive
additional grants of RSUs (or benefits in lieu of RSUs) at any time or in any amount and (iv) all determinations with respect to any additional grants, including (without limitation) the times when RSUs will be granted, the number of Shares
offered, and the vesting schedule, will be at the sole discretion of the Company. 
 (d) Termination of Service. You understand and
acknowledge that participation in the Plan ceases upon termination of your Service for any reason, except as may explicitly be provided otherwise in the Plan or this Agreement. 

(e) Extraordinary Compensation. The value of your RSUs and the Shares issuable thereunder shall be an extraordinary item of compensation
outside the scope of your employment contract, if any, and shall not be considered a part of your normal or expected compensation for purposes of calculating severance, resignation, redundancy or end-of-service payments, bonuses, long-service awards, pension or retirement benefits or similar payments. 

(f) Authorization to Disclose. You hereby authorize and direct your employer to disclose to the Company or any Subsidiary any
information regarding your employment, the nature and amount of your compensation and the fact and conditions of your participation in the Plan, as your employer deems necessary or appropriate to facilitate the administration of the Plan. 

(g) Personal Data Authorization. You consent to the collection, use and transfer of personal data as described in this
Subsection (g). You understand and acknowledge that the Company, your employer and the Company’s other Subsidiaries hold certain personal information regarding you for the purpose of managing and administering the Plan, including (without
limitation) your name, home address, telephone number, date of birth, social insurance number, salary, nationality, job title, any Shares or directorships held in the Company and details of all RSUs or any other entitlements to Shares awarded,
canceled, exercised, vested, unvested or outstanding in your favor (the “Data”). You further understand and acknowledge that the Company and/or its Subsidiaries will transfer Data among themselves as necessary for the purpose of
implementation, administration and management of your participation in the Plan and that the Company and/or any Subsidiary may each further transfer Data to any third party assisting the Company in the implementation, administration and management
of the Plan. You understand and acknowledge that the recipients of Data may be located in the United States or elsewhere. You authorize such recipients to receive, possess, use, retain and transfer Data, in electronic or other form, for the purpose
of administering your participation in the Plan, including a transfer to any broker or other third party with whom you elect to deposit Shares acquired under the Plan of such Data as may be required for the administration of the Plan and/or the
subsequent holding of Shares on your behalf. You may, at any time, view the Data, require any necessary modifications of Data or withdraw the consents set forth in this Subsection (g) by contacting the Company in writing. 

  
 9 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 SECTION 11. DEFINITIONS. 

(a) “Agreement” means this Restricted Stock Unit Agreement. 

(b) “Board of Directors” means the Board of Directors of the Company, as constituted from time to time or, if a Committee has
been appointed, such Committee. 
 (c) “Code” means the Internal Revenue Code of 1986, as amended. 

(d) “Company” means Urban Compass, Inc., a Delaware corporation. 

(e) “Date of Grant” means the date specified in the Notice of Restricted Stock Unit Award, which date shall be the later of
(i) the date on which the Board of Directors resolved to grant these RSUs or (ii) your first date of Service. 
 (f)
“Expiration Date” means the expiration date of the RSUs as set forth in the Notice of Restricted Stock Unit Award. 
 (g)
“Offer Letter” means the employment offer letter, by and between you and the Company. 
 (h) “Plan” means
the Urban Compass, Inc. Third Amended & Restated 2012 Stock Incentive Plan, as in effect on the Date of Grant. 
 (i)
“RSUs” means the Restricted Stock Units granted to you by the Company as set forth in the Notice of Restricted Stock Unit Award. 

(j) “Service” means service as an Employee, Consultant or Outside Director. In the event of any dispute over whether and when
Service has terminated, the Board of Directors shall have sole discretion to determine whether such termination has occurred and the effective date of such termination. 

(k) “Transferee” means any person to whom you have directly or indirectly transferred any Shares acquired under this
Agreement. 
 (l) “Vesting Requirement” means the requirement to provide Service over the period of time set forth in the
Notice of Restricted Stock Unit Award. 
  

  
 10 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 Hello, 
 Please
find a stock option agreement as approved by the Board of Urban Compass, Inc. d/b/a Compass (“Compass”) on ###GRANT_DATE###. By signing this stock option agreement, you are not agreeing to purchase any common shares of Compass. Rather, you
are agreeing that you have the right to purchase common shares of Compass at a price of ###GRANT_PRICE### per common share, subject to all of the terms of the agreement. The total number of common shares under your option is stated in the first
paragraph of the attached stock option agreement.*** Also attached are: (1) an FAQ about Compass equity, (2) an informational memorandum about our Stock Incentive Plan, including a brief summary of the tax consequences in connection with
exercising your stock option, and the information described in Rules 701(e)(2), (3), (4) and (5) under the Securities Act of 1933, as amended (the “Securities Act”), and (3) the current Stock Incentive Plan. If you have any
questions after reading the attachments, please feel free to send them to equity@compass.com. 
 Best, 

The Compass Equity Team 
 URBAN COMPASS, INC.

 Nonstatutory Stock Option Agreement (Early Exercise) 

Granted Under the Third Amended & Restated 2012 Stock Incentive Plan 

 

	1.	 Grant of Option. 

This agreement evidences the grant by Urban Compass, Inc., a Delaware corporation (the “Company”), on ###GRANT_DATE### (the “Grant Date”)
to ###PARTICIPANT_NAME###, an employee, consultant or director of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s Third Amended & Restated 2012
Stock Incentive Plan (as amended, the “Plan”), a total of ###TOTAL_AWARDS### shares (the “Shares”) of Class A Common Stock, $0.0001 par value per share, of the Company (“Common Stock”) at ###GRANT_PRICE### per
Share (the “Exercise Price”). Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on ###EXPIRY_DATE### (the “Final Exercise Date”). 

It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code
of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the
right to exercise this option validly under its terms. 
  

	2.	 Vesting Schedule. 

This option will be exercisable at any time after the Grant Date for all or any part of the Shares subject to this option. The Shares subject to this
option shall initially be Restricted Shares subject to the Company’s Right of Repurchase until the Right of Repurchase lapses (i.e., the Shares “vest”). The Right of Repurchase shall lapse as to [25% of the original number of
Shares on the first anniversary of the Vesting Commencement Date (as defined below) and as to an additional 1/48th of the original number of Shares at the end of each successive month
following the first anniversary of the Vesting Commencement Date until the fourth anniversary of the Vesting Commencement Date]. On the [fourth] anniversary of the Vesting Commencement Date, all of the Shares subject to this option will be
vested and no longer subject to the Right of Repurchase. For purposes of this Agreement, “Vesting Commencement Date” shall mean ###ALTERNATIVE_VEST_BASE_DATE###. 

 

	3.	 Exercise of Option. 

(a) Form of Exercise. Each election to exercise this option shall be accompanied by (i) a completed Notice of Stock Option Exercise in the
form attached hereto as Exhibit A, signed by the Participant, and received by the Company at its principal office, (ii) if requested by the Company, a counterpart signature page to that certain Seventh Amended and Restated Voting
Agreement, dated as of July 26, 2019, as the same may be amended from time to time, signed by the Participant, and received by the Company at its principal office, (iii) if requested by the Company, a counterpart signature page to that
certain Second Amended and Restated First Refusal and Co-Sale Agreement, dated as of July 26, 2019, as the same may be amended from time to time, signed by the Participant, and received by the Company at
its principal office, (iv) this agreement, and (v) payment in full in the manner provided in the Plan. The Participant may purchase less than the number of Shares covered hereby, provided that no partial exercise of this option may be
for any fractional share or for fewer than ten whole shares. 
  

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (b) Continuous Relationship with the Company Required. Except as otherwise provided in this
Section 3, this option may not be exercised unless the Participant, at the time he or she exercises this option, is, and has been at all times since the Grant Date, an employee or officer of, or consultant or advisor to, the Company or any
parent or subsidiary of the Company as defined in Section 424(e) or (f) of the Code (an “Eligible Participant”). 
 (c) Termination of
Relationship with the Company. If the Participant ceases to be an Eligible Participant for any reason, then, except as provided in paragraphs (d) and (e) below, the right to exercise this option shall terminate three months after
such cessation (but in no event after the Final Exercise Date), provided that this option shall be exercisable only to the extent that the Participant was entitled to exercise this option for Shares that are not
Restricted Shares on the date of such cessation. Notwithstanding the foregoing, if the Participant, prior to the Final Exercise Date, violates the non-competition or confidentiality provisions of any
employment contract, confidentiality and nondisclosure agreement or other agreement between the Participant and the Company, the right to exercise this option shall terminate immediately upon such violation. 

(d) Exercise Period Upon Death or Disability. If the Participant dies or becomes disabled (within the meaning of Section 22(e)(3) of the Code)
prior to the Final Exercise Date while he or she is an Eligible Participant and the Company has not terminated such relationship for “cause” as specified in paragraph (e) below, this option shall be exercisable, within the period of
one year following the date of death or disability of the Participant, by the Participant (or in the case of death by an authorized transferee), provided that this option shall be exercisable only to the extent that this
option was exercisable by the Participant on the date of his or her death or disability, and further provided that this option shall not be exercisable after the Final Exercise Date. 

(e) Termination for Cause. If, prior to the Final Exercise Date, the Participant’s employment or other relationship with the Company is
terminated by the Company for Cause (as defined below), the right to exercise this option shall terminate immediately upon the effective date of such termination of employment or other relationship. If, prior to the Final Exercise Date, the
Participant is given notice by the Company of the termination of his or her employment or other relationship by the Company for Cause, and the effective date of such employment or other termination is subsequent to the date of the delivery of such
notice, the right to exercise this option shall be suspended from the time of the delivery of such notice until the earlier of (i) such time as it is determined or otherwise agreed that the Participant’s employment or other relationship
shall not be terminated for Cause as provided in such notice or (ii) the effective date of such termination of employment or other relationship (in which case the right to exercise this option shall, pursuant to the preceding sentence,
terminate immediately upon the effective date of such termination of employment or other relationship). If the Participant is party to an employment, consulting or severance agreement with the Company that contains a definition of “cause”
for termination of employment or other relationship, “Cause” shall have the meaning ascribed to such term in such agreement. Otherwise, “Cause” shall mean willful misconduct by the Participant or willful failure by the
Participant to perform his or her responsibilities to the Company (including, without limitation, breach by the Participant of any provision of any employment, consulting, advisory, nondisclosure,
non-competition or other similar agreement between the Participant and the Company), as determined by the Company, which determination shall be conclusive. The Participant’s employment or other
relationship shall be considered to have been terminated for “Cause” if the Company determines, within 30 days after the Participant’s resignation, that termination for Cause was warranted. 

 

	4.	 Company Right of Repurchase. 

(a) Scope of Repurchase Right. Until they vest in accordance with Section 2, the Shares acquired under this Agreement shall be
“Restricted Shares” and shall be subject to the Company’s right to repurchase Restricted Shares set forth in this Section 4 (the “Right of Repurchase”). The Company, however, may decline to exercise its Right of
Repurchase or may exercise its Right of Repurchase only with respect to a portion of the Restricted Shares. The Company may exercise its Right of Repurchase only during the period of 90 consecutive days commencing on the date when the
Participant ceases to be an Eligible Participant for any reason, including (without limitation) death or disability (the “Repurchase Period”), but the Right of Repurchase may be exercised automatically under Subsection
(c) below. If the Right of Repurchase is exercised, the Company shall pay the Participant an amount equal to the lower of (i) the Exercise Price of each Restricted Share being repurchased or (ii) the Fair Market Value of such
Restricted Share at the time the Right of Repurchase is exercised. 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (b) Escrow. Upon issuance, the certificate(s) for Restricted Shares shall be deposited in escrow
with the Company to be held in accordance with the provisions of this Agreement. Any additional or exchanged securities or other property described in Subsection (e) below shall immediately be delivered to the Company to be held in
escrow. Restricted Shares, together with any other assets held in escrow under this Agreement, shall be (i) surrendered to the Company for repurchase upon exercise of the Right of Repurchase or the Right of First Refusal or
(ii) released to the Participant upon his or her request to the extent that the Shares have ceased to be Restricted Shares (but not more frequently than once every six months). In any event, all shares that have ceased to be Restricted
Shares, together with any other vested assets held in escrow under this Agreement, shall be released within 90 days after the earlier of (i) the Participant ceasing to be an Eligible Participant or (ii) the lapse of the Right of First
Refusal. 
 (c) Exercise of Repurchase Right. The Company shall be deemed to have exercised its Right of Repurchase automatically for all
Restricted Shares as of the commencement of the Repurchase Period, unless the Company during the Repurchase Period notifies the holder of the Restricted Shares at the holder’s most recent address on file with the Company that the Company will
not exercise its Right of Repurchase for some or all of the Restricted Shares. The Company shall pay to the holder of the Restricted Shares the purchase price determined under Subsection (a) above for the Restricted Shares being
repurchased. Payment shall be made in cash or cash equivalents and/or by canceling indebtedness to the Company incurred by the Participant in the purchase of the Restricted Shares. The certificate(s) representing the Restricted Shares
being repurchased shall be delivered to the Company. 
 (d) Termination of Rights as Stockholder. If the Right of Repurchase is exercised in
accordance with this Section 4 and the Company makes available the consideration for the Restricted Shares being repurchased, then the person from whom the Restricted Shares are repurchased shall no longer have any rights as a holder of the
Restricted Shares (other than the right to receive payment of such consideration). Such Restricted Shares shall be deemed to have been repurchased pursuant to this Section 4, whether or not the certificate(s) for such Restricted Shares
have been delivered to the Company or the consideration for such Restricted Shares has been accepted. 
 (e) Additional or Exchanged Securities and
Property. In the event of a merger or consolidation of the Company, a sale of all or substantially all of the Company’s stock or assets, any other corporate reorganization, a stock split, the declaration of a stock dividend, the
declaration of an extraordinary dividend payable in a form other than stock, a spin-off, an adjustment in conversion ratio, a recapitalization or a similar transaction affecting the Company’s outstanding
securities, any securities or other property (including cash or cash equivalents) that are by reason of such transaction exchanged for, or distributed with respect to, any Restricted Shares shall immediately be subject to the Right of
Repurchase. Appropriate adjustments to reflect the exchange or distribution of such securities or property shall be made to the number and/or class of the Restricted Shares. Appropriate adjustments shall also be made to the price per share
to be paid upon the exercise of the Right of Repurchase, provided that the aggregate purchase price payable for the Restricted Shares shall remain the same. In the event of a merger or consolidation of the Company with or into another entity or
any other corporate reorganization, the Right of Repurchase may be exercised by the Company’s successor. 
 (f) Transfer of Restricted
Shares. The Participant shall not transfer, assign, encumber or otherwise dispose of any Restricted Shares without the Company’s written consent, except as provided in the following sentence. The Participant may transfer
Restricted Shares to one or more members of the Participant’s Immediate Family or to a trust established by the Participant for the benefit of the Participant and/or one or more members of the Participant’s Immediate Family, provided in
either case that the transferee agrees in writing on a form prescribed by the Company to be bound by all provisions of this Agreement. If the Participant transfers any Restricted Shares, then this Agreement shall apply to the transferee to the
same extent as to the Participant. For purposes of this Agreement, “Immediate Family” shall mean any child, stepchild, grandchild or other lineal descendant, any parent, stepparent, grandparent or other ancestor, any spouse, former
spouse, sibling, niece, nephew, uncle, aunt, mother-in-law, father-in-law, son-in-law, daughter-in-law,
brother-in-law or sister-in-law, including adoptive relationships, or any Spousal
Equivalent (as defined in the Company’s Amended and Restated Bylaws, as may be amended and/or restated from time to time). 
 (g) Assignment of
Repurchase Right. The Company’s Board of Directors (the “Board”) may freely assign the Company’s Right of Repurchase, in whole or in part. Any person who accepts an assignment of the Right of Repurchase from the
Company shall assume all of the Company’s rights and obligations under this Section 4. 
 5. Company Right of First Refusal. 

(a) Notice of Proposed Transfer. If the Participant proposes to sell, assign, transfer, pledge, hypothecate or otherwise dispose of, by operation
of law or otherwise (collectively, “transfer”) any Shares acquired upon exercise of this option, then the Participant shall first give written notice of the proposed transfer (the “Transfer Notice”) to the Company. The
Transfer Notice shall name the proposed transferee and state the number of such Shares the Participant proposes to transfer (the “Offered Shares”), the price per share and all other material terms and conditions of the transfer. 

 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (b) Company Right to Purchase. For 30 days following its receipt of such Transfer Notice, the
Company shall have the option to purchase all or part of the Offered Shares at the price and upon the terms set forth in the Transfer Notice. In the event the Company elects to purchase all or part of the Offered Shares, it shall give written
notice of such election to the Participant within such 30-day period. Within 10 days after his or her receipt of such notice, the Participant shall tender to the Company at its principal offices the
certificate or certificates representing the Offered Shares to be purchased by the Company, duly endorsed in blank by the Participant or with duly endorsed stock powers attached thereto, all in a form suitable for transfer of the Offered Shares to
the Company. Promptly following receipt of such certificate or certificates, the Company shall deliver or mail to the Participant a check in payment of the purchase price for such Offered Shares; provided that if
the terms of payment set forth in the Transfer Notice were other than cash against delivery, the Company may pay for the Offered Shares on the same terms and conditions as were set forth in the Transfer Notice;
and provided further that any delay in making such payment shall not invalidate the Company’s exercise of its option to purchase the Offered Shares. 

(c) Shares Not Purchased By Company. If the Company does not elect to acquire all of the Offered Shares, the Participant may, within the 30-day period following the expiration of the option granted to the Company under subsection (b) above, transfer the Offered Shares which the Company has not elected to acquire to the proposed
transferee, provided that such transfer shall not be on terms and conditions more favorable to the transferee than those contained in the Transfer Notice. Notwithstanding any of the above, all Offered Shares
transferred pursuant to this Section 5 shall remain subject to the right of first refusal set forth in this Section 5 and such transferee shall, as a condition to such transfer, deliver to the Company a written instrument confirming that
such transferee shall be bound by all of the terms and conditions of this Section 5. 
 (d) Consequences of
Non-Delivery. After the time at which the Offered Shares are required to be delivered to the Company for transfer to the Company pursuant to subsection (b) above, the Company shall not pay any
dividend to the Participant on account of such Offered Shares or permit the Participant to exercise any of the privileges or rights of a stockholder with respect to such Offered Shares, but shall, insofar as permitted by law, treat the Company as
the owner of such Offered Shares. 
 (e) Exempt Transactions. The following transactions shall be exempt from the provisions of this
Section 5: 
 (1) any transfer of Shares to or for the benefit of any spouse, child or grandchild of the Participant, or to a trust for their benefit;

 (2) any transfer pursuant to an effective registration statement filed by the Company under the Securities Act; 

(3) the sale of all or substantially all of the outstanding shares of capital stock of the Company (including pursuant to a merger or consolidation); and 

(4) any transfer in exchange for Nonvoting Shares (as defined below) in accordance with Section 10; 

provided, however, that in the case of a transfer pursuant to clause (1) above, such Shares shall remain subject to the right of first
refusal set forth in this Section 5 and in the case of an exchange pursuant to clause (4) above, any Nonvoting Shares issued in exchange for the Shares shall be deemed to be “Shares” pursuant to this Agreement and shall be
subject to all the terms and conditions of this Agreement, including without limitation the right of first refusal in this Section 5. 
 (f)
Assignment of Company Right. The Company may assign its rights to purchase Offered Shares under this Section 5, in general or with respect to any particular transaction, to one or more persons or entities. 

(g) Termination. The provisions of this Section 5 shall terminate upon the earlier of the following events: 

(1) the closing of the sale of shares of Common Stock in an underwritten public offering pursuant to an effective registration statement filed by the
Company under the Securities Act; or 
 (2) the sale of all or substantially all of the outstanding shares of capital stock, assets or business of the
Company, by merger, consolidation, sale of assets or otherwise (other than a merger or consolidation in which all or substantially all of the individuals and entities who were beneficial owners of the Company’s voting securities immediately
prior to such transaction beneficially own, directly or indirectly, more than 75% (determined on an as-converted basis) of the outstanding securities entitled to vote generally in the election of directors of
the resulting, surviving or acquiring corporation in such transaction). 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (h) No Obligation to Recognize Invalid Transfer. The Company shall not be required (1) to
transfer on its books any of the Shares which shall have been sold or transferred in violation of any of the provisions set forth in this Section 5, or (2) to treat as owner of such Shares or to pay dividends to any transferee to whom any
such Shares shall have been so sold or transferred. 
 (i) Legends. The certificate representing Shares shall bear legends substantially in the
following form (in addition to, or in combination with, any legend required by applicable federal and state securities laws and agreements relating to the transfer of the Company securities): 

“THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO A RIGHT OF FIRST REFUSAL IN FAVOR OF THE COMPANY, AS PROVIDED IN A CERTAIN STOCK OPTION
AGREEMENT WITH THE COMPANY. 
 THE SHARES REPRESENTED BY THIS CERTIFICATE MAY NOT BE SOLD, ASSIGNED, TRANSFERRED, PLEDGED, ENCUMBERED OR IN ANY MANNER
DISPOSED OF, EXCEPT IN COMPLIANCE WITH THE BYLAWS OF THE CORPORATION. COPIES OF THE BYLAWS OF THE CORPORATION MAY BE OBTAINED UPON WRITTEN REQUEST TO THE SECRETARY OF THE CORPORATION.” 

(j) Additional or Exchanged Securities and Property. In the event of a merger or consolidation of the Company, a sale of all or substantially all
of the Company’s stock or assets, any other corporate reorganization, a stock split, the declaration of a stock dividend, the declaration of an extraordinary dividend payable in a form other than stock, a
spin-off, an adjustment in conversion ratio, a recapitalization or a similar transaction affecting the Company’s outstanding securities, any securities or other property (including cash or cash
equivalents) that are by reason of such transaction exchanged for, or distributed with respect to, any Shares subject to this Section 5 shall immediately be subject to the Right of First Refusal. Appropriate adjustments to reflect the
exchange or distribution of such securities or property shall be made to the number and/or class of the Shares subject to this Section 5. 
 6.
Agreement in Connection with Initial Public Offering. 
 The Participant agrees, in connection with the initial underwritten public offering of the
Common Stock pursuant to a registration statement under the Securities Act, (i) not to (a) offer, pledge, announce the intention to sell, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to
sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock or any other securities of the Company or (b) enter into any swap or other agreement that transfers,
in whole or in part, any of the economic consequences of ownership of shares of Common Stock or other securities of the Company, whether any transaction described in clause (a) or (b) is to be settled by delivery of securities, in cash or
otherwise, during the period beginning on the date of the filing of such registration statement with the Securities and Exchange Commission and ending 180 days after the date of the final prospectus relating to the offering (plus up to an additional
34 days to the extent requested by the managing underwriters for such offering in order to address FINRA Rule 2711(f)(4) or NYSE Rule 472(f)(4) or any similar successor provision), and (ii) to execute any agreement reflecting clause
(i) above as may be requested by the Company or the managing underwriters at the time of such offering. The Company may impose stop-transfer instructions with respect to the shares of Common Stock or other securities subject to the
foregoing restriction until the end of the “lock-up” period. 
 7. Withholding.

No Shares will be issued pursuant to the exercise of this option unless and until the Participant pays to the Company, or makes provision satisfactory to the
Company for payment of, any federal, state or local withholding taxes required by law to be withheld in respect of this option. 
 8. Transfer
Restrictions. 
 (a) This option may not be sold, assigned, transferred, pledged or otherwise encumbered by the Participant, either voluntarily or by
operation of law, except by will or the laws of descent and distribution, and, during the lifetime of the Participant, this option shall be exercisable only by the Participant. 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (b) The Participant agrees that he or she will not transfer any Shares issued pursuant to the exercise of
this option unless the transferee, as a condition to such transfer, delivers to the Company a written instrument confirming that such transferee shall be bound by all of the terms and conditions of Section 4, Section 5 and Section 6;
provided that such a written confirmation shall not be required with respect to (1) Section 5 after such provision has terminated in accordance with Section 5(g) or (2) Section 6 after the completion of the lock-up period in connection with the Company’s initial underwritten public offering.
 (c) Notwithstanding
Section 8(b), if any Shares issued pursuant to the exercise of this option are converted into Nonvoting Shares (as defined below) in accordance with Section 10, such Nonvoting Shares shall be subject to all of the terms and conditions of
this Agreement, including without limitation Section 4, Section 5 and Section 6 (each, to the extent then applicable). 
 (d) The Shares
acquired under this Agreement shall be subject to the transfer restrictions in Article X of the Company’s Amended and Restated Bylaws in addition to, and not in limitation of, the provisions of Section 5 of this Agreement. 

 

	9.	 Provisions of the Plan. 

This option is subject to the provisions of the Plan (including the provisions relating to amendments to the Plan), a copy of which is furnished to the
Participant with this option. 
  

	10.	 Conversion of Shares to Nonvoting Shares

At such time as deemed necessary or advisable by the Company (including any officer of the Company and any employee on the Company’s equity administration
team or such other team that performs similar functions) to comply with Part 175.22 of the New York Real Estate Licensing Law, any similar or successor rule or statue of New York or any similar law, rule or statute of any other jurisdiction (the
“Regulation”), or at such time the Participant notifies the Company that such Participant is subject to the Regulation, any Shares issued pursuant to the exercise of this option shall automatically be converted, with no further action by
the Participant, into an equal number of shares of nonvoting Class B Common Stock, $0.0001 par value per share, of the Company (“Nonvoting Shares”). To effectuate such conversion to Nonvoting Shares, the Participant hereby
constitutes and appoints each officer and director of the Company as his, her or its agent and attorney-in-fact for purposes of executing or approving such documents,
and taking such actions, as may be deemed necessary or advisable by such agent and attorney-in-fact with respect to the conversion of such Shares. This power of
attorney, being coupled with an interest, is irrevocable and shall survive the death, disability or incapacitation of the Participant. 
  

	11.	 Miscellaneous.

(a) Entire Agreement. This Agreement and the Plan constitute the entire contract between the Participant and the Company with regard to the subject
matter hereof. They supersede any other agreements, representations or understandings (whether oral or written and whether express or implied) that relate to the subject matter hereof. 

(b) Modifications and Waivers. No provision of this Agreement shall be modified, waiver or discharged unless the modification, waiver or discharge
is agreed to in writing and signed by the Participant and an authorized officer of the Company (other than the Participant). No waiver by either party of any breach of, or of compliance with, any condition or provision of this Agreement by the
other party shall be considered a waiver of any other condition or provision or of the same condition or provision at another time. 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

  

 
 IN WITNESS WHEREOF, the Company has caused this
option to be executed under its corporate seal by its duly authorized officer. This option shall take effect as a sealed instrument. 
  

	
	 URBAN COMPASS, INC.
  

By: ###SIGNATURE###
  

Name: Robert Reffkin
  

Title: CEO

 PARTICIPANT’S ACCEPTANCE 

The undersigned hereby accepts the foregoing option and agrees to the terms and conditions thereof. The undersigned hereby acknowledges receipt of a copy
of the Company’s Third Amended & Restated 2012 Stock Incentive Plan. 
  

			
	PARTICIPANT:
	Name: ###PARTICIPANT_NAME###
	Address:	  	###HOME_ADDRESS###
		  	###ACCEPTANCE_DATE###

 Reminder: Please review the provided attachments below. 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 Hello, 
 Please
find a stock option agreement as approved by the Board of Urban Compass, Inc. d/b/a Compass (“Compass”) on ###GRANT_DATE###. By signing this stock option agreement, you are not agreeing to purchase any common shares of Compass. Rather, you
are agreeing that you have the right to purchase common shares of Compass at a price of ###GRANT_PRICE### per common share, subject to all of the terms of the agreement. The total number of common shares under your option is stated in the first
paragraph of the attached stock option agreement.*** Also attached are: (1) an FAQ about Compass equity, (2) an informational memorandum about our Stock Incentive Plan, including a brief summary of the tax consequences in connection with
exercising your stock option, and the information described in Rules 701(e)(2), (3), (4) and (5) under the Securities Act of 1933, as amended (the “Securities Act”), and (3) the current Stock Incentive Plan. If you have any
questions after reading the attachments, please feel free to send them to equity@compass.com. 
 Best, 

The Compass Equity Team 
 URBAN COMPASS, INC.

 Nonstatutory Stock Option Agreement (Installment Exercise) 

Granted Under the Third Amended & Restated 2012 Stock Incentive Plan 

 

	1.	 Grant of Option. 

This agreement evidences the grant by Urban Compass, Inc., a Delaware corporation (the “Company”), on ###GRANT_DATE### (the “Grant Date”)
to ###PARTICIPANT_NAME###, an employee, consultant or director of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s Third Amended & Restated 2012
Stock Incentive Plan (as amended, the “Plan”), a total of ###TOTAL_AWARDS### shares (the “Shares”) of Class A Common Stock, $0.0001 par value per share, of the Company (“Common Stock”) at ###GRANT_PRICE### per
Share (the “Exercise Price”). Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on ###EXPIRY_DATE### (the “Final Exercise Date”). 

It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code
of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the
right to exercise this option validly under its terms. 
  

	2.	 Vesting Schedule. 

This option will become exercisable (i.e., “vest”) as to [25% of the original number of Shares on the first anniversary of the Vesting Commencement
Date (as defined below) and as to an additional 1/48th of the original number of Shares at the end of each successive month following the first anniversary of the Vesting Commencement Date
until the fourth anniversary of the Vesting Commencement Date]. On the [fourth anniversary of the Vesting Commencement Date], this option will be vested and exercisable for all of the Shares. For purposes of this Agreement, “Vesting
Commencement Date” shall mean ###ALTERNATIVE_VEST_BASE_DATE###. 
 The right of exercise shall be cumulative so that to the extent the option is not
exercised in any period to the maximum extent permissible, it shall continue to be exercisable, in whole or in part, with respect to all Shares for which it is vested until the earlier of the Final Exercise Date or the termination of this option
under Section 3 hereof or the Plan. 
  

	3.	 Exercise of Option. 

(a) Form of Exercise. Each election to exercise this option shall be accompanied by (i) a completed Notice of Stock Option Exercise in the
form attached hereto as Exhibit A, signed by the Participant, and received by the Company at its principal office, (ii) if requested by the Company, a counterpart signature page to that certain Seventh Amended and Restated Voting
Agreement, dated as of July 26, 2019, as the same may be amended from time to time, signed by the Participant, and received by the Company at its principal office, (iii) if requested by the Company, a counterpart signature page to that
certain Second Amended and Restated First Refusal and Co-Sale Agreement, dated as of July 26, 2019, as the same may be amended from time to time, signed by the Participant, and received by the Company at
its principal office, (iv) this agreement, and (v) payment in full in the manner provided in the Plan. The Participant may purchase less than the number of Shares covered hereby, provided that no partial exercise of this option may be
for any fractional share or for fewer than ten whole shares. 
  

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (b) Continuous Relationship with the Company Required. Except as otherwise provided in this
Section 3, this option may not be exercised unless the Participant, at the time he or she exercises this option, is, and has been at all times since the Grant Date, an employee or officer of, or consultant or advisor to, the Company or any
parent or subsidiary of the Company as defined in Section 424(e) or (f) of the Code (an “Eligible Participant”). 
 (c) Termination of
Relationship with the Company. If the Participant ceases to be an Eligible Participant for any reason, then, except as provided in paragraphs (d) and (e) below, the right to exercise this option shall terminate three months after
such cessation (but in no event after the Final Exercise Date), provided that this option shall be exercisable only to the extent that the Participant was entitled to exercise this option Notwithstanding the
foregoing, if the Participant, prior to the Final Exercise Date, violates the non-competition or confidentiality provisions of any employment contract, confidentiality and nondisclosure agreement or other
agreement between the Participant and the Company, the right to exercise this option shall terminate immediately upon such violation. 
 (d) Exercise
Period Upon Death or Disability. If the Participant dies or becomes disabled (within the meaning of Section 22(e)(3) of the Code) prior to the Final Exercise Date while he or she is an Eligible Participant and the Company has not
terminated such relationship for “cause” as specified in paragraph (e) below, this option shall be exercisable, within the period of one year following the date of death or disability of the Participant, by the Participant (or in the
case of death by an authorized transferee), provided that this option shall be exercisable only to the extent that this option was exercisable by the Participant on the date of his or her death or disability, and further
provided that this option shall not be exercisable after the Final Exercise Date. 
 (e) Termination for Cause. If, prior to the Final Exercise
Date, the Participant’s employment or other relationship with the Company is terminated by the Company for Cause (as defined below), the right to exercise this option shall terminate immediately upon the effective date of such termination of
employment or other relationship. If, prior to the Final Exercise Date, the Participant is given notice by the Company of the termination of his or her employment or other relationship by the Company for Cause, and the effective date of such
employment or other termination is subsequent to the date of the delivery of such notice, the right to exercise this option shall be suspended from the time of the delivery of such notice until the earlier of (i) such time as it is determined
or otherwise agreed that the Participant’s employment or other relationship shall not be terminated for Cause as provided in such notice or (ii) the effective date of such termination of employment or other relationship (in which case the
right to exercise this option shall, pursuant to the preceding sentence, terminate immediately upon the effective date of such termination of employment or other relationship). If the Participant is party to an employment, consulting or severance
agreement with the Company that contains a definition of “cause” for termination of employment or other relationship, “Cause” shall have the meaning ascribed to such term in such agreement. Otherwise, “Cause” shall mean
willful misconduct by the Participant or willful failure by the Participant to perform his or her responsibilities to the Company (including, without limitation, breach by the Participant of any provision of any employment, consulting, advisory,
nondisclosure, non-competition or other similar agreement between the Participant and the Company), as determined by the Company, which determination shall be conclusive. The Participant’s employment or
other relationship shall be considered to have been terminated for “Cause” if the Company determines, within 30 days after the Participant’s resignation, that termination for Cause was warranted. 

 

	4.	 Company Right of First Refusal. 

(a) Notice of Proposed Transfer. If the Participant proposes to sell, assign, transfer, pledge, hypothecate or otherwise dispose of, by operation
of law or otherwise (collectively, “transfer”) any Shares acquired upon exercise of this option, then the Participant shall first give written notice of the proposed transfer (the “Transfer Notice”) to the Company. The
Transfer Notice shall name the proposed transferee and state the number of such Shares the Participant proposes to transfer (the “Offered Shares”), the price per share and all other material terms and conditions of the transfer. 

(b) Company Right to Purchase. For 30 days following its receipt of such Transfer Notice, the Company shall have the option to purchase all or part
of the Offered Shares at the price and upon the terms set forth in the Transfer Notice. In the event the Company elects to purchase all or part of the Offered Shares, it shall give written notice of such election to the Participant within such 30-day period. Within 10 days after his or her receipt of such notice, the Participant shall tender to the Company at its principal offices the certificate or certificates representing the Offered Shares to be
purchased by the Company, duly endorsed in blank by the Participant or with duly endorsed stock powers attached thereto, all in a form suitable for transfer of the Offered Shares to the Company. Promptly following

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 
receipt of such certificate or certificates, the Company shall deliver or mail to the Participant a check in payment of the purchase price for such Offered
Shares; provided that if the terms of payment set forth in the Transfer Notice were other than cash against delivery, the Company may pay for the Offered Shares on the same terms and conditions as were set forth in the
Transfer Notice; and provided further that any delay in making such payment shall not invalidate the Company’s exercise of its option to purchase the Offered Shares. 

(c) Shares Not Purchased By Company. If the Company does not elect to acquire all of the Offered Shares, the Participant may, within the 30-day period following the expiration of the option granted to the Company under subsection (b) above, transfer the Offered Shares which the Company has not elected to acquire to the proposed
transferee, provided that such transfer shall not be on terms and conditions more favorable to the transferee than those contained in the Transfer Notice. Notwithstanding any of the above, all Offered Shares
transferred pursuant to this Section 4 shall remain subject to the right of first refusal set forth in this Section 4 and such transferee shall, as a condition to such transfer, deliver to the Company a written instrument confirming that
such transferee shall be bound by all of the terms and conditions of this Section 4. 
 (d) Consequences of
Non-Delivery. After the time at which the Offered Shares are required to be delivered to the Company for transfer to the Company pursuant to subsection (b) above, the Company shall not pay any
dividend to the Participant on account of such Offered Shares or permit the Participant to exercise any of the privileges or rights of a stockholder with respect to such Offered Shares, but shall, insofar as permitted by law, treat the Company as
the owner of such Offered Shares. 
 (e) Exempt Transactions. The following transactions shall be exempt from the provisions of this
Section 4: 
 (1) any transfer of Shares to or for the benefit of any spouse, child or grandchild of the Participant, or to a trust for their benefit;

 (2) any transfer pursuant to an effective registration statement filed by the Company under the Securities Act; 

(3) the sale of all or substantially all of the outstanding shares of capital stock of the Company (including pursuant to a merger or consolidation); and 

(4) any transfer in exchange for Nonvoting Shares (as defined below) in accordance with Section 9; 

provided, however, that in the case of a transfer pursuant to clause (1) above, such Shares shall remain subject to the right of first
refusal set forth in this Section 4 and in the case of an exchange pursuant to clause (4) above, any Nonvoting Shares issued in exchange for the Shares shall be deemed to be “Shares” pursuant to this Agreement and shall be
subject to all the terms and conditions of this Agreement, including without limitation the right of first refusal in this Section 4. 
 (f)
Assignment of Company Right. The Company may assign its rights to purchase Offered Shares under this Section 4, in general or with respect to any particular transaction, to one or more persons or entities. 

(g) Termination. The provisions of this Section 4 shall terminate upon the earlier of the following events: 

(1) the closing of the sale of shares of Common Stock in an underwritten public offering pursuant to an effective registration statement filed by the
Company under the Securities Act; or 
 (2) the sale of all or substantially all of the outstanding shares of capital stock, assets or business of the
Company, by merger, consolidation, sale of assets or otherwise (other than a merger or consolidation in which all or substantially all of the individuals and entities who were beneficial owners of the Company’s voting securities immediately
prior to such transaction beneficially own, directly or indirectly, more than 75% (determined on an as-converted basis) of the outstanding securities entitled to vote generally in the election of directors of the resulting, surviving or acquiring
corporation in such transaction). 
 (h) No Obligation to Recognize Invalid Transfer. The Company shall not be required (1) to transfer on
its books any of the Shares which shall have been sold or transferred in violation of any of the provisions set forth in this Section 4, or (2) to treat as owner of such Shares or to pay dividends to any transferee to whom any such Shares
shall have been so sold or transferred. 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (i) Legends. The certificate representing Shares shall bear legends substantially in the
following form (in addition to, or in combination with, any legend required by applicable federal and state securities laws and agreements relating to the transfer of the Company securities): 

“THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO A RIGHT OF FIRST REFUSAL IN FAVOR OF THE COMPANY, AS PROVIDED IN A CERTAIN STOCK OPTION
AGREEMENT WITH THE COMPANY. 
 THE SHARES REPRESENTED BY THIS CERTIFICATE MAY NOT BE SOLD, ASSIGNED, TRANSFERRED, PLEDGED, ENCUMBERED OR IN ANY MANNER
DISPOSED OF, EXCEPT IN COMPLIANCE WITH THE BYLAWS OF THE CORPORATION. COPIES OF THE BYLAWS OF THE CORPORATION MAY BE OBTAINED UPON WRITTEN REQUEST TO THE SECRETARY OF THE CORPORATION.” 

(j) Additional or Exchanged Securities and Property. In the event of a merger or consolidation of the Company, a sale of all or substantially all
of the Company’s stock or assets, any other corporate reorganization, a stock split, the declaration of a stock dividend, the declaration of an extraordinary dividend payable in a form other than stock, a
spin-off, an adjustment in conversion ratio, a recapitalization or a similar transaction affecting the Company’s outstanding securities, any securities or other property (including cash or cash
equivalents) that are by reason of such transaction exchanged for, or distributed with respect to, any Shares subject to this Section 4 shall immediately be subject to the Right of First Refusal. Appropriate adjustments to reflect the
exchange or distribution of such securities or property shall be made to the number and/or class of the Shares subject to this Section 4. 
  

	5.	 Agreement in Connection with Initial Public Offering. 

The Participant agrees, in connection with the initial underwritten public offering of the Common Stock pursuant to a registration statement under the
Securities Act, (i) not to (a) offer, pledge, announce the intention to sell, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, or
otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock or any other securities of the Company or (b) enter into any swap or other agreement that transfers, in whole or in part, any of the economic consequences of
ownership of shares of Common Stock or other securities of the Company, whether any transaction described in clause (a) or (b) is to be settled by delivery of securities, in cash or otherwise, during the period beginning on the date of the
filing of such registration statement with the Securities and Exchange Commission and ending 180 days after the date of the final prospectus relating to the offering (plus up to an additional 34 days to the extent requested by the managing
underwriters for such offering in order to address FINRA Rule 2711(f)(4) or NYSE Rule 472(f)(4) or any similar successor provision), and (ii) to execute any agreement reflecting clause (i) above as may be requested by the Company or the
managing underwriters at the time of such offering. The Company may impose stop-transfer instructions with respect to the shares of Common Stock or other securities subject to the foregoing restriction until the end of the “lock-up” period. 
  

	6.	 Withholding.

No Shares will be issued pursuant to the exercise of this option unless and until the Participant pays to the Company, or makes provision satisfactory to the
Company for payment of, any federal, state or local withholding taxes required by law to be withheld in respect of this option. 
  

	7.	 Transfer Restrictions. 

(a) This option may not be sold, assigned, transferred, pledged or otherwise encumbered by the Participant, either voluntarily or by operation of law, except
by will or the laws of descent and distribution, and, during the lifetime of the Participant, this option shall be exercisable only by the Participant. 

(b) The Participant agrees that he or she will not transfer any Shares issued pursuant to the exercise of this option unless the transferee, as a condition to
such transfer, delivers to the Company a written instrument confirming that such transferee shall be bound by all of the terms and conditions of Section 4 and Section 5; provided that such a written confirmation shall not be required with
respect to (1) Section 4 after such provision has terminated in accordance with Section 4(g) or (2) Section 5 after the completion of the lock-up period in connection with the
Company’s initial underwritten public offering.
 (c) Notwithstanding Section 7(b), if any Shares issued pursuant to the exercise of this option
are converted into Nonvoting Shares (as defined below) in accordance with Section 9, such Nonvoting Shares shall be subject to all of the terms and conditions of this Agreement, including without limitation Section 4 and Section 5
(each, to the extent then applicable). 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (d) The Shares acquired under this Agreement shall be subject to the transfer restrictions in Article X of
the Company’s Amended and Restated Bylaws in addition to, and not in limitation of, the provisions of Section 4 of this Agreement. 
  

	8.	 Provisions of the Plan. 

This option is subject to the provisions of the Plan (including the provisions relating to amendments to the Plan), a copy of which is furnished to the
Participant with this option. 
  

	9.	 Conversion of Shares to Nonvoting Shares. 

At such time as deemed necessary or advisable by the Company (including any officer of the Company and any employee on the Company’s equity administration
team or such other team that performs similar functions) to comply with Part 175.22 of the New York Real Estate Licensing Law, any similar or successor rule or statue of New York or any similar law, rule or statute of any other jurisdiction (the
“Regulation”), or at such time the Participant notifies the Company that such Participant is subject to the Regulation, any Shares issued pursuant to the exercise of this option shall automatically be converted, with no further action by
the Participant, into an equal number of shares of nonvoting Class B Common Stock, $0.0001 par value per share, of the Company (“Nonvoting Shares”). To effectuate such conversion to Nonvoting Shares, the Participant hereby
constitutes and appoints each officer and director of the Company as his, her or its agent and attorney-in-fact for purposes of executing or approving such documents,
and taking such actions, as may be deemed necessary or advisable by such agent and attorney-in-fact with respect to the conversion of such Shares. This power of
attorney, being coupled with an interest, is irrevocable and shall survive the death, disability or incapacitation of the Participant. 
  

	10.	 Miscellaneous.

(a) Entire Agreement. This Agreement and the Plan constitute the entire contract between the Participant and the Company with regard to the subject
matter hereof. They supersede any other agreements, representations or understandings (whether oral or written and whether express or implied) that relate to the subject matter hereof. 

(b) Modifications and Waivers. No provision of this Agreement shall be modified, waiver or discharged unless the modification, waiver or discharge
is agreed to in writing and signed by the Participant and an authorized officer of the Company (other than the Participant). No waiver by either party of any breach of, or of compliance with, any condition or provision of this Agreement by the
other party shall be considered a waiver of any other condition or provision or of the same condition or provision at another time. 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

  

 
 IN WITNESS WHEREOF, the Company has caused this option
to be executed under its corporate seal by its duly authorized officer. This option shall take effect as a sealed instrument. 
  

	
	 URBAN COMPASS, INC.
  

By: ###SIGNATURE###
  

Name: Robert Reffkin
  

Title: CEO

 PARTICIPANT’S ACCEPTANCE 

The undersigned hereby accepts the foregoing option and agrees to the terms and conditions thereof. The undersigned hereby acknowledges receipt of a copy
of the Company’s Third Amended & Restated 2012 Stock Incentive Plan. 
  

			
	PARTICIPANT:
	Name: ###PARTICIPANT_NAME###
	Address:	  	###HOME_ADDRESS###
		  	###ACCEPTANCE_DATE###

 Reminder: Please review the provided attachments below. 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 Hello, 
 Please
find a stock option agreement as approved by the Board of Urban Compass, Inc. d/b/a Compass (“Compass”) on ###GRANT_DATE###. By signing this stock option agreement, you are not agreeing to purchase any common shares of Compass. Rather, you
are agreeing that you have the right to purchase common shares of Compass at a price of ###GRANT_PRICE### per common share, subject to all of the terms of the agreement. The total number of common shares under your option is stated in the first
paragraph of the attached stock option agreement.*** Also attached are: (1) an FAQ about Compass equity, (2) an informational memorandum about our Stock Incentive Plan including a brief summary of the tax consequences in connection with
exercising your stock option, and the information described in Rules 701(e)(2), (3), (4) and (5) under the Securities Act of 1933, as amended (the “Securities Act”), and (3) the current Stock Incentive Plan. If you have any
questions after reading the attachments, please feel free to send them to equity@compass.com. 
 Best, 

The Compass Equity Team 
 URBAN COMPASS, INC.

 Incentive Stock Option Agreement (Early Exercise) 

Granted Under the Third Amended & Restated 2012 Stock Incentive Plan 

 

	1.	 Grant of Option. 

This agreement evidences the grant by Urban Compass, Inc., a Delaware corporation (the “Company”), on ###GRANT_DATE### (the “Grant Date”)
to ###PARTICIPANT_NAME###, an employee of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s Third Amended & Restated 2012 Stock Incentive Plan
(as amended, the “Plan”), a total of ###CF_EE_GRANT_Total Options Granted### shares (the “Shares”) of Class A Common Stock, $0.0001 par value per share, of the Company (“Common Stock”) at ###GRANT_PRICE### per
Share (the “Exercise Price”). Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on ###EXPIRY_DATE### (the “Final Exercise Date”). 

It is intended that the option evidenced by this agreement shall be an incentive stock option as defined in Section 422 of the Internal Revenue Code of
1986, as amended, and any regulations promulgated thereunder (the “Code”), to the extent permissible under the Code. To the extent this option does not satisfy the requirements to be an incentive stock option under Section 422 of
the Code, this option shall be deemed a nonstatutory stock option. Even though this option is designated as an incentive stock option, it shall be deemed to be a nonstatutory stock option to the extent required by the $100,000 annual limitation
under Section 422(d) of the Code. In addition, this option will cease to qualify for favorable tax treatment as an incentive stock option to the extent that it is exercised: 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (a) More than three months after the date when the Participant ceases to be an employee of the Company or any
parent or subsidiary of the Company for any reason other than death or permanent and total disability (as defined in Section 22(e)(3) of the Code); 

(b) More than 12 months after the date when the Participant ceases to be an employee of the Company or any parent or subsidiary of the Company by reason of
permanent and total disability (as defined in Section 22(e)(3) of the Code); or 
 (c) More than three months after the date when the Participant has
been on a leave of absence for 90 days, unless the Participant’s reemployment rights following such leave were guaranteed by statute or by contract. 

Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the
right to exercise this option validly under its terms. 
  

	2.	 Vesting Schedule. 

This option will be exercisable at any time after the Grant Date for all or any part of the Shares subject to this option. The Shares subject to this
option shall initially be Restricted Shares subject to the Company’s Right of Repurchase until the Right of Repurchase lapses (i.e., the Shares “vest”). The Right of Repurchase shall lapse as to [25% of the original number of
Shares on the first anniversary of the Vesting Commencement Date (as defined below) and as to an additional 1/48th of the original number of Shares at the end of each successive month
following the first anniversary of the Vesting Commencement Date until the fourth anniversary of the Vesting Commencement Date]. On the [fourth anniversary of the Vesting Commencement Date], all of the Shares subject to this option will be
vested and no longer subject to the Right of Repurchase. For purposes of this Agreement, “Vesting Commencement Date” shall mean ###ALTERNATIVE_VEST_BASE_DATE###. 

 

	3.	 Exercise of Option. 

(a) Form of Exercise. Each election to exercise this option shall be accompanied by (i) a completed Notice of Stock Option Exercise in the
form attached hereto as Exhibit A, signed by the Participant, and received by the Company at its principal office, (ii) if requested by the Company, a counterpart signature page to that certain Seventh Amended and Restated Voting
Agreement, dated as of July 26, 2019, as the same may be amended from time to time, signed by the Participant, and received by the Company at its principal office, (iii) if requested by the Company, a counterpart signature page to that
certain Second Amended and Restated Refusal and Co-Sale Agreement, dated as of July 26, 2019, as the same may be amended from time to time, signed by the Participant, and received by the Company at its
principal office, (iv) this agreement, and (v) payment in full in the manner provided in the Plan. The Participant may purchase less than the number of Shares covered hereby, provided that no partial exercise of this option may be for any
fractional share or for fewer than ten whole shares. 
 (b) Continuous Relationship with the Company Required. Except as otherwise provided in
this Section 3, this option may not be exercised unless the Participant, at the time he or she exercises this option, is, and has been at all times since the Grant Date, an employee or officer of, or consultant or advisor to, the Company or any
parent or subsidiary of the Company as defined in Section 424(e) or (f) of the Code (an “Eligible Participant”). 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (c) Termination of Relationship with the Company. If the Participant ceases to be an Eligible
Participant for any reason, then, except as provided in paragraphs (d) and (e) below, the right to exercise this option shall terminate three months after such cessation (but in no event after the Final Exercise
Date), provided that this option shall be exercisable only to the extent that the Participant was entitled to exercise this option for Shares that are not Restricted Shares on the date of such
cessation. Notwithstanding the foregoing, if the Participant, prior to the Final Exercise Date, violates the non-competition,“non-solicitation,” or
confidentiality provisions of any employment contract, confidentiality and nondisclosure agreement or other agreement between the Participant and the Company, the right to exercise this option shall terminate immediately upon such violation. 

(d) Exercise Period Upon Death or Disability. If the Participant dies or becomes disabled (within the meaning of Section 22(e)(3) of the Code)
prior to the Final Exercise Date while he or she is an Eligible Participant and the Company has not terminated such relationship for “cause” as specified in paragraph (e) below, this option shall be exercisable, within the period of
one year following the date of death or disability of the Participant, by the Participant (or in the case of death by an authorized transferee), provided that this option shall be exercisable only to the extent that this
option was exercisable by the Participant on the date of his or her death or disability, and further provided that this option shall not be exercisable after the Final Exercise Date. 

(e) Termination for Cause. If, prior to the Final Exercise Date, the Participant’s employment is terminated by the Company for Cause (as
defined below), the right to exercise this option shall terminate immediately upon the effective date of such termination of employment. If, prior to the Final Exercise Date, the Participant is given notice by the Company of the termination of
his or her employment by the Company for Cause, and the effective date of such employment termination is subsequent to the date of delivery of such notice, the right to exercise this option shall be suspended from the time of the delivery of such
notice until the earlier of (i) such time as it is determined or otherwise agreed that the Participant’s employment shall not be terminated for Cause as provided in such notice or (ii) the effective date of such termination of
employment (in which case the right to exercise this option shall, pursuant to the preceding sentence, terminate upon the effective date of such termination of employment). If the Participant is party to an employment or severance agreement
with the Company that contains a definition of “cause” for termination of employment, “Cause” shall have the meaning ascribed to such term in such agreement. Otherwise, “Cause” shall mean willful misconduct by the
Participant or willful failure by the Participant to perform his or her responsibilities to the Company (including, without limitation, breach by the Participant of any provision of any employment, consulting, advisory, nondisclosure, non-competition or other similar agreement between the Participant and the Company), as determined by the Company, which determination shall be conclusive. The Participant’s employment shall be considered
to have been terminated for Cause if the Company determines, within 30 days after the Participant’s resignation, that termination for Cause was warranted. 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 4. Company Right of Repurchase. 

(a) Scope of Repurchase Right. Until they vest in accordance with Section 2, the Shares acquired under this Agreement shall be
“Restricted Shares” and shall be subject to the Company’s right to repurchase Restricted Shares set forth in this Section 4 (the “Right of Repurchase”). The Company, however, may decline to exercise its Right of
Repurchase or may exercise its Right of Repurchase only with respect to a portion of the Restricted Shares. The Company may exercise its Right of Repurchase only during the period of 90 consecutive days commencing on the date when the
Participant ceases to be an Eligible Participant for any reason, including (without limitation) death or disability (the “Repurchase Period”), but the Right of Repurchase may be exercised automatically under Subsection
(c) below. If the Right of Repurchase is exercised, the Company shall pay the Participant an amount equal to the lower of (i) the Exercise Price of each Restricted Share being repurchased or (ii) the Fair Market Value of such
Restricted Share at the time the Right of Repurchase is exercised. 
 (b) Escrow. Upon issuance, the certificate(s) for Restricted Shares shall
be deposited in escrow with the Company to be held in accordance with the provisions of this Agreement. Any additional or exchanged securities or other property described in Subsection (e) below shall immediately be delivered to the
Company to be held in escrow. Restricted Shares, together with any other assets held in escrow under this Agreement, shall be (i) surrendered to the Company for repurchase upon exercise of the Right of Repurchase or the Right of First
Refusal or (ii) released to the Participant upon his or her request to the extent that the Shares have ceased to be Restricted Shares (but not more frequently than once every six months). In any event, all shares that have ceased to be
Restricted Shares, together with any other vested assets held in escrow under this Agreement, shall be released within 90 days after the earlier of (i) the Participant ceasing to be an Eligible Participant or (ii) the lapse of the Right of
First Refusal. 
 (c) Exercise of Repurchase Right. The Company shall be deemed to have exercised its Right of Repurchase automatically for all
Restricted Shares as of the commencement of the Repurchase Period, unless the Company during the Repurchase Period notifies the holder of the Restricted Shares at the holder’s most recent address on file with the Company that the Company will
not exercise its Right of Repurchase for some or all of the Restricted Shares. The Company shall pay to the holder of the Restricted Shares the purchase price determined under Subsection (a) above for the Restricted Shares being
repurchased. Payment shall be made in cash or cash equivalents and/or by canceling indebtedness to the Company incurred by the Participant in the purchase of the Restricted Shares. The certificate(s) representing the Restricted Shares
being repurchased shall be delivered to the Company. 
 (d) Termination of Rights as Stockholder. If the Right of Repurchase is exercised in
accordance with this Section 4 and the Company makes available the consideration for the Restricted Shares being repurchased, then the person from whom the Restricted Shares are repurchased shall no longer have any rights as a holder of the
Restricted Shares (other than the right to receive payment of such consideration). Such Restricted Shares shall be deemed to have been repurchased pursuant to this Section 4, whether or not the certificate(s) for such Restricted Shares
have been delivered to the Company or the consideration for such Restricted Shares has been accepted. 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (e) Additional or Exchanged Securities and Property. In the event of a merger or consolidation of
the Company, a sale of all or substantially all of the Company’s stock or assets, any other corporate reorganization, a stock split, the declaration of a stock dividend, the declaration of an extraordinary dividend payable in a form other than
stock, a spin-off, an adjustment in conversion ratio, a recapitalization or a similar transaction affecting the Company’s outstanding securities, any securities or other property (including cash or cash
equivalents) that are by reason of such transaction exchanged for, or distributed with respect to, any Restricted Shares shall immediately be subject to the Right of Repurchase. Appropriate adjustments to reflect the exchange or distribution of
such securities or property shall be made to the number and/or class of the Restricted Shares. Appropriate adjustments shall also be made to the price per share to be paid upon the exercise of the Right of Repurchase, provided that the
aggregate purchase price payable for the Restricted Shares shall remain the same. In the event of a merger or consolidation of the Company with or into another entity or any other corporate reorganization, the Right of Repurchase may be
exercised by the Company’s successor. 
 (f) Transfer of Restricted Shares. The Participant shall not transfer, assign, encumber or
otherwise dispose of any Restricted Shares without the Company’s written consent, except as provided in the following sentence. The Participant may transfer Restricted Shares to one or more members of the Participant’s Immediate
Family or to a trust established by the Participant for the benefit of the Participant and/or one or more members of the Participant’s Immediate Family, provided in either case that the transferee agrees in writing on a form prescribed by the
Company to be bound by all provisions of this Agreement. If the Participant transfers any Restricted Shares, then this Agreement shall apply to the transferee to the same extent as to the Participant. For purposes of this Agreement,
“Immediate Family” shall mean any child, stepchild, grandchild or other lineal descendant, any parent, stepparent, grandparent or other ancestor, any spouse, former spouse, sibling, niece, nephew, uncle, aunt, mother-in-law, father-in-law,
son-in-law, daughter-in-law, brother-in-law or sister-in-law, including adoptive relationships, or any Spousal Equivalent (as defined in the Company’s
Amended and Restated Bylaws, as may be amended and/or restated from time to time). 
 (g) Assignment of Repurchase Right. The Company’s
Board of Directors (the “Board”) may freely assign the Company’s Right of Repurchase, in whole or in part. Any person who accepts an assignment of the Right of Repurchase from the Company shall assume all of the Company’s
rights and obligations under this Section 4. 
 5. Company Right of First Refusal. 

(a) Notice of Proposed Transfer. If the Participant proposes to sell, assign, transfer, pledge, hypothecate or otherwise dispose of, by operation
of law or otherwise (collectively, “transfer”) any Shares acquired upon exercise of this option, then the Participant shall first give written notice of the proposed transfer (the “Transfer Notice”) to the Company. The
Transfer Notice shall name the proposed transferee and state the number of such Shares the Participant proposes to transfer (the “Offered Shares”), the price per share and all other material terms and conditions of the transfer. 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (b) Company Right to Purchase. For 30 days following its receipt of such Transfer Notice, the
Company shall have the option to purchase all or part of the Offered Shares at the price and upon the terms set forth in the Transfer Notice. In the event the Company elects to purchase all or part of the Offered Shares, it shall give written
notice of such election to the Participant within such 30-day period. Within 10 days after his or her receipt of such notice, the Participant shall tender to the Company at its principal offices the
certificate or certificates representing the Offered Shares to be purchased by the Company, duly endorsed in blank by the Participant or with duly endorsed stock powers attached thereto, all in a form suitable for transfer of the Offered Shares to
the Company. Promptly following receipt of such certificate or certificates, the Company shall deliver or mail to the Participant a check in payment of the purchase price for such Offered Shares; provided that if
the terms of payment set forth in the Transfer Notice were other than cash against delivery, the Company may pay for the Offered Shares on the same terms and conditions as were set forth in the Transfer Notice;
and provided further that any delay in making such payment shall not invalidate the Company’s exercise of its option to purchase the Offered Shares. 

(c) Shares Not Purchased By Company. If the Company does not elect to acquire all of the Offered Shares, the Participant may, within the 30-day period following the expiration of the option granted to the Company under subsection (b) above, transfer the Offered Shares which the Company has not elected to acquire to the proposed
transferee, provided that such transfer shall not be on terms and conditions more favorable to the transferee than those contained in the Transfer Notice. Notwithstanding any of the above, all Offered Shares
transferred pursuant to this Section 5 shall remain subject to the right of first refusal set forth in this Section 5 and such transferee shall, as a condition to such transfer, deliver to the Company a written instrument confirming that
such transferee shall be bound by all of the terms and conditions of this Section 5. 
 (d) Consequences of
Non-Delivery. After the time at which the Offered Shares are required to be delivered to the Company for transfer to the Company pursuant to subsection (b) above, the Company shall not pay any
dividend to the Participant on account of such Offered Shares or permit the Participant to exercise any of the privileges or rights of a stockholder with respect to such Offered Shares, but shall, insofar as permitted by law, treat the Company as
the owner of such Offered Shares. 
 (e) Exempt Transactions. The following transactions shall be exempt from the provisions of this
Section 5: 
 (1) any transfer of Shares to or for the benefit of any spouse, child or grandchild of the Participant, or to a trust for their benefit;

 (2) any transfer pursuant to an effective registration statement filed by the Company under the Securities Act; 

(3) the sale of all or substantially all of the outstanding shares of capital stock of the Company (including pursuant to a merger or consolidation); and 

(4) any transfer in exchange for Nonvoting Shares (as defined below) in accordance with Section 10; 

provided, however, that in the case of a transfer pursuant to clause (1) above, such Shares shall remain subject to the right of first
refusal set forth in this Section 5 and in the case of an exchange pursuant to clause (4) above, any Nonvoting Shares issued in exchange for the Shares shall be deemed to be “Shares” pursuant to this Agreement and shall be
subject to all the terms and conditions of this Agreement, including without limitation the right of first refusal in this Section 5. 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (f) Assignment of Company Right. The Company may assign its rights to purchase Offered Shares
under this Section 5, in general or with respect to any particular transaction, to one or more persons or entities. 
 (g) Termination. The
provisions of this Section 5 shall terminate upon the earlier of the following events: 
 (1) the closing of the sale of shares of Common Stock in an
underwritten public offering pursuant to an effective registration statement filed by the Company under the Securities Act; or 
 (2) the sale of all or
substantially all of the outstanding shares of capital stock, assets or business of the Company, by merger, consolidation, sale of assets or otherwise (other than a merger or consolidation in which all or substantially all of the individuals and
entities who were beneficial owners of the Company’s voting securities immediately prior to such transaction beneficially own, directly or indirectly, more than 75% (determined on an as-converted basis)
of the outstanding securities entitled to vote generally in the election of directors of the resulting, surviving or acquiring corporation in such transaction). 

(h) No Obligation to Recognize Invalid Transfer. The Company shall not be required (1) to transfer on its books any of the Shares which shall
have been sold or transferred in violation of any of the provisions set forth in this Section 5, or (2) to treat as owner of such Shares or to pay dividends to any transferee to whom any such Shares shall have been so sold or transferred.

 (i) Legends. The certificate representing Shares shall bear legends substantially in the following form (in addition to, or in combination
with, any legend required by applicable federal and state securities laws and agreements relating to the transfer of the Company securities): 
 “THE
SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO A RIGHT OF FIRST REFUSAL IN FAVOR OF THE COMPANY, AS PROVIDED IN A CERTAIN STOCK OPTION AGREEMENT WITH THE COMPANY. 

THE SHARES REPRESENTED BY THIS CERTIFICATE MAY NOT BE SOLD, ASSIGNED, TRANSFERRED, PLEDGED, ENCUMBERED OR IN ANY MANNER DISPOSED OF, EXCEPT IN COMPLIANCE WITH
THE BYLAWS OF THE CORPORATION. COPIES OF THE BYLAWS OF THE CORPORATION MAY BE OBTAINED UPON WRITTEN REQUEST TO THE SECRETARY OF THE CORPORATION.” 

In the case of any uncertificated Shares, notice of such legend(s) shall be sent in accordance with applicable law. 

(j) Additional or Exchanged Securities and Property. In the event of a merger or consolidation of the Company, a sale of all or substantially all
of the Company’s stock or assets, any other corporate reorganization, a stock split, the declaration of a stock dividend, the declaration of an extraordinary dividend payable in a form other than stock, a
spin-off, an adjustment in conversion ratio, a recapitalization or a similar transaction affecting the Company’s outstanding 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 
securities, any securities or other property (including cash or cash equivalents) that are by reason of such transaction exchanged for, or distributed with respect to, any Shares subject to this
Section 5 shall immediately be subject to the Right of First Refusal. Appropriate adjustments to reflect the exchange or distribution of such securities or property shall be made to the number and/or class of the Shares subject to this
Section 5. 
 6. Agreement in Connection with Initial Public Offering. 

The Participant agrees, in connection with the initial underwritten public offering of the Common Stock pursuant to a registration statement under the
Securities Act, (i) not to (a) offer, pledge, announce the intention to sell, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, or
otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock or any other securities of the Company or (b) enter into any swap or other agreement that transfers, in whole or in part, any of the economic consequences of
ownership of shares of Common Stock or other securities of the Company, whether any transaction described in clause (a) or (b) is to be settled by delivery of securities, in cash or otherwise, during the period beginning on the date of the
filing of such registration statement with the Securities and Exchange Commission and ending 180 days after the date of the final prospectus relating to the offering (plus up to an additional 34 days to the extent requested by the managing
underwriters for such offering in order to address FINRA Rule 2711(f)(4) or NYSE Rule 472(f)(4) or any similar successor provision), and (ii) to execute any agreement reflecting clause (i) above as may be requested by the Company or the
managing underwriters at the time of such offering. The Company may impose stop-transfer instructions with respect to the shares of Common Stock or other securities subject to the foregoing restriction until the end of the “lock-up” period. 
 7. Tax Matters. 

(a) Withholding. No Shares will be issued pursuant to the exercise of this option unless and until the Participant pays to the Company, or makes
provision satisfactory to the Company for payment of, any federal, state or local withholding taxes required by law to be withheld in respect of this option. 

(b) Disqualifying Disposition. If the Participant disposes of Shares acquired upon exercise of this option within two years from the Grant Date or
one year after such Shares were acquired pursuant to exercise of this option, the Participant shall notify the Company in writing of such disposition. 
 8.
Transfer Restrictions. 
 (a) This option may not be sold, assigned, transferred, pledged or otherwise encumbered by the Participant, either
voluntarily or by operation of law, except by will or the laws of descent and distribution, and, during the lifetime of the Participant, this option shall be exercisable only by the Participant. 

(b) The Participant agrees that he or she will not transfer any Shares issued pursuant to the exercise of this option unless the transferee, as a condition to
such transfer, delivers to the Company a written instrument confirming that such transferee shall be bound by all of the terms and conditions of Section 4, Section 5 and Section 6; provided that such a written confirmation shall not
be required with respect to (1) Section 5 after such provision has terminated in accordance with Section 5(g) or (2) Section 6 after the completion of the lock-up period in connection
with the Company’s initial underwritten public offering.

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (c) Notwithstanding Section 8(b), if any Shares issued pursuant to the exercise of this option are
converted into Nonvoting Shares (as defined below) in accordance with Section 10, such Nonvoting Shares shall be subject to all of the terms and conditions of this Agreement, including without limitation Section 4, Section 5 and
Section 6 (each, to the extent then applicable). 
 (d) The Shares acquired under this Agreement shall be subject to the transfer restrictions in
Article X of the Company’s Amended and Restated Bylaws in addition to, and not in limitation of, the provisions of Section 5 of this Agreement. 

9. Provisions of the Plan. 
 This option is subject to the
provisions of the Plan (including the provisions relating to amendments to the Plan), a copy of which is furnished to the Participant with this option. 

10. Conversion of Shares to Nonvoting Shares. 
 At such
time as deemed necessary or advisable by the Company (including any officer of the Company and any employee on the Company’s equity administration team or such other team that performs similar functions) to comply with Part 175.22 of the New
York Real Estate Licensing Law, any similar or successor rule or statue of New York or any similar law, rule or statute of any other jurisdiction (the “Regulation”), or at such time the Participant notifies the Company that such
Participant is subject to the Regulation, any Shares issued pursuant to the exercise of this option shall automatically be converted, with no further action by the Participant, into an equal number of shares of nonvoting Class B Common Stock,
$0.0001 par value per share, of the Company (“Nonvoting Shares”). To effectuate such conversion to Nonvoting Shares, the Participant hereby constitutes and appoints each officer and director of the Company as his, her or its agent and
attorney-in-fact for purposes of executing or approving such documents, and taking such actions, as may be deemed necessary or advisable by such agent and attorney-in-fact with respect to the conversion of such Shares. This power of attorney, being coupled with an interest, is irrevocable and shall survive the death,
disability or incapacitation of the Participant. 
 11. Miscellaneous.

(a) Entire Agreement. This Agreement and the Plan constitute the entire contract between the Participant and the Company with regard to the subject
matter hereof. They supersede any other agreements, representations or understandings (whether oral or written and whether express or implied) that relate to the subject matter hereof. 

(b) Modifications and Waivers. No provision of this Agreement shall be modified, waiver or discharged unless the modification, waiver or discharge
is agreed to in writing and signed by the Participant and an authorized officer of the Company (other than the Participant). No waiver by either party of any breach of, or of compliance with, any condition or provision of this Agreement by the
other party shall be considered a waiver of any other condition or provision or of the same condition or provision at another time. 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

  
 IN
WITNESS WHEREOF, the Company has caused this option to be executed under its corporate seal by its duly authorized officer. This option shall take effect as a sealed instrument. 

 

			
	URBAN COMPASS, INC.
		
	By:	 	###SIGNATURE###
	
	Name: Robert Reffkin
	
	Title: CEO

 PARTICIPANT’S ACCEPTANCE 

The undersigned hereby accepts the foregoing option and agrees to the terms and conditions thereof. The undersigned hereby acknowledges receipt of a copy
of the Company’s Third Amended & Restated 2012 Stock Incentive Plan. 
  

			
	PARTICIPANT:
	
	Name: ###PARTICIPANT_NAME###
		
	Address:	  	        ###HOME_ADDRESS###
		
		  	        ###ACCEPTANCE_DATE###

 Reminder: Please review the provided attachments below. 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 Hello, 
 Please
find a stock option agreement as approved by the Board of Urban Compass, Inc. d/b/a Compass (“Compass”) on ###GRANT_DATE###. By signing this stock option agreement, you are not agreeing to purchase any common shares of Compass. Rather, you
are agreeing that you have the right to purchase common shares of Compass at a price of ###GRANT_PRICE### per common share, subject to all of the terms of the agreement. The total number of common shares under your option is stated in the first
paragraph of the attached stock option agreement.*** Also attached are: (1) an FAQ about Compass equity, (2) an informational memorandum about our Stock Incentive Plan including a brief summary of the tax consequences in connection with
exercising your stock option, and the information described in Rules 701(e)(2), (3), (4) and (5) under the Securities Act of 1933, as amended (the “Securities Act”) and (3) the current Stock Incentive Plan. If you have any
questions after reading the attachments, please feel free to send them to equity@compass.com. 
 Best, 

The Compass Equity Team 
 URBAN COMPASS, INC.

 Stock Option Agreement (Installment Exercise) 

Granted Under the Third Amended & Restated 2012 Stock Incentive Plan 

1. Grant of Option. 
 This agreement evidences the grant
by Urban Compass, Inc., a Delaware corporation (the “Company”), on ###GRANT_DATE### (the “Grant Date”) to ###PARTICIPANT_NAME###, an employee of the Company (the “Participant”), of an option to purchase, in whole or in
part, on the terms provided herein and in the Company’s Third Amended & Restated 2012 Stock Incentive Plan (as amended, the “Plan”), a total of ###[CF_IE_GRANT_Total Options Granted]### shares (the “Shares”) of
Class A Common Stock, $0.0001 par value per share, of the Company (“Common Stock”) at ###GRANT_PRICE### per Share (the “Exercise Price”). Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time,
on ###EXPIRY_DATE### (the “Final Exercise Date”). 
 It is intended that the option evidenced by this agreement shall be an incentive stock option
as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”), to the extent permissible under the Code. To the extent this option does not satisfy the
requirements to be an incentive stock option under Section 422 of the Code, this option shall be deemed a nonstatutory stock option. Even though this option is designated as an incentive stock option, it shall be deemed to be a
nonstatutory stock option to the extent required by the $100,000 annual limitation under Section 422(d) of the Code. In addition, this option will cease to qualify for favorable tax treatment as an incentive stock option to the extent that
it is exercised: 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (a) More than three months after the date when the Participant ceases to be an employee of the Company or any
parent or subsidiary of the Company for any reason other than death or permanent and total disability (as defined in Section 22(e)(3) of the Code); 

(b) More than 12 months after the date when the Participant ceases to be an employee of the Company or any parent or subsidiary of the Company by reason of
permanent and total disability (as defined in Section 22(e)(3) of the Code); or 
 (c) More than three months after the date when the Participant has
been on a leave of absence for 90 days, unless the Participant’s reemployment rights following such leave were guaranteed by statute or by contract. 

Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the
right to exercise this option validly under its terms. 
 2. Vesting Schedule. 

This option will become exercisable (i.e., “vest”) as to [25% of the original number of Shares on the first anniversary of the Vesting Commencement
Date (as defined below) and as to an additional 1/48th of the original number of Shares at the end of each successive month following the first anniversary of the Vesting Commencement Date
until the fourth anniversary of the Vesting Commencement Date]. On the [fourth anniversary of the Vesting Commencement Date], this option will be vested and exercisable for all of the Shares. For purposes of this Agreement, “Vesting
Commencement Date” shall mean ###ALTERNATIVE_VEST_BASE_DATE###. 
 The right of exercise shall be cumulative so that to the extent the option is not
exercised in any period to the maximum extent permissible, it shall continue to be exercisable, in whole or in part, with respect to all Shares for which it is vested until the earlier of the Final Exercise Date or the termination of this option
under Section 3 hereof or the Plan. 
 3. Exercise of Option. 

(a) Form of Exercise. Each election to exercise this option shall be accompanied by (i) a completed Notice of Stock Option Exercise in the
form attached hereto as Exhibit A, signed by the Participant, and received by the Company at its principal office, (ii) if requested by the Company, a counterpart signature page to that certain Seventh Amended and Restated Voting
Agreement, dated as of July 26, 2019, as the same may be amended from time to time, signed by the Participant, and received by the Company at its principal office, (iii) if requested by the Company, a counterpart signature page to that
certain Second Amended and Restated First Refusal and Co-Sale Agreement, dated as of July 26, 2019, as the same may be amended from time to time, signed by the Participant, and received by the Company at
its principal office, (iv) this agreement, and (v) payment in full in the manner provided in the Plan. The Participant may purchase less than the number of Shares covered hereby, provided that no partial exercise of this option may be for
any fractional share or for fewer than ten whole shares. 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (b) Continuous Relationship with the Company Required. Except as otherwise provided in this
Section 3, this option may not be exercised unless the Participant, at the time he or she exercises this option, is, and has been at all times since the Grant Date, an employee or officer of, or consultant or advisor to, the Company or any
parent or subsidiary of the Company as defined in Section 424(e) or (f) of the Code (an “Eligible Participant”). 
 (c) Termination of
Relationship with the Company. If the Participant ceases to be an Eligible Participant for any reason, then, except as provided in paragraphs (d) and (e) below, the right to exercise this option shall terminate three months after
such cessation (but in no event after the Final Exercise Date), provided that this option shall be exercisable only to the extent that the Participant was entitled to exercise this option on the date of such
cessation. Notwithstanding the foregoing, if the Participant, prior to the Final Exercise Date, violates the non-competition,“non-solicitation,” or
confidentiality provisions of any employment contract, confidentiality and nondisclosure agreement or other agreement between the Participant and the Company, the right to exercise this option shall terminate immediately upon such violation. 

(d) Exercise Period Upon Death or Disability. If the Participant dies or becomes disabled (within the meaning of Section 22(e)(3) of the Code)
prior to the Final Exercise Date while he or she is an Eligible Participant and the Company has not terminated such relationship for “cause” as specified in paragraph (e) below, this option shall be exercisable, within the period of
one year following the date of death or disability of the Participant, by the Participant (or in the case of death by an authorized transferee), provided that this option shall be exercisable only to the extent that this
option was exercisable by the Participant on the date of his or her death or disability, and further provided that this option shall not be exercisable after the Final Exercise Date. 

(e) Termination for Cause. If, prior to the Final Exercise Date, the Participant’s employment is terminated by the Company for Cause (as
defined below), the right to exercise this option shall terminate immediately upon the effective date of such termination of employment. If, prior to the Final Exercise Date, the Participant is given notice by the Company of the termination of
his or her employment by the Company for Cause, and the effective date of such employment termination is subsequent to the date of delivery of such notice, the right to exercise this option shall be suspended from the time of the delivery of such
notice until the earlier of (i) such time as it is determined or otherwise agreed that the Participant’s employment shall not be terminated for Cause as provided in such notice or (ii) the effective date of such termination of
employment (in which case the right to exercise this option shall, pursuant to the preceding sentence, terminate upon the effective date of such termination of employment). If the Participant is party to an employment or severance agreement
with the Company that contains a definition of “cause” for termination of employment, “Cause” shall have the meaning ascribed to such term in such agreement. Otherwise, “Cause” shall mean willful misconduct by the
Participant or willful failure by the Participant to perform his or her responsibilities to the Company (including, without limitation, breach by the Participant of any provision of any employment, consulting, advisory, nondisclosure, non-competition or other similar agreement between the Participant and the Company), as determined by the Company, which determination shall be conclusive. The Participant’s employment shall be considered
to have been terminated for Cause if the Company determines, within 30 days after the Participant’s resignation, that termination for Cause was warranted. 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 4. Company Right of First Refusal. 

(a) Notice of Proposed Transfer. If the Participant proposes to sell, assign, transfer, pledge, hypothecate or otherwise dispose of, by operation
of law or otherwise (collectively, “transfer”) any Shares acquired upon exercise of this option, then the Participant shall first give written notice of the proposed transfer (the “Transfer Notice”) to the Company. The
Transfer Notice shall name the proposed transferee and state the number of such Shares the Participant proposes to transfer (the “Offered Shares”), the price per share and all other material terms and conditions of the transfer. 

(b) Company Right to Purchase. For 30 days following its receipt of such Transfer Notice, the Company shall have the option to purchase all or part
of the Offered Shares at the price and upon the terms set forth in the Transfer Notice. In the event the Company elects to purchase all or part of the Offered Shares, it shall give written notice of such election to the Participant within such 30-day period. Within 10 days after his or her receipt of such notice, the Participant shall tender to the Company at its principal offices the certificate or certificates representing the Offered Shares to be
purchased by the Company, duly endorsed in blank by the Participant or with duly endorsed stock powers attached thereto, all in a form suitable for transfer of the Offered Shares to the Company. Promptly following receipt of such certificate or
certificates, the Company shall deliver or mail to the Participant a check in payment of the purchase price for such Offered Shares; provided that if the terms of payment set forth in the Transfer Notice were other than
cash against delivery, the Company may pay for the Offered Shares on the same terms and conditions as were set forth in the Transfer Notice; and provided further that any delay in making such payment shall not invalidate
the Company’s exercise of its option to purchase the Offered Shares. 
 (c) Shares Not Purchased By Company. If the Company does not elect
to acquire all of the Offered Shares, the Participant may, within the 30-day period following the expiration of the option granted to the Company under subsection (b) above, transfer the Offered Shares
which the Company has not elected to acquire to the proposed transferee, provided that such transfer shall not be on terms and conditions more favorable to the transferee than those contained in the Transfer
Notice. Notwithstanding any of the above, all Offered Shares transferred pursuant to this Section 4 shall remain subject to the right of first refusal set forth in this Section 4 and such transferee shall, as a condition to such
transfer, deliver to the Company a written instrument confirming that such transferee shall be bound by all of the terms and conditions of this Section 4. 

(d) Consequences of Non-Delivery. After the time at which the Offered Shares are required to be delivered
to the Company for transfer to the Company pursuant to subsection (b) above, the Company shall not pay any dividend to the Participant on account of such Offered Shares or permit the Participant to exercise any of the privileges or rights of a
stockholder with respect to such Offered Shares, but shall, insofar as permitted by law, treat the Company as the owner of such Offered Shares. 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (e) Exempt Transactions. The following transactions shall be exempt from the provisions of this
Section 4: 
 (1) any transfer of Shares to or for the benefit of any spouse, child or grandchild of the Participant, or to a trust for their benefit;

 (2) any transfer pursuant to an effective registration statement filed by the Company under the Securities Act; 

(3) the sale of all or substantially all of the outstanding shares of capital stock of the Company (including pursuant to a merger or consolidation); and 

(4) any transfer in exchange for Nonvoting Shares (as defined below) in accordance with Section 9; 

provided, however, that in the case of a transfer pursuant to clause (1) above, such Shares shall remain subject to the right of first
refusal set forth in this Section 4 and in the case of an exchange pursuant to clause (4) above, any Nonvoting Shares issued in exchange for the Shares shall be deemed to be “Shares” pursuant to this Agreement and shall be
subject to all the terms and conditions of this Agreement, including without limitation the right of first refusal in this Section 4. 
 (f)
Assignment of Company Right. The Company may assign its rights to purchase Offered Shares under this Section 4, in general or with respect to any particular transaction, to one or more persons or entities. 

(g) Termination. The provisions of this Section 4 shall terminate upon the earlier of the following events: 

(1) the closing of the sale of shares of Common Stock in an underwritten public offering pursuant to an effective registration statement filed by the Company
under the Securities Act; or 
 (2) the sale of all or substantially all of the outstanding shares of capital stock, assets or business of the Company, by
merger, consolidation, sale of assets or otherwise (other than a merger or consolidation in which all or substantially all of the individuals and entities who were beneficial owners of the Company’s voting securities immediately prior to such
transaction beneficially own, directly or indirectly, more than 75% (determined on an as-converted basis) of the outstanding securities entitled to vote generally in the election of directors of the resulting,
surviving or acquiring corporation in such transaction). 
 (h) No Obligation to Recognize Invalid Transfer. The Company shall not be required
(1) to transfer on its books any of the Shares which shall have been sold or transferred in violation of any of the provisions set forth in this Section 4, or (2) to treat as owner of such Shares or to pay dividends to any transferee
to whom any such Shares shall have been so sold or transferred. 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 (i) Legends. The certificate representing Shares shall bear legends substantially in the
following form (in addition to, or in combination with, any legend required by applicable federal and state securities laws and agreements relating to the transfer of the Company securities): 

“THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO A RIGHT OF FIRST REFUSAL IN FAVOR OF THE COMPANY, AS PROVIDED IN A CERTAIN STOCK OPTION
AGREEMENT WITH THE COMPANY. 
 THE SHARES REPRESENTED BY THIS CERTIFICATE MAY NOT BE SOLD, ASSIGNED, TRANSFERRED, PLEDGED, ENCUMBERED OR IN ANY MANNER
DISPOSED OF, EXCEPT IN COMPLIANCE WITH THE BYLAWS OF THE CORPORATION. COPIES OF THE BYLAWS OF THE CORPORATION MAY BE OBTAINED UPON WRITTEN REQUEST TO THE SECRETARY OF THE CORPORATION.” 

In the case of any uncertificated Shares, notice of such legend(s) shall be sent in accordance with applicable law. 

(j) Additional or Exchanged Securities and Property. In the event of a merger or consolidation of the Company, a sale of all or substantially all
of the Company’s stock or assets, any other corporate reorganization, a stock split, the declaration of a stock dividend, the declaration of an extraordinary dividend payable in a form other than stock, a
spin-off, an adjustment in conversion ratio, a recapitalization or a similar transaction affecting the Company’s outstanding securities, any securities or other property (including cash or cash
equivalents) that are by reason of such transaction exchanged for, or distributed with respect to, any Shares subject to this Section 4 shall immediately be subject to the Right of First Refusal. Appropriate adjustments to reflect the
exchange or distribution of such securities or property shall be made to the number and/or class of the Shares subject to this Section 4. 
 5.
Agreement in Connection with Initial Public Offering. 
 The Participant agrees, in connection with the initial underwritten public offering of the
Common Stock pursuant to a registration statement under the Securities Act, (i) not to (a) offer, pledge, announce the intention to sell, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to
sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock or any other securities of the Company or (b) enter into any swap or other agreement that transfers,
in whole or in part, any of the economic consequences of ownership of shares of Common Stock or other securities of the Company, whether any transaction described in clause (a) or (b) is to be settled by delivery of securities, in cash or
otherwise, during the period beginning on the date of the filing of such registration statement with the Securities and Exchange Commission and ending 180 days after the date of the final prospectus relating to the offering (plus up to an additional
34 days to the extent requested by the managing underwriters for such offering in order to address FINRA Rule 2711(f)(4) or NYSE Rule 472(f)(4) or any similar successor provision), and (ii) to execute any agreement reflecting clause
(i) above as may be requested by the Company or the managing underwriters at the time of such offering. The Company may impose stop-transfer instructions with respect to the shares of Common Stock or other securities subject to the
foregoing restriction until the end of the “lock-up” period. 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 6. Tax Matters. 

(a) Withholding. No Shares will be issued pursuant to the exercise of this option unless and until the Participant pays to the Company, or makes
provision satisfactory to the Company for payment of, any federal, state or local withholding taxes required by law to be withheld in respect of this option. 

(b) Disqualifying Disposition. If the Participant disposes of Shares acquired upon exercise of this option within two years from the Grant Date or
one year after such Shares were acquired pursuant to exercise of this option, the Participant shall notify the Company in writing of such disposition. 
 7.
Transfer Restrictions. 
 (a) This option may not be sold, assigned, transferred, pledged or otherwise encumbered by the Participant, either
voluntarily or by operation of law, except by will or the laws of descent and distribution, and, during the lifetime of the Participant, this option shall be exercisable only by the Participant. 

(b) The Participant agrees that he or she will not transfer any Shares issued pursuant to the exercise of this option unless the transferee, as a condition to
such transfer, delivers to the Company a written instrument confirming that such transferee shall be bound by all of the terms and conditions of Section 4 and Section 5; provided that such a written confirmation shall not be required with
respect to (1) Section 4 after such provision has terminated in accordance with Section 4(g) or (2) Section 5 after the completion of the lock-up period in connection with the
Company’s initial underwritten public offering.
 (c) Notwithstanding Section 7(b), if any Shares issued pursuant to the exercise of this option
are converted into Nonvoting Shares (as defined below) in accordance with Section 9, such Nonvoting Shares shall be subject to all of the terms and conditions of this Agreement, including without limitation Section 4 and Section 5
(each, to the extent then applicable). 
 (d) The Shares acquired under this Agreement shall be subject to the transfer restrictions in Article X of the
Company’s Amended and Restated Bylaws in addition to, and not in limitation of, the provisions of Section 4 of this Agreement. 
 8. Provisions
of the Plan. 
 This option is subject to the provisions of the Plan (including the provisions relating to amendments to the Plan), a copy of which is
furnished to the Participant with this option. 
 9. Conversion of Shares to Nonvoting Shares. 

At such time as deemed necessary or advisable by the Company (including any officer of the Company and any employee on the Company’s equity administration
team or such other team that performs similar functions) to comply with Part 175.22 of the New York Real Estate Licensing Law, any similar or successor rule or statue of New York or any similar law, rule or statute of any other jurisdiction (the
“Regulation”), or at such time the Participant notifies the 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 
Company that such Participant is subject to the Regulation, any Shares issued pursuant to the exercise of this option shall automatically be converted, with no further action by the Participant,
into an equal number of shares of nonvoting Class B Common Stock, $0.0001 par value per share, of the Company (“Nonvoting Shares”). To effectuate such conversion to Nonvoting Shares, the Participant hereby constitutes and
appoints each officer and director of the Company as his, her or its agent and attorney-in-fact for purposes of executing or approving such documents, and taking such
actions, as may be deemed necessary or advisable by such agent and attorney-in-fact with respect to the conversion of such Shares. This power of attorney, being
coupled with an interest, is irrevocable and shall survive the death, disability or incapacitation of the Participant. 
 10. Miscellaneous.

(a) Entire Agreement. This Agreement and the Plan constitute the entire contract between the Participant and the Company with regard to the subject
matter hereof. They supersede any other agreements, representations or understandings (whether oral or written and whether express or implied) that relate to the subject matter hereof. 

(b) Modifications and Waivers. No provision of this Agreement shall be modified, waiver or discharged unless the modification, waiver or discharge
is agreed to in writing and signed by the Participant and an authorized officer of the Company (other than the Participant). No waiver by either party of any breach of, or of compliance with, any condition or provision of this Agreement by the
other party shall be considered a waiver of any other condition or provision or of the same condition or provision at another time. 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

  
 IN
WITNESS WHEREOF, the Company has caused this option to be executed under its corporate seal by its duly authorized officer. This option shall take effect as a sealed instrument. 

URBAN COMPASS, INC. 
 By: ###SIGNATURE### 

Name: Robert Reffkin 
 Title: CEO 

PARTICIPANT’S ACCEPTANCE 
 The undersigned hereby accepts
the foregoing option and agrees to the terms and conditions thereof. The undersigned hereby acknowledges receipt of a copy of the Company’s Third Amended & Restated 2012 Stock Incentive Plan. 

 

			
	PARTICIPANT:
	
	Name: ###PARTICIPANT_NAME###
		
	Address:	 	###HOME_ADDRESS###
		
		 	###ACCEPTANCE_DATE###

 Reminder: Please review the provided attachments below. 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 NOTICE OF STOCK OPTION EXERCISE 

TO: 
 Solium Capital Inc. and its subsidiaries (together,
“Solium”) 
 1500—600 3rd Avenue SW, Calgary, AB, T2P 0G5 

I, _____________, hereby exercise the following Stock Option, (the “Option”) granted to me under the Urban Compass, Inc. (the
“Company”) Third Amended and Restated 2012 Stock Incentive Plan, as amended (the “Plan”), as outlined in the table below. Any capitalized terms used but not defined herein shall have the respective meanings given to
them in the applicable stock option agreement. 
  

											
	 Grant Name
	  	Award Type	  	Grant Price	  	Grant Date	  	Vested Quantity	  	Unvested Quantity

 I understand that it is my
responsibility to wire Urban Compass Inc. payment in the amount of $________________USD to the wire instructions below: 

Wire Instructions 
 Domestic: 

Beneficiary: Urban Compass Inc. 
 Name of Bank: First Republic
Bank 
 City and State: San Francisco, CA 
 ABA Number: 

Account Number: 
 International: 

Pay to: First Republic Bank 
 11 Pine Street 

San Francisco, CA 94111 
 Swift Code: 

I understand that the full payment for the option and all applicable taxes must be received by the Company prior to the expiration of the Option and such
payment must clearly designate my name and Shareworks account number in order for the exercise to be processed. 
 Upon receipt of the above payment
prior to the expiration of the Option and satisfaction of the conditions set forth in this Notice of Stock Option Exercise, I understand that Compass will process the exercise and confirm in Shareworks that my payment has been received. I understand
that my digital shares will be available via Shareworks once the exercise has been processed. 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

 Home Location: New York, United States (Please confirm) 

I understand that this exercise shall be deemed effective only after I have: 
  

	 	1.	 Submitted this Notice of Stock Option Exercise via Solium; 

 

	 	2.	 either (a) reviewed the Company’s disclosure materials under Rule 701 of the Securities Act (as
defined below) or (b) been provided access to such materials and elected not to review them; 

  

	 	3.	 if requested by the Company, submitted a completed and signed Adoption Agreement to the Seventh Amended and
Restated Voting Agreement, dated as of July 26, 2019, by and among the Company and certain other shareholders party thereto (as amended from time to time, the “Voting Agreement”); and 

 

	 	4.	 submitted to the Company via wire to the account stated above a payment for the full option exercise price plus
payment of any federal, state or local withholding taxes required by law to be withheld in respect of this option. 

 I understand that it
is my responsibility to ensure Solium properly received this Notice of Stock Option Exercise. I also acknowledge that (a) this Notice of Stock Option Exercise will remain in effect for a period of two (2) business days including the
exercise date, pending receipt of the option exercise price and applicable withholding taxes and, if (i) the option exercise price, (ii) any applicable withholding taxes and (iii) if requested by the Company, the Adoption Agreement to
the Voting Agreement, are not received by the Company within such two (2) business day period, the exercise hereunder will expire, and I will be required to submit a new Notice of Stock Option Exercise to Solium (for the avoidance of doubt, if
the Option expires on its own terms prior to the end of the two (2) business day period, the option exercise price, applicable withholding taxes and (if applicable) the Adoption Agreement to the Voting Agreement must be received by the Company
prior to the expiration of the Option in order for the exercise to be effective and such two (2) business day period shall not in any way extend the term of the Option) and, (b) the effective date of exercise of this option will be the
date that the Company has received all of the materials in clause (a) of this sentence (including this Notice of Stock Option Exercise). 
 I
represent, warrant and covenant as follows: 
  

	 	1.	 I am purchasing the Shares for my own account for investment only, and not with a view to, or for sale in
connection with, any distribution of the Shares in violation of the Securities Act of 1933, as amended (the “Securities Act”), or any rule or regulation under the Securities Act. 

 

	 	2.	 I have had such opportunity as I have deemed adequate to obtain from representatives of the Company such
information as is necessary to permit me to evaluate the merits and risks of my investment in the Company. 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

	 	3.	 I have sufficient experience in business, financial and investment matters to be able to evaluate the
risks involved in the purchase of the Shares and to make an informed investment decision with respect to such purchase. 

  

	 	4.	 I can afford a complete loss of the value of the Shares and am able to bear the economic risk of holding
such Shares for an indefinite period. 

  

	 	5.	 I understand that (i) the Shares have not been registered under the Securities Act and
are “restricted securities” within the meaning of Rule 144 under the Securities Act, (ii) the Shares cannot be sold, transferred or otherwise disposed of unless they are subsequently registered under the Securities Act or an
exemption from registration is then available; (iii) in any event, the exemption from registration under Rule 144 will not be available for at least one year and even then will not be available unless a public market then exists for the Common
Stock, adequate information concerning the Company is then available to the public, and other terms and conditions of Rule 144 are complied with; and (iv) there is now no registration statement on file with the Securities and Exchange
Commission with respect to any stock of the Company and the Company has no obligation or current intention to register the Shares under the Securities Act. 

  

	 	6.	 I will not sell, transfer or otherwise dispose of the Shares in violation of the Securities Act, the
Securities Exchange Act of 1934, or the rules promulgated thereunder, including Rule 144 under the Securities Act. 

  

	 	7.	 I acknowledge that I am acquiring the Shares subject to all other terms of the Plan and the applicable
stock option agreement, including the requirement to execute and be bound by the terms of the Voting Agreement if requested by the Company. 

  

	 	8.	 I acknowledge that (i) the Shares remain subject to the Company’s right of first refusal and a “lock-up” (in connection with an initial public offering of the Company’s common stock) and (ii) if the Option is early exercisable and I am electing to exercise the Option for unvested shares,
the Shares may remain subject to the Company’s right of repurchase, all in accordance with the applicable stock option agreement. 

  

	 	9.	 I acknowledge that the Shares remain subject to the transfer restrictions in Article X of
the Company’s Amended and Restated Bylaws. 

  

	 	10.	 I acknowledge that, if the Option is early exercisable and I am electing to exercise the Option for unvested
shares, I have received a copy of the Company’s explanation of the federal income tax consequences of an option exercise and the tax election under section 83(b) of the Internal Revenue Code. In the event that I choose to make a section
83(b) election, I acknowledge that it is my responsibility—and not the Company’s responsibility—to file the election in a timely manner, even if I ask the Company or its agents to make the filing on my behalf. I acknowledge that the
Company has encouraged me to consult my own adviser to determine the tax consequences of acquiring the Shares at this time. 

  

 Confidential Treatment Requested by Compass, Inc. 

Pursuant to 17 C.F.R. Section 200.83 
  

	 	11.	 I understand and agree that at such time as deemed necessary or advisable by the Company (including any officer
of the Company and any employee on the Company’s equity administration team or such other team that performs similar functions) to comply with Part 175.22 of the New York Real Estate Licensing Law, any similar or successor rule or statute of
New York or any similar law, rule or statute of any other jurisdiction (the “Regulation”), or at such time I notify the Company that I am subject to the Regulation, the Shares shall automatically be converted, with no further action by me,
into an equal number of shares of nonvoting Class B Common Stock of the Company (“Nonvoting Shares”). To effectuate such conversion to Nonvoting Shares, I hereby constitute and appoint each officer and director of the Company
as my agent and attorney-in-fact for purposes of executing or approving such documents, and taking such actions, as may be deemed necessary or advisable by such agent
and attorney-in-fact with respect to the conversion of the Shares. I understand and agree that this power of attorney, being coupled with an interest, is irrevocable and
shall survive my death, disability or incapacitation. 

 Solium does not provide investment advice with respect to the purchase or sale of
securities. You therefore will receive no investment advice from Solium concerning the purchase or sale of securities and are solely responsible for assessing the appropriateness of any transaction through your Solium account without the benefit of
the assistance of a broker or dealer. If you wish to receive any form of investment advice in connection with the purchase or sale of securities, it is your responsibility to contact your own broker or dealer for investment advice. 

Important Notice: 
 If the Option is early exercisable and
you are electing to exercise the Option for unvested shares, you will also need to complete and sign the 83(b) Election form and mail it to the IRS within 30 days of your exercise. A copy of this form can be found within the Documents tab of
your profile. A copy of the completed and signed form must also be submitted to the Company’s equity team at equity@compass.com.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00322-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00322-of-00352.parquet"}]]